<?xml version="1.0" encoding="UTF-8"?><ml:doc-envelope xmlns:ml="http://marklogic.com/poolparty/worldbank"><ml:original-txt>Document of&#13;
The World Bank&#13;
Report No: 15596-KH&#13;
STAFF APPRAISAL REPORT&#13;
KINGDOM OF CAMBODIA&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT PROJECT&#13;
November 15, 1996&#13;
Human Resources Operations Division&#13;
Country Department I&#13;
East Asia and Pacific Region&#13;
&#13;
&#13;
&amp;#12;&#13;
CURRENCY EQUIVALENTS&#13;
(Official Rate as of October, 1996)&#13;
Riel 2,600 = 1 US dollar&#13;
WEIGHTS AND MEASURES&#13;
Metric System&#13;
LIST OF ACRONYMS&#13;
ADB          Asian Development Bank&#13;
ARI          Annual Risk of Infection&#13;
AusAID       Australian Agency for International Development&#13;
CDC          Cambodia Development Council&#13;
CENAT        National Anti-Tuberculosis Center&#13;
CNM          National Malaria Center&#13;
EPI          Expanded Program of Immunization&#13;
EU           European Union&#13;
GPA          Global Program on AIDS&#13;
HIV          Human Immuno-deficiencyVirus&#13;
HMA          Health Management Agreements&#13;
ICRC         International Commission for the Red Cross&#13;
ITF          Interim Trust Fund&#13;
MOEF         Ministry of Economy and Finance&#13;
MOH          Ministry of Health&#13;
MOP          Ministry of Planning&#13;
NAO          National AIDS Office&#13;
NGO          Non Governmental Organization&#13;
NMP          National Malaria Program&#13;
NTP          National Tuberculosis Program&#13;
ODA          Overseas Development Assistance&#13;
PCU          Project Coordination Unit&#13;
PHA          Provincial Health Advisor&#13;
PROV. P.U. Provincial Project Unit&#13;
SFKC         Social Fund of the Kingdom of Cambodia&#13;
STD          Sexually Transmitted Disease&#13;
UNDP         United Nations Development Program&#13;
UNICEF       United Nations Children's Fund&#13;
WHO          World Health Organization&#13;
FISCAL YEAR&#13;
January I - December 31&#13;
&#13;
&#13;
&amp;#12;&#13;
KINGDOM OF CAMBODIA&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT PROJECT&#13;
CREDIT AND PROJECT SUMMARY&#13;
Borrower:                Kingdom of Cambodia&#13;
Implementing Agency:    Ministry of Health&#13;
Beneficiary:             Not applicable&#13;
Poverty:                 Program of Targeted Interventions&#13;
Amount:                  SDR 20.6 million (US$ 30.4 million equivalent)&#13;
Terms:                   Standard IDA, with 40 years of maturity and 10 years grace&#13;
Commitment Fee:          0.5% on undisbursed credit balances, beginning 60 days after&#13;
signing, less any waiver&#13;
Onlending Terms:         Not applicable&#13;
Financing Plan:          See para. 4.6&#13;
Net Present Value:       Not applicable&#13;
Map Number:             IBRD 27986&#13;
Project ID Number:       4034&#13;
Vice President: Nicholas Hope, Acting, EAP&#13;
Director:      Javad Khalilzadeh-Shirazi, EA 1&#13;
Division Chief:  Sven Burmester, EA 1 HR&#13;
Task Manager:  Christopher Chamberlin, Sr. Economist&#13;
&#13;
&#13;
&amp;#12;&#13;
&#13;
&#13;
&amp;#12;&#13;
KINGDOM OF CAMBODIA&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT PROJECT&#13;
Table of Contents&#13;
Pages&#13;
1. INTRODUCTION ..........................1&#13;
2. THE SECTOR ..........................2&#13;
A. BACKGROUND .........................2&#13;
B. SECTORAL ISSUES .........................6&#13;
C. GOVERNMENT STRATEGY ..........................7&#13;
D. PROJECT RATIONALE ..........................8&#13;
3.THE PROJECT.11&#13;
3.T E P    O  E   T ...........................................................................................................II&#13;
A. OBJECTIVES AND SCOPE ..................................................                     11&#13;
B. PROJECT DESCRIPTION ..................................................                      11&#13;
4. PROJECT COSTS, FINANCING, PROCUREMENT AND DISBURSEMENT . 20&#13;
A. COST ESTIMATES ................................................... 20&#13;
B. FINANCING ...................................................                               22&#13;
C. PROCUREMENT ...................................................                             23&#13;
D. DISBURSEMENT ...................................................                            26&#13;
5. PROJECT MANAGEMENT AND IMPLEMENTATION ..................................... 28&#13;
A. ORGANIZATION ................................................... 28&#13;
B. IMPLEMENTATION ARRANGEMENTS ................................. .................. 29&#13;
C. ACCOUNTS AND AUDITING ...................................................                   32&#13;
D. PROJECT MONITORING, EVALUATION AND REPORTING ........................... 33&#13;
E. ENVIRONMENTAL ASPECTS ................................................... 33&#13;
F. PARTICIPATION ...................................................                           34&#13;
This report is based on findings of an appraisal mission that visited Cambodia in February-March 1996. The&#13;
mission comprised Christopher Chamberlin (Task Manager), Stanley Scheyer (Sr. Public Health Specialist);&#13;
Rama Lakshminarayanan (Health Specialist), Mostafa El-Erian (Legal), Ji An Zhou (Human Resources&#13;
Specialist) and consultants Michael Porter (HIV/AIDS specialist), Jim Herm (Management Specialist) and&#13;
Cyril Bowman (Architect). Sarah Foster and consultants Chris Braden, Clydette Powell, Jenny Hill and&#13;
Michael Cheng contributed to the preparation of the project in earlier phases.  Peer reviewers were&#13;
Willy de Geyndt (ASTHR), Bernhard Liese (HSDDR) and Maureen Lewis (LA2HR). The report was cleared&#13;
by Sven Burmester (Chief, EA I HR) and J. Khalilzadeh-Shirazi (Director, EA I).&#13;
&#13;
&#13;
&amp;#12;&#13;
- 11 -&#13;
6. PROJECT BENEFITS, RISKS AND SUSTAINABILITY ..................................... 35&#13;
A. BENEFITS ..............................................................                                          35&#13;
B. RISKS ...............................................................                                            36&#13;
C. SUSTAINABILITY ..............................................................                                    37&#13;
7. AGREEMENTS REACHED AND RECOMMENDATION ................................... 38&#13;
TEXT TABLES&#13;
TABLE 4.1: SUMMARY OF PROJECT COST BY COMPONENT .............................................. 20&#13;
TABLE 4.2: SUMMARY OF PROJECT COST BY CATEGORY OF EXPENDITURE .................... 21&#13;
TABLE 4.3: FINANCING PLAN ....................................                                  :                   22&#13;
TABLE 4.4: SUMMARY OF PROPOSED PROCUREMENT ARRANGEMENTS .......................... 23&#13;
TABLE 4.5: DISBURSEMENT CATEGORIES .................................................                                26&#13;
ANNEXES&#13;
1.  SUPPORT TO NATIONAL TUBERCULOSIS PROGRAM ................................................. 41&#13;
2.  MOSQUITO NET DISTRIBUTION AND TREATMENT .....................................                                   45&#13;
3.  HIV/AIDS COMPONENT: MANAGEMENT AND IMPLEMENTATION ............................. 52&#13;
4. HEALTH SERVICES STRENGTHENING - PROVINCIAL SELECTION AND PHASING ......... 58&#13;
5. LIST OF MEDICAL EQUIPMENT FOR HEALTH CENTERS AND REFERRAL HOSPITALS ... 62&#13;
6. LIST OF PRIORITY DRUGS AND MEDICAL SUPPLIES SUPPORTED UNDER THE&#13;
NATIONAL DRUG SUPPLY SYSTEM .............................................................                      67&#13;
7.  PROJECT MANAGEMENT ARRANGEMENTS .............................................................   70&#13;
8.  HEALTH MANAGEMENT AGREEMENTS .............................................................                       77&#13;
9.  PROJECT PERFORMANCE INDICATORS .............................................................                     84&#13;
10. PROJECT COSTS                            ..0......................................................... g&#13;
11. PROCUREMENT AND DISBURSEMENT MATRIX ........................................................... 94&#13;
12. DISBURSEMENT SCHEDULE AND PROFILE                                 ........................................ 95&#13;
13. PROJECT IMPLEMENTATION SCHEDULE                                 ......................................... 96&#13;
14. IDA  SUPERVISION PLAN .............................................................                            97&#13;
15. SELECTED DOCUMENTS AVAILABLE IN THE PROJECT FILE                                             . .    99&#13;
MAP SECTION&#13;
IBRD 27986&#13;
&#13;
&#13;
&amp;#12;&#13;
KINGDOM OF CAMBODIA&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT&#13;
PROJECT&#13;
1. INTRODUCTION&#13;
1.1   The development prospects of Cambodia are strongly shaped by three constraints: poorly&#13;
developed official institutions and services as a result of 20 years of war and international&#13;
isolation; a depleted human resource base due to the destructive policies of the Khmer Rouge&#13;
government in the 1970s; and a continuing rural insurgency that isolates certain areas of the&#13;
country and distorts government expenditures. These constraints are balanced by long term&#13;
development potential based on valuable assets: abundant mineral and forest resources,&#13;
compelling tourist attractions, extensive arable land, and trade and investment opportunities with&#13;
the dynamic economies on its borders. The Government's development objectives are structured&#13;
to address the above constraints in the near term and in the longer term to expand the productive&#13;
sustainable use of the country's considerable assets and endowments. The project would address&#13;
a key aspect of human resource development: improving the controi of three communicable&#13;
diseases and rehabilitating primary health care services.&#13;
1.2   Health conditions in the country are particularly unfavorable; mortality levels from easily&#13;
preventable diseases rival the highest rates in the world. Over half of Cambodia's population&#13;
carries the TB bacillus, and from this pool of infection, an estimated 35-40,000 active cases of&#13;
TB are prevalent each year, making TB a leading cause of death among young adults. Malaria is&#13;
also a leading killer, causing up to 5,000 deaths a year out of 500,000 probable cases, and with&#13;
drug resistance a major problem for treatment strategies. HIV/AIDS has grown geometrically&#13;
each year into an epidemic, with risk groups reporting up to 40 percent sero-positivity for HIV.&#13;
The primary health care system is poorly developed to manage and deliver the services that could&#13;
have an impact on these and other preventive and communicable diseases.&#13;
1.3   The Disease Control and Health Development Project (CDCP) will help finance a&#13;
focused five year effort to assist the Government in the reconstruction and expansion of&#13;
Cambodia's health system with particular attention paid to reducing death and sickness from&#13;
three leading communicable diseases: tuberculosis, malaria and HIV/AIDS. Tuberculosis and&#13;
malaria control efforts will be expanded and improved and the rapidly expanding HIV/AIDS&#13;
epidemic will be checked through a range of preventive measures focusing on blood safety,&#13;
information and behavioral change. To ensure the effectiveness of these programs and other&#13;
primary health care interventions, the project will also help rehabilitate the long neglected public&#13;
health services and establish modern management techniques focused on objectives and&#13;
performance.&#13;
&#13;
&#13;
&amp;#12;&#13;
2. THE SECTOR&#13;
A. BACKGROUND&#13;
Health Situation&#13;
2.1    Health conditions in Cambodia are extremely poor and have barely improved over the&#13;
last twenty years, due to the virtual dismantling of the health system during the 1970s and overall&#13;
lack of investment in the health system since then. Data on the health situation is limited,&#13;
however, it is known that Cambodia suffers from a very high burden of mortality from&#13;
preventable and curable diseases. An estimated 115 out of every 1,000 infants under the age of&#13;
one die-nearly three times the regional infant mortality rate of 42 per 1,000 live births -- while&#13;
the under-five mortality rate is 181 per 1,000 live births as compared to the regional rate of 56&#13;
per 1,000 -- with acute respiratory infections, diarrhea and malaria being the leading causes of&#13;
childhood mortality. Maternal health is little better -- the maternal mortality ratio estimated at&#13;
900 per 100,000 births is the highest in East Asia. Tuberculosis and malaria are widespread and&#13;
are leading causes of death, and HIV/AIDS is rapidly reaching epidemic proportions.&#13;
2.2    Tuberculosis. Cambodia harbors some of the highest rates of TB in the world, with&#13;
active TB cases reported to be over 800 per 100,000 population in some areas. Over half the&#13;
population is infected with the TB bacillus, and from this pool of infection, 35-40,000 active&#13;
cases exist at any one time, making TB a leading killer of young adults and a significant threat to&#13;
children.&#13;
2.3   Even with increased disease control efforts, a decrease in the number of active TB cases&#13;
may not be realized for many years. Rather, over the next five years, Cambodia is likely to see&#13;
an increase in the number of TB patients due to the effects of HIV infection, which dramatically&#13;
increases the risk of developing TB; the increased availability and capacity of medical staff to&#13;
diagnose TB; and the increased reliability and quality of TB treatment attracting a greater&#13;
number of patients. In order to decrease the prevalence of TB in the population and reduce the&#13;
number of new cases over a five to ten year time frame, about 70 percent of active cases (24,000&#13;
cases) will need to be treated each year, a 50 percent increase over the number of cases treated in&#13;
1994 and 1995.&#13;
2.4   Malaria. Malaria is a major cause of illness and death in Cambodia, with 100,000&#13;
laboratory confirmed cases and 1,100 recorded deaths in 1994. The real figures may be up to&#13;
five times higher, with the overall case fatality rate estimated at about 1 percent, and rising to&#13;
over 10 percent, in some malaria-prone districts.&#13;
2.5    An estimated 17 percent of the country's population live in areas where there is a high&#13;
risk of malaria transmission. These high risk areas are the forested areas and rubber plantations&#13;
towards the borders of the country. The densely populated central and south-eastern rice&#13;
growing areas, along the Tonle Sap River, are low risk areas for malaria. However, there is a&#13;
&#13;
&#13;
&amp;#12;&#13;
- 3 -&#13;
large transient population, mainly made up of young men, who venture into the forests to make a&#13;
living, thereby increasing the population at high risk of malaria infection.&#13;
2.6   Drug resistant malaria is a rising problem in Cambodia. About 80 percent of the malaria&#13;
infections are caused by Plasmodium falciparum malaria, which has developed a high level of&#13;
drug resistance, especially in the western provinces. An additional problem is that many people&#13;
rely on drugs bought in the marketplace to treat malaria, sometimes spending more than US$100&#13;
on inappropriate and dangerous medicines. Such inappropriate treatment is thought to be a major&#13;
factor behind the high case fatality rates among malaria victims in Cambodia.&#13;
2.7   HIV/AIDS. Compared globally, the human immunodeficiency virus (HIV) emerged late&#13;
in Cambodia. First detected in 1991, the virus continues a relentless spread in the community,&#13;
and the country faces, potentially, the worst HIV epidemic in Asia. The rate of increase of HIV&#13;
prevalence among blood donors is phenomenal and alarming, rising in Phnom Penh from 0.075&#13;
percent in 1991 to 8 percent in October 1995. Figures of HIV prevalence in mid-1995 derived&#13;
from surveillance activities are similarly of concern. Not surprisingly, prostitutes show the&#13;
highest infection rates, ranging up to 40 percent of those tested in Battambang. Especially&#13;
disturbing is the number of pregnant women found HIV-positive, over 4 percent in Siem Reap&#13;
and Sihanoukville. The military and police are increasingly infected, with around 10 percent of&#13;
the force tested being HIV-positive in some locations, and patients with sexually transmitted&#13;
diseases (STDs) in Phnom Penh showing similar levels of infection in a 1994 survey. Among&#13;
tuberculosis patients in 1995, between 20 and 31 percent were HIV-positive.&#13;
2.8   From the available epidemiological data, the virus appears to be relatively evenly spread&#13;
across the main urban centers. The epidemic is mainly sexually transmitted and of those&#13;
identified with HIV, about 75 percent are men. An assessment of intravenous drug use&#13;
conducted by the World Bank in November 1995 revealed little evidence of such practices&#13;
despite the high volume of drug trafficking in the region. However, there were early indications&#13;
that the situation may be changing. Indiscriminate use of needles for injections by providers of&#13;
medical care is clearly a threat and may have contributed to the rapid rise of HIV prevalence.&#13;
The Health System&#13;
2.9  In theory, the public health system in Cambodia consists of a clinic in each commune, a&#13;
referral hospital in each district capital, and a provincial hospital in each provincial capital. In&#13;
reality, most clinics are non-existent or virtually non-functioning at the commune level, with&#13;
poorly motivated staff offering very limited services. Few of the district hospitals offer referral&#13;
services. Instead they function more like clinics offering an outpatient clinic, mother and child&#13;
health care, vaccinations and limited in-patient care for TB patients. Medical, surgical and&#13;
obstetrical emergencies can only be treated in provincial hospitals, in national hospitals, and in a&#13;
limited number of district hospitals. Overall, existing services are heavily biased in favor of&#13;
Phnom Penh and the provincial capitals, with only 13 percent of the Ministry of Health (MOH)&#13;
workforce employed in rural areas.&#13;
&#13;
&#13;
&amp;#12;&#13;
2.10   Where services are available, their quality is often poor and utilization of existing&#13;
facilities low. Reasons for this include the poor state of facilities, inadequate equipment and&#13;
drug supplies, the lack of quality and relevant training for health workers, and the low level of&#13;
staff salaries leading to widespread informal fee charging for drugs and services by public health&#13;
workers. The high maternal mortality ratio in Cambodia is to a large extent due to the lack of&#13;
qualified surgeons/obstetricians in the country. Where donors have helped upgrade the clinical&#13;
skills of the staff, ensured a reliable drug supply, and rehabilitated the facilities, utilization has&#13;
increased dramatically, pointing to the large unmet demand for quality modem health services.&#13;
2.11   Up until 1993, the public health system was decentralized, and the provincial authorities&#13;
were relatively autonomous in the management and financing of health services. This resulted in&#13;
a weak central level and a large variation in terms of resource allocation and the quality of health&#13;
care among the different provinces. Since 1993, the Ministry of Health, with the support of&#13;
advisors from WHO and UNICEF, has endeavored to develop policies and plans to restructure&#13;
and rationalize the health system. This resulted in the publication of the "National Health&#13;
Development Plan 1994-1996" which redefines the institutional framework for the health system&#13;
and the services offered at each level, in an aim to rationalize the use of resources. The focus of&#13;
the plan is the development of the district health system to deliver essential primary health care&#13;
to meet communities' basic health needs.&#13;
2.12   The reform of the health system implies a revision of the expected roles of each level of&#13;
care as well as a revision of infrastructure coverage in accordance with population distribution,&#13;
not administrative divisions, as before. Under the Health Plan, the health system is to be&#13;
organized into three levels:&#13;
(a)    Peripheral level (or "operational district"), made up of health centers and district&#13;
referral hospitals.  Health centers will be the point of first contact for the&#13;
population and would provide a minimum package of services (public health and&#13;
minor curative) for a 10,000 person catchment area. Referral hospitals will offer&#13;
first referral support to the health centers and provide a complementary package&#13;
of public health and essential clinical services.&#13;
(b)   Intermediate level consisting of provincial directorates, hospitals and health&#13;
institutions in the province. The Provincial Health Directorate is the link between&#13;
the MOH and the operational districts. Provincial hospitals will act as referral&#13;
hospitals for the district in which they are situated and will offer a number of&#13;
specialized services that are not provided by the district hospitals.&#13;
(c)    Central level consisting of the MOH, national institutes, national programs and&#13;
national hospitals.&#13;
2.13   Health coverage plans are being developed at the provincial level, in consultation with&#13;
local authorities and communities, to define clearly the location of district-level health facilities,&#13;
the services offered and their catchment areas.&#13;
&#13;
&#13;
&amp;#12;&#13;
2.14  As part of the Health Plan the national disease control programs are to be strengthened,&#13;
including those for TB, malaria and AIDS. In the past, these programs have been run as vertical&#13;
programs with management and reporting structures separate from the general health system.&#13;
However, they are now in the process of being integrated with the other health care services&#13;
provided at the district and provincial level, and the capacity within the MOH to play a more&#13;
active role in their management and evaluation is being developed.&#13;
2.15 National Tuberculosis Program (NTP). The NTP was established in 1980 under the&#13;
management authority of the National Anti-Tuberculosis Center (CENAT) based in Phnom&#13;
Penh. CENAT has responsibility for managing and supervising TB control activities, including&#13;
the definition of drug requirements and equipment for TB diagnosis and treatment and training&#13;
provincial and district-level health workers in diagnosis and patient care. In 1993, a National&#13;
Tuberculosis Control Plan was completed with the assistance of WHO. It sets out objectives and&#13;
targets for the program. The main targets are to increase the case detection rate from 30 percent&#13;
to 70 percent and the cure rate to 85 percent by the year 2000. As of late 1995, the NTP had&#13;
covered over half of all public hospitals with its new short-course therapy procedures, drugs and&#13;
training.&#13;
2.16  Treatment for TB is generally administered on an in-patient basis (directly observed&#13;
treatment) for the first two to three months. Food supplements are provided to patients on a daily&#13;
basis while in the hospital, and on a monthly basis during the follow-up ambulatory phase. This&#13;
food program, mostly financed by the World Food Program until now, encourages patients to&#13;
remain in hospital for intensive treatment and acts as an incentive for completing their therapy as&#13;
an out-patient.&#13;
2.17 National Malaria Program (NMP). The NMP, also established in 1980, is managed at&#13;
the central level by the National Malaria Center (CNM). As with the tuberculosis program,&#13;
malaria treatment activities are undertaken primarily by provincial and district level health&#13;
workers, with CNM providing technical supervision, training and support. Malaria vector&#13;
control activities, including impregnated bednet supervision, is coordinated by CNM at the&#13;
central level.&#13;
2.18  The primary objective of the NMP is to reduce malaria mortality and morbidity, with a&#13;
target of supplying all central, provincial and district hospitals with sufficient antimalarial drugs&#13;
effective for their area and achieving less than 2 percent hospital mortality from malaria by the&#13;
year 2000. A three-fold strategy has been developed to achieve this: first, improve the access to&#13;
early, accurate diagnosis and prompt, effective treatment; second, increase the use of preventive&#13;
measures, particularly impregnated bednets; and third, develop community understanding of the&#13;
prevention and recognition of the disease and its rational treatment. The second objective of the&#13;
NMP is to develop the institutional capacity to control vector borne diseases through improved&#13;
management, training and research.&#13;
2.19 National AIDS Program. Given the relatively recent incidence of AIDS in Cambodia,&#13;
the national program for its prevention and control is relatively undeveloped. The response to&#13;
the epidemic has been largely driven by external concern and support through WHO, UNDP and&#13;
&#13;
&#13;
&amp;#12;&#13;
-6 -&#13;
the international NGO community. This has been critical in assisting the Government to focus&#13;
on the issue and organize a response. A National AIDS Committee, chaired by the Minister of&#13;
Health, was formed in 1992 to provide a multisectoral response to the epidemic. In 1993, a&#13;
National AIDS Office (NAO) was established, located within the Ministry of Health. Staffed by&#13;
six professionals, all doctors, the office manages the national program and acts as a de facto&#13;
secretariat for the recently renamed National STD and AIDS Control Committee.&#13;
2.20  Despite the establishment of the NAO, there is still scant intersectoral coordination and&#13;
limited program effort on HIV/AIDS. The NAO has insufficient resources, both human and&#13;
financial, to be able to conduct a program on the scale needed if the epidemic is to be slowed. To&#13;
date, NAO has relied on financing from the WHO/GPA (Global Program on AIDS), which is&#13;
expected to stop at the end of 1995. The termination of WHO/GPA financing creates uncertainty&#13;
and a loss of resources for NAO, which in 1996 and 1997 only has commitments of&#13;
US$150,000/year from UNAIDS and an uncertain future government allocation. Given the&#13;
limited resources for the national program, in effect, most HIV/AIDS activities are supported by&#13;
NGOs. Particularly successful NGO programs include the social marketing of condoms, which&#13;
has expanded the market for safe, reliable condoms. Recently, with the increasing need to take&#13;
action on the HIV issue, the spotlight has been cast on high risk behaviors and how they could be&#13;
modified.&#13;
B. SECTORAL ISSUES&#13;
2.21  Low coverage and impact of public health programs. The public health system in&#13;
Cambodia was virtually dismantled during the 1970s, and today, aside from EPI, national public&#13;
health programs have yet to exert a sustained impact on disease and death from preventable and&#13;
communicable diseases. EPI has been operating for many years with sustained support from&#13;
UNICEF and WHO and is often the only public health service available to rural communities.&#13;
Similar sustained efforts are required to have the desired impact on malaria, TB and AIDS.&#13;
2.22  Low public spending on health services. Public budgets for health have historically&#13;
been very low in Cambodia, rising to about 49 billion riels (approx. US$20 million) or 0.7&#13;
percent of GDP in 1995. This is equivalent to less than US$2 per capita, far less than the US$12&#13;
per capita recommended for low income countries. Cost estimates by the MOH indicate that&#13;
US$5-6 per capita will be needed to provide a minimum package of services at commune clinic&#13;
and district hospital levels alone. The historically low levels of public expenditures for health is&#13;
compounded by the even lower share given to essential services. Currently, government&#13;
resources are dedicated heavily to the running costs of hospital services in Phnom Penh and&#13;
provincial and district facilities -- 50 percent of the government budget is spent on tertiary and&#13;
secondary hospitals. Very limited services are provided in TB, malaria and maternal and child&#13;
care, particularly at the commune level, where only 15 percent of the public health budget is&#13;
directed. The lack of public health services has meant that many people turn to the private sector&#13;
for medical care. The Socio-Economic Survey of Cambodia 1993-94 indicates that households&#13;
spend about US$22 a year per capita on health care, 7 percent of a household budget. These&#13;
expenditures are primarily for drugs purchased at pharmacies and local drug sellers. Often these&#13;
drugs are wrongly prescribed or administered and can worsen health problems.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 7 -&#13;
2.23  Inappropriate distribution of health system resources. The present composition of the&#13;
health care workforce and facilities and their distribution are not meeting the health care needs of&#13;
the Cambodian population. An estimated 25 percent of the rural population do not have access&#13;
to public health care. Health workers are poorly trained, poorly motivated and poorly paid.&#13;
Reform of the health system is needed with particular emphasis given to rationalizing and&#13;
improving the services of clinics and referral hospitals, and the managerial links between the&#13;
two. This need is well-recognized by the MOH and is addressed through their strategy of&#13;
developing provincial health coverage plans and an operational district-based health system. The&#13;
main challenge now is to finalize these plans and implement them. The issue of staff pay levels&#13;
is being addressed at the national level, through civil service reform. The MOH is a pilot&#13;
ministry for this effort, which has substantial donor support.&#13;
2.24 Weak management capacity. Management and supervisory linkages between the MOH&#13;
and the provinces are weak, in part because of the historical autonomy of the provincial level.&#13;
Responsibility and accountability between the center and intermediary and peripheral levels of&#13;
the health system are lacking. Few staff are trained in managerial techniques or in planning,&#13;
budgeting and supervision. Invariably, it has been the presence of NGO support or provincial&#13;
health advisors, financed by WHO and UNICEF, that have enabled management issues to be&#13;
dealt with, in spite of system deficiencies. Improving the responsiveness and accountability&#13;
between the Ministry of Health and the provincial and lower levels of the health system will&#13;
require reforming the "contractual" responsibilities of various parties in the public health system,&#13;
to increase the degree of accountability and expected performance of health care providers at all&#13;
levels.&#13;
C. GOVERNMENT STRATEGY&#13;
2.25 Following a period of intense policy dialogue and assistance from external advisors, the&#13;
Ministry of Health has defined clear policies and service delivery strategies for the health sector.&#13;
The overall aim of the Government's National Health Policy is to "improve the health and well-&#13;
being of the Cambodian people by making full use of both public and private health care&#13;
systems, giving special attention to health education, preventative and curative health care for&#13;
people living in rural areas."&#13;
2.26 At the heart of the Government's strategy is the strengthening of a district-based health&#13;
care system through which a cost-effective but essential minimum package of primary and&#13;
preventive health services can be delivered to rural areas. Other priorities include reducing the&#13;
incidence of communicable diseases, in particular, priority diseases that account for most of the&#13;
burden of disease in Cambodia, including malaria, tuberculosis, sexually transmitted diseases&#13;
and HIV; rehabilitating and upgrading the system infrastructure, including human resources, so&#13;
as to deliver health services more effectively down to the primary service level; ensuring an&#13;
adequate and secure supply of drugs throughout the health system; and ensuring the full&#13;
participation of both the public and private sectors in the delivery of health services, within&#13;
appropriate regulatory frameworks to raise service standards.&#13;
&#13;
&#13;
&amp;#12;&#13;
2.27  Through a process of restructuring and investment, the Government aims to develop an&#13;
affordable and rational health service that meets the priority health needs of the population. The&#13;
strategy to attain this objective embraces four key principles: increase the direct links between&#13;
MOH and provincial and district systems on policy, budget and management matters; build-up&#13;
the relevant national disease control programs;- expand national budgetary support for the health&#13;
system; and more effectively coordinate donor support to fill identified gaps in financing. Thus,&#13;
malaria and TB control programs require a full range of facilities, equipment and drugs in&#13;
referral hospitals and health centers in order for these programs to be effective.&#13;
2.28 Donors are strongly supportive of the government's health plan and have assisted in its&#13;
development and implementation. In particular, UNICEF and WHO have been supporting local&#13;
service delivery (UNICEF finances provincial health advisors, immunization and essential drug&#13;
programs) and building policy and management capacities at the central MOH (WHO, ODA and&#13;
UNDP). The Asian Development Bank (ADB) has approved a Basic Health Services project in&#13;
five provinces, and has coordinated its plans closely with World Bank project preparation.&#13;
Together, the two projects will provide facility, equipment and essential drugs for 15 provinces&#13;
and 80 percent of the population. Overall, donor coordination is good, as is the integration of&#13;
NGO-supported activities into the government's program. NGOs have played an important role&#13;
in providing health services and training in Cambodia over the past five years. Over 70 NGOs&#13;
are active in the health sector, the majority running small-scale primary health care projects in&#13;
rural districts. Many of them have well-qualified and skilled staff and have helped establish&#13;
well-run health facilities. Their experience is likely to prove invaluable in implementing the&#13;
government's district-based health plan.&#13;
D. PROJECT RATIONALE&#13;
2.29 The Disease Control and Health Development Project (CDCP) has been designed to help&#13;
attain the Government's health sector objectives through financial and technical support of the&#13;
MOH's strategy. The objectives of the Project are consistent with IDA's Country Assistance&#13;
Strategy for 1996-1997.&#13;
2.30 The choice among alternative interventions for project financing followed a four step&#13;
process: (i) the epidemiologic profile was assessed to determine leading causes of premature&#13;
mortality; (ii) those leading causes with clear public health characteristics (communicable&#13;
diseases that individuals would not adequately control using their private resources) were&#13;
selected as meriting public financing and project support (heart disease and injuries were ranked&#13;
much lower, for example); (iii) the availability of substantial donor support was estimated so as&#13;
to exclude well financed interventions (family planning and immunizations, for example); and&#13;
(iv) the cost-effectiveness ratios for the remaining interventions were obtained in the secondary&#13;
literature. This process led to the choice of three national disease control programs, namely TB,&#13;
malaria and HIV, all of which are cost-effective interventions, high priorities of the Government,&#13;
and are also underfinanced.&#13;
2.31  The treatment of TB by means of chemotherapy is ranked highly cost effective and is&#13;
considered a core public health intervention. Specifically, short course chemotherapy involving&#13;
&#13;
&#13;
&amp;#12;&#13;
- 9 -&#13;
two month hospitalization has been estimated to cost US$3 per Disability Adjusted Life Year saved&#13;
(DALY'). Treatment of malaria, another comrmunicable threat to public health, is also justified on&#13;
cost effectiveness and public health grounds, although at higher cost (US$200 per DALY in areas&#13;
of high case fatality and endemicity, as is the case in Cambodia). HIV prevention activities have&#13;
been accorded the highest public health priority, especially in the early phases of the epidemic, as in&#13;
Cambodia. Spread of the disease from the "core" risk groups, such as prostitutes and soldiers, to&#13;
the general population involves a major escalation of the epidemic and of future lives lost. Market&#13;
failure in the control of such an epidemic is widely acknowledged. Moreover, the benefit of saving&#13;
those lives and of averting the high costs to the health system of treating AIDS patients constitutes&#13;
a compelling rationale on cost-effectiveness grounds for early and large scale preventive efforts.&#13;
The epidemic in Cambodia is in just such early stages. Treatment of HIV/AIDS on the other hand&#13;
2&#13;
is not considered highly cost-effective , thus narrowing the intervention choices to preventive&#13;
measures given current medical technologies.&#13;
2.32   Several key strategic choices were agreed with the Government in order to maximize&#13;
sustainability and the impact of project investments. First, the project has opted for a two track&#13;
approach of disease control and health system strengthening. A narrower focus on disease&#13;
control would be simpler to implement centrally, but would encounter capacity and&#13;
implementation constraints at the service delivery level. On the other hand, a health service&#13;
strengthening project alone (facilities, equipment, drugs, training) would inject large quantities of&#13;
inputs into health facilities, but with no clear disease control and public health objective or&#13;
impact. Disease control programs are in fact highly dependent on the integrated service delivery&#13;
structure at the provincial level and below. Given the unexpectedly rapid development of MOH&#13;
and provincial capacities, the project will support both tracks to ensure the success of the disease&#13;
control programs and to build capacities to deliver basic health services.&#13;
2.33 Second, during project design, an analysis of alternatives concerning "least cost" issues&#13;
within the broad disease control strategies was done. For example, distribution of insecticide-&#13;
treated bednets is considered a highly promising intervention to control the disease vector, and&#13;
experiments and pilots in Cambodia have shown impressive results in reducing transmission of&#13;
the disease. Bednet distribution is thus a replacement intervention for household residual&#13;
spraying, the cost-effectiveness of which has been called into question in recent work. To tailor&#13;
the bednet strategy to Cambodia and to identify least cost approaches, two studies were&#13;
undertaken and their results incorporated in the formulation of the bednet distribution strategy of&#13;
the National Malaria Program.&#13;
2.34   Similarly, in the case of TB control, a study on patient food supplements was conducted&#13;
to estimate more accurately the minimum level of such supplementation to assure high patient&#13;
compliance with the short course chemotherapy regimen. Although the project will not finance&#13;
such costs, an effective incentive program for patient compliance is vital to the success of the TB&#13;
I  Jamison, et al, Disease Control Priorities in Developing Countries, World Bank, 1993.&#13;
2   N. Prescott, Economic Analysis of Antiretroviral Policy Options in Thailand (paper presented to Third&#13;
International Conference on AIDS in Asia and the Pacific, Chiang Mai, Thailand, 1995).&#13;
&#13;
&#13;
&amp;#12;&#13;
- 10-&#13;
control prograrn. Based on the study, the Government agreed to provide adequate resources to&#13;
this activity at current levels of supplementation in cooperation with the World Food Program.&#13;
2.35   Third, the project will emphasize several management reforms to establish accountability&#13;
for specific health outputs and ultimately outcomes. A MOH-provincial Health Management&#13;
Agreement, limited organizational restructuring at the provincial level, and a special fund to&#13;
support program supervision and management training will be supported by the project to&#13;
improve management practices and orient the system to performance and results.&#13;
2.36  Fourth, given that the current phase of development in Cambodia is one of reconstruction&#13;
and rehabilitation, the project will support the limited reconstruction and expansion of the&#13;
publicly subsidized health system, rather than attempt to restructure the health system or its&#13;
financing. Thus, the project will not seek to implement far-reaching reforms on personnel&#13;
compensation a major issue, as it is tied to wider civil service reform efforts now underway.&#13;
However, it will be structured to support cost recovery schemes both at health centers and in the&#13;
social marketing strategy for bednet distribution. The project will also develop private sector&#13;
capacities in specialized areas where the private sector can be expected to contribute to the public&#13;
health objectives. Social marketing of impregnated bednets through private sector channels will&#13;
be supported, as will NGO and other private sector initiatives in HIV/AIDS prevention and&#13;
outreach.&#13;
2.37  Fifth, the project is structured to finance public subsidies justified on a public&#13;
finance/public good rationale. The government and the Bank agreed at the outset that control of&#13;
communicable diseases is a fundamental priority for any government, and that basic principles of&#13;
public finance and epidemiology dictate a sharp focus on strengthening the capacities of the&#13;
government to exert an impact on the severe public health problems in malaria, TB, and HIV.&#13;
Thus the project will not support tertiary hospitals, sophisticated equipment used in the treatment&#13;
of non-communicable diseases, or training of highly specialized medical personnel.&#13;
2.38  Finally, the project has been costed based upon a programmatic approach. First, the&#13;
government assessed likely donor and budget flows to the three priority programs and made a&#13;
decision on which of its priorities merited ITF financing3. Costs were estimated based on the&#13;
total needs for the Government's public health programs in those project supported areas.&#13;
Available financing from the government and donors has been estimated for these same&#13;
programs, and financing gaps were then calculated. The ITF-assisted project is costed to fill&#13;
these gaps. Primary care priorities, such as maternal and child care, family planning,&#13;
immunizations and nutrition will be assisted indirectly by the health strengthening component,&#13;
and are also receiving considerable support from other donors.&#13;
3  The project will be financed by the Interim Trust Fund (ITF), and IDA will serve as administrator of the ITF.&#13;
&#13;
&#13;
&amp;#12;&#13;
3. THE PROJECT&#13;
A. OBJECTIVES AND SCOPE&#13;
3.1   Project Objectives. The project aims to support the Government of Cambodia in&#13;
pursuing two of its principal health sector objectives: (i) reduce death and sickness from&#13;
preventable diseases, especially malaria, TB and HIV/AIDS; and (ii) rehabilitate the health&#13;
system infrastructure so as to deliver basic health services and disease control programs more&#13;
effectively down to the community level.&#13;
3.2   Project Scope.  To achieve these objectives the project will have the following&#13;
components:&#13;
(a)   National Program Support for the malaria, tuberculosis and HIV/AIDS control&#13;
programs, including provision of (i) drugs and laboratory supplies;&#13;
(ii) impregnated bednets; (iii) training; (iv) logistical support; and (v) technical&#13;
assistance in order to expand and increase the impact of these programs.&#13;
(b)   Basic Health Strengthening including investments in (i) the reconstruction and&#13;
rehabilitation of first and referral-level facilities; (ii) medical equipment and&#13;
furniture; (iii) essential drugs; (iv) in-service training; and (v) MOH&#13;
strengthening.&#13;
B. PROJECT DESCRIPTION&#13;
Component I. National Program Support&#13;
(US$13.0 million equivalent estimated base cost)&#13;
3.3   The project would support three national health programs, namely malaria, tuberculosis&#13;
and HIV/AIDS. In all cases, ITF financing is being directed towards areas where available&#13;
financing from the Government and other donors falls short of projected needs. Since the project&#13;
will cover the estimated total financing gap of these national programs, the geographic coverage&#13;
of this component is effectively nationwide. The parallel ADB supported Basic Health Services&#13;
Project will provide the necessary health strengthening investments in five additional provinces,&#13;
thus enhancing the impact of the three disease control programs nationally.&#13;
National Tuberculosis Program (US$3.0 million equivalent estimated base cost)&#13;
3.4   The overall objective of this sub-component is to assist the NTP (see Annex 1) in its&#13;
efforts to reduce tuberculosis prevalence by sustaining (i) a yearly combined cure rate and&#13;
therapy completion rate of at least 85 percent, and (ii) a sustained yearly relapse rate of less than&#13;
5 percent. Specifically, the sub-component would: (a) improve the quality and accessibility of&#13;
tuberculosis services in health centers and referral hospitals, including case diagnosis and&#13;
&#13;
&#13;
&amp;#12;&#13;
- 12 -&#13;
management; and (b) strengthen the institutional capacity of the National Anti-Tuberculosis&#13;
Center (CENAT), through improved management, training, and research.&#13;
3.5   The total financing base cost requirement for the NTP throughout the period 1996-2000 is&#13;
estimated to be US$9.3 million base cost. Other major financing for the program is expected&#13;
from the Government, WHO, JICA and the World Food Program (WFP). Under the project, the&#13;
following activities will be supported:&#13;
Disease Management&#13;
3.6   Improvements will be made to laboratories at referral hospitals and health centers with&#13;
TB ward facilities to increase the capability for and accuracy of TB diagnosis. Inputs would&#13;
consist of diagnostic equipment (primarily microscopes), reagents and supplies.  Where&#13;
laboratories are established in referral hospitals, the TB and malaria laboratory services will be&#13;
integrated. In full referral hospitals, radiology equipment and additional TB beds will be&#13;
supplied under Health Strengthening (Component II). TB drugs will also be supplied under&#13;
Component II.&#13;
Program Management&#13;
3.7   Support will be provided to CENAT in the form of (a) staff training including short&#13;
courses in drug treatment and program supervision and short-termn overseas courses; (b) technical&#13;
assistance; (c) office renovation and upgrading; (d) office equipment; and (e) vehicles for&#13;
provincial level supervision.&#13;
3.8   Three different training courses will be supported: the bi-annual NTP meeting with&#13;
approximately 100 participants; the short-course chemotherapy seminar conducted five times&#13;
each year with approximately 80 participants; and workshops conducted five times each year&#13;
with about 40 participants. In addition, the travel and per diem costs of CENAT staff traveling to&#13;
the provinces four times each year for training and supervision will be covered. International&#13;
training activities include participation in the meeting of the International Union Against&#13;
Tuberculosis and Lung Disease, usually held in Europe, the regional tuberculosis control&#13;
meetings (Thailand, Vietnam), and overseas courses in TB control and epidemiology.&#13;
3.9   Technical assistance will consist of a national program advisor and a laboratory advisor.&#13;
To date, these positions have been financed by WHO and JICA on a full-time basis. This&#13;
support is ending at the end of 1997, after which the project will support the cost on a-6 month&#13;
basis in 1998, and four months per year thereafter.&#13;
Evaluation and Research&#13;
3.10 Four types of epidemiologic survey will be financed: a national TB prevalence survey, a&#13;
tuberculin skin test survey every five years, a drug-resistance survey each year, and an HIV&#13;
infection survey among TB patients each year. Per diem costs and equipment are included in the&#13;
financing of the surveys.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 13 -&#13;
3.11  Food requirements for TB patients are included in the costs of the national program.&#13;
However, these costs will be financed by the Government and the WFP, not by ITF.&#13;
Malaria Control Program (US$3.5 million equivalent estimated base cost)&#13;
3.12  The overall objective of this component is to support the CNM in implementing the&#13;
National Malaria Program which aims to reduce malaria transmission and case mortality and&#13;
morbidity through a treatment and community-based preventive program (see Annex 2).&#13;
Specifically, the component would (i) improve the access to early, accurate diagnosis and&#13;
prompt, effective treatment of malaria; (ii) expand the community-level use of impregnated&#13;
mosquito nets in high and medium risk areas; (iii) support pilot testing of a social marketing&#13;
approach for impregnated mosquito nets; and (iv) increase the capacity of the CNM to manage,&#13;
supervise and monitor the program.&#13;
3.13  The total base cost financing for the NMP for the period 1996-2000 is estimated to be&#13;
US$11.9 million. Major financing for the program is expected from WHO, EU, ODA and&#13;
AusAID. The project will support the following activities:&#13;
Disease Management&#13;
3.14 Financing in the area of disease management will assist the CNM to expand diagnostic&#13;
and treatment services into more peripheral areas. Inputs include microscopes and laboratory&#13;
equipment for referral hospitals and selected health centers.  Where feasible, integrated&#13;
laboratories will be established which carry out TB and malaria diagnosis, as well as other&#13;
laboratory tests. The supply of laboratory equipment under the project has, therefore, been&#13;
rationalized to take into account existing stock and shared usage across programs. Anti-malarial&#13;
drugs will also be supplied and are budgeted under the Health Strengthening Component.&#13;
Vector Control&#13;
3.15  A key objective of the NMP is to expand and evaluate the use of insecticide-treated&#13;
mosquito nets, through both public channels and development of a social marketing strategy&#13;
implemented by the private sector and NGOs (see Annex 2). The project would support this&#13;
initiative by financing (a) mosquito nets, insecticide and basic equipment for net treatment (if not&#13;
funded by other donors); (b) vehicles (to be shared with other disease control programs);&#13;
(c) training; (d) IEC materials; (e) operations budget for implementation; and (f) operations&#13;
research in alternative, cost-effective personal protection methods, IEC strategies, cost recovery&#13;
schemes and alternative distribution strategies. Details of the program strategy and its phasing&#13;
are provided in the Project Implementation Plan.&#13;
Program Management&#13;
3.16 Support will be provided to CNM in the form of (a) staff training; (b) technical&#13;
assistance; (c) facility renovation and upgrading; (d) office equipment; and (e) vehicles&#13;
(motorcycles) for program supervision at the provincial level.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 14-&#13;
3.17  Training to be supported includes training of trainers programs, short courses for health&#13;
workers in malaria treatment and control, and CNM staff training, including foreign scholarships,&#13;
in areas such as information, education and communication, health policy and management,&#13;
medical sociology, parasitology/entomology and epidemiology.&#13;
Evaluation and Research&#13;
3.18  Current NMP strategies and activities are based on limited information. The expanded&#13;
interventions that are to be supported will require more effort in evaluation and operational&#13;
research if they are to have the desired impact. Financing will therefore be provided for a series&#13;
of evaluation and research studies, including evaluations of in vivo drug resistance, expanding&#13;
the use of artemesinin based anti-malarials, vector prevalence and mosquito biting habits, malaria&#13;
parasite prevalence, the impact of impregnated mosquito nets, social marketing, and operational&#13;
research into rapid antigen test kits and examination of malaria during pregnancy and early&#13;
childhood.&#13;
HIV/AIDS Program (US$6.5 million equivalent estimated base cost)&#13;
3.19  The objective of this sub-component is to counter the spread of the HIV virus. Assistance&#13;
will be provided to increase the staff and financial resource base of the National AIDS Office&#13;
(NAO) so as to enhance its ability to provide the overall guidance and management of the&#13;
HIV/AIDS program. Providing direction and leadership to the program and coordinating donor&#13;
and NGO contributions will improve a situation marked by a matrix of initiatives, undertaken&#13;
with good intentions but lacking coordination and possibly sustainability.&#13;
3.20  Ultimately, the Bank's support for the HIV/AIDS program is expected to contribute to&#13;
reduction in the transmission rate thus limiting the spread of the virus. Evidence from other&#13;
countries indicates that such an outcome is possible through effecting behavior change. It is&#13;
known to require an intensive effort and to take time. Achieving this objective will result in&#13;
diminished morbidity and mortality among the working population, reduce child mortality and&#13;
the number of orphans and lower the considerable direct and indirect financial burden of an&#13;
unchecked epidemic. The total base cost financing for the HIV/AIDS program for the period&#13;
1996-2000 is estimated to be US$ 10 million.&#13;
3.21  The project will support the key elements of a national strategy to address the problem&#13;
both at the country and provincial level through the following activities:&#13;
Institutional Development&#13;
3.22 National Level. The National AIDS Office will be strengthened through the provision of&#13;
(i) supplies and equipment, including communication equipment; (ii) training; (iii) technical&#13;
assistance; and (iv) logistical and financial support for supervision of national activities for&#13;
which the NAO will be directly responsible, as well as of provincial AIDS programs (see&#13;
Annex 3). Travel to attend international meetings about HIV/AIDS and STDs will be provided.&#13;
Technical assistance will be provided to support program management and implementation and&#13;
related activities on a declining basis over the life of the project.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 15-&#13;
3.23  Provincial Level. Support in the form of supplies, equipment and motorcycles will be&#13;
provided for provincial HIV/AIDS programs to increase their capacity to implement and&#13;
supervise AIDS program activities, including sentinel surveillance activities, monitoring NGO&#13;
programs funded out of the Small Grants Programs, peer education activities and supervising&#13;
counseling services at the provincial blood banks.&#13;
Prevention Programs&#13;
3.24 Information, Education and Communication. The project will support a broad and&#13;
intensive program of ensuring the population is well informed about the nature of the AIDS&#13;
epidemic and how personal risk may be minimized. It is expected that much of the creative work&#13;
which this entails, such as preparing radio and TV spots, will be contracted out to the private&#13;
sector. Similarly, the actual broadcasting of prepared material will be undertaken by private&#13;
radio and TV stations in addition to Government channels. The resources for this program will&#13;
be managed through the NAO. A media director and supporting staff will be hired by the NAO&#13;
to assist the NAO with its responsibility for managing the IEC program. Technical assistance&#13;
will be provided to assist in the preparation of communication strategies and advise on message&#13;
content and programming.&#13;
3.25  Blood Transfusion Services.  To ensure that the blood supply remains HIV-free,&#13;
financing will be provided for a supply of testing reagents for HIV screening in those centers&#13;
already established and also for in-service training and a quality control program. Selected staff&#13;
at the National Blood Transfusion Center and the provincial level will receive training in&#13;
counseling for donors found to be HIV+. Assistance will also be provided for the establishment&#13;
of a further 8 provincial blood transfusion centers (Kandal, Koh Kong, Mundalkiri, Preah Vihear,&#13;
Prey Veng, Rattanankiri, Sihanoukville, and Stung Treng).&#13;
3.26 Risk Behavior Reduction:&#13;
(a)   Outreach Program. The NAO currently administers an outreach program to&#13;
raise AIDS awareness. This program will be expanded with project support for&#13;
the first two years. During negotiations, agreement was reached that program&#13;
performance will be evaluated and the evaluation report submitted to IDA not&#13;
later than December 31, 1997. Further support for outreach activities will be&#13;
made available from unallocated project funds, provided the evaluation is fully&#13;
satisfactory (para 7.1 (g)). Financing will be made available for motorcycles for&#13;
outreach workers, and supplies such as T-shirts for the peer educators trained by&#13;
the outreach workers; and a program of workshops for the outreach workers,&#13;
which will include counseling skills. A program of central-level support will be&#13;
initiated and technical assistance will be provided to assist with program&#13;
development.  Study tours to neighboring countries will enhance program&#13;
effectiveness through observing alternative approaches and networking with&#13;
colleagues. An incentive program will be maintained for peer educators and&#13;
outreach workers.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 16 -&#13;
(b)   Condom Promotion. Condoms are successfully socially marketed throughout&#13;
Cambodia, and the project will not support this activity. However, limited&#13;
support will be provided for condom supplies used for special activities, such as&#13;
the outreach program and STD clinics where condoms are initially provided free&#13;
to commercial sex workers and patients.&#13;
Treatment Program for Sexually Transmitted Diseases (STDs)&#13;
3.27  The National Center for Dermatology and Venereology will be strengthened to enable it&#13;
to perform more adequately its function as a national referral center for STDs and as a core&#13;
training center. To accomplish this aim, the training and laboratory facilities will be expanded&#13;
and upgraded accompanied by a program of staff improvement both at the laboratory and clinical&#13;
levels. The core staff will be responsible for introducing the syndromic approach to STD&#13;
diagnosis and management through a systematic program of training trainers at the provincial&#13;
AIDS office, who will become responsible for conducting training for provincial and district&#13;
health staff. This will be supported with technical assistance and resources to conduct specific&#13;
epidemiological and other studies related to STD management. At the provincial level, five&#13;
additional STD provincial referral clinics will be established at Kampong Speu, Kampong Thom,&#13;
Kampot/Kep, Kratie and Rattanakiri. Developing activities among private sector providers will&#13;
be entrusted to NGOs through the Small Grants Program.&#13;
Monitoring, Research and Evaluation&#13;
3.28  The sentinel surveillance program will be sustained throughout the life of the project on&#13;
an annual basis. A behavioral surveillance system, which will determine whether behavior&#13;
change is occurring, will be introduced on a trial basis at a limited number of sites. For ongoing&#13;
program monitoring and evaluation, resources for studies and operational research will be&#13;
established to be used in a flexible manner and in response to identified problems and needs. An&#13;
annual program evaluation will be undertaken through a workshop using technical assistance.&#13;
Small Grants Program&#13;
3.29  A fund will be established under the NAO to provide grant financing for HIV/AIDS-&#13;
related activities to be undertaken by the NGO community/private sector. It is anticipated that&#13;
these resources will largely be directed towards local Cambodian NGOs. Identification of&#13;
activities will be a two way process, by the NGOs themselves and by the NAO program which&#13;
may require NGO capacity to carry out Government policy and program interventions. While&#13;
the fund will be managed by the NAO, the decisions on grant awards will be subject to approval&#13;
by a Project Grant Committee, charged with reviewing and approving proposals for Grants&#13;
submitted by prospective Grantees. The proposed operational polices and procedures of the&#13;
Project Grants Program and management arrangements for this committee are detailed in Annex&#13;
3. During negotiations the government provided assurances to appoint an HIVWAIDS Project&#13;
Grant Committee not later than January 31, 1997, with responsibilities and membership&#13;
satisfactory to IDA (para. 7. 1 (s)).&#13;
&#13;
&#13;
&amp;#12;&#13;
- 17-&#13;
Component II. Health Service Strengthening&#13;
(US$18.1 million eguivalent estimated base cost)&#13;
3.30  In order to ensure the effectiveness of the malaria, tuberculosis, and HIV/AIDS programs,&#13;
the overall health delivery system in which these programs operate and on which they depend for&#13;
implementation needs to be strengthened. Under this component, the project will support&#13;
investments to upgrade the Ministry of Health and its basic health service delivery apparatus at&#13;
the provincial level and below and to restore acceptable standards of facilities, equipment, and&#13;
essential drug supply. Basic management procedures will be also introduced to improve&#13;
performance and accountability within the public health system (see para. 5.4).&#13;
3.31   The national Health Coverage Plan, according to which the distribution of facilities,&#13;
equipment, staff and services will be rationalized by population, epidemiologic patterns, special&#13;
access conditions, and affordability, provides a sound framework for planning and phasing the&#13;
health strengthening component. The Government's immediate objective is to increase the flow&#13;
of resources to the peripheral level so as to establish an efficient district health system that&#13;
provides communities with accessible and quality health care. In keeping with this policy,&#13;
project financing will predominantly be directed to upgrading health centers and referral&#13;
hospitals.&#13;
3.32 During the transitional phase while the Health Coverage Plan is being implemented, in&#13;
effect, four categories of health facilities would exist at the district level and below: health&#13;
centers which offer the minimum package of services; district hospitals which would operate as&#13;
health centers in the future, but would maintain their TB diagnosis and treatment capacity; basic&#13;
referral hospitals which would support essential public health programs but would offer only&#13;
limited surgical services; and full referral hospitals which would provide services corresponding&#13;
to the full complementary package of services as defined under the Health Coverage Plan.&#13;
3.33  Selection of Provinces and Facilities for Upgrading.  Due to the widespread&#13;
destruction and neglect of health infrastructure, the total needs for health facility upgrading are&#13;
high, and well exceed the capacity of the MOH to staff, equip, supply and manage over five&#13;
years. Therefore, a set of criteria was developed to prioritize provinces for project investment.&#13;
The five criteria are: (i) disease incidence and prevalence (TB and malaria), (ii) management&#13;
capacity, (iii) accessibility, (iv) population size, and (v) support from the ADB Basic Health&#13;
Services Project (see Annex 4). Using the above methodology, a practical phased program of&#13;
construction and support was developed for ten priority provinces in two phases (I and II). The&#13;
six phase I provinces (upgrading to begin in the first year of implementation) are Battambang,&#13;
Kampot/Kep, Kandal, Kompong Speu, Phnom Penh and Siem Reap. The four phase II provinces&#13;
(upgrading to begin in the second year of implementation) are Kampong Thom, Kratie, Pursat&#13;
and Rattanakiri. The project will support the needs of this program over a five year period,&#13;
beginning in late 1996.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 18-&#13;
3.34  The project will support the following activities:&#13;
Facilities Upgrading (US$10.2 million eguivalent estimated base cost)&#13;
3.35  The project will support investments in the construction and rehabilitation of 26 referral&#13;
hospitals and 230 health centers in the ten provinces. 57 health centers (including 26 with TB&#13;
ward renovations), 6 basic referral hospitals and 15 full referral hospitals would be rehabilitated,&#13;
173 health centers would be newly constructed and 2 basic referral hospitals and 3 full referral&#13;
hospitals would undergo major renovations (see Annex 4 for details by province and phasing&#13;
arrangements).&#13;
Medical Equipment, Furniture and Transportation (US$2.9 million equivalent estimated base&#13;
cost)&#13;
3.36 The Health Coverage Plan outlines the minimum package of activities to be provided at&#13;
the first level health center as well as at the referral hospital. Using this as a basis, and in&#13;
consultation with relevant donors, MOH has identified a standard list of. equipment to be&#13;
provided under the project which would support the core public health activities in these&#13;
facilities. Lists of equipment to be provided for the health centers and referral hospitals under&#13;
the project are provided in Annex 5. The quantities of equipment and furniture to be provided at&#13;
each level have been adjusted to reflect expected inputs from other donors. The delivery of&#13;
equipment will be synchronized with the phasing plan for facility upgrading.&#13;
Essential Drugs (US$2.3 million equivalent estimated base cost)&#13;
3.37  The national needs for essential drugs, including those needed for the treatment of&#13;
tuberculosis, malaria and STDs was estimated, based on an agreed list, and the projected costs&#13;
were matched with the expected government and donor financing. The project will provide&#13;
funding at the national level to cover the financing gap. The list of drugs to be supplied is&#13;
provided in Annex 6.&#13;
In-Service Training (US$0.2 million eguivalent estimated base cost)&#13;
3.38  Substantial donor support has already been committed for in-service training, particularly&#13;
through an ADB Basic Skills Development Project and a WHO/UNDP/ODA Health Systems&#13;
Strengthening Project. It is estimated that the total flow of donor funds into in-service training&#13;
will be at least US$5.3 million over the next five years. Based on an analysis of the training&#13;
needs and costs for health staff throughout the country, it appears that in the medium-term no&#13;
additional donor resources are required for training of basic health staff. However, there is an&#13;
urgent need to train surgeons, obstetricians and anesthetists to provide emergency obstetric and&#13;
surgical care. An MOH committee is in the process of designing a national in-service training&#13;
strategy in obstetrics/surgery for the country. A one year curriculum will be developed and&#13;
training institutes identified and strengthened by the end of 1996. The project will directly&#13;
support the training of two surgeons/obstetricians and one anesthetist in each of the full referral&#13;
hospitals upgraded under the project. During project implementation, staff of the MOH and&#13;
Project Coordination Unit (PCU) will work closely with the institutions and NGOs involved in&#13;
&#13;
&#13;
&amp;#12;&#13;
- 19 -&#13;
training to ensure that the management and in-service training needs of other health staff in the&#13;
project provinces are met.&#13;
MOH Strengthening (US$2.6 million equivalent estimated base cost)&#13;
3.39  The Disease Control Project, and the ADB Basic Health Services Project, are the first&#13;
major investment projects in support of the MOH and will require some strengthening of the&#13;
MOH to coordinate and manage. The purpose of this sub-component, therefore, is to establish an&#13;
effective coordination mechanism and management team within the MOH; build-up skills in&#13;
areas such as procurement, disbursement, financial management and accounting; and improve the&#13;
capacity of MOH and the provincial directorates in program management, including field&#13;
supervision, data collection, progress monitoring and reporting.&#13;
3.40  The health centers specified in para 3.32 above are new types of facilities, and very few&#13;
currently exist in the country. Health staff are not used to working in and operating this type of&#13;
facility nor are they used to working as a facility based health service team at anything below the&#13;
current district hospitals. Therefore, a program of training, operational support, and intensive&#13;
supervision needs to be provided to each health center staff team at the time of commissioning of&#13;
the facility. The initial development and implementation of this process will be provided in a&#13;
central technical assistance contract, but the effort should be integrated into provinces' and the&#13;
MOH Training Division's normal operations as quickly as possible. This effort should draw on&#13;
the experience of NGOs who have constructed and commissioned the few health centers which&#13;
exist. This effort should also be supported by provincial health advisors and other managerial&#13;
technical assistance provided to the MOH, particularly the Accelerated District Development&#13;
scheme support. The agreement on quantities and level of effort for this commissioning process&#13;
should form part of each province's annual Health Management Agreements (see Chapter 5,&#13;
Section B).&#13;
3.41  To achieve these objectives, the project will finance: (i) the running costs of a Project&#13;
Coordination Unit (PCU) in MOH, including technical assistance, fellowships and operational&#13;
support; (ii) office equipment and communication equipment to link the center and the provinces;&#13;
(iii) limited renovation and construction of MOH administration buildings and the Department of&#13;
Pharmacy; (iv) a baseline survey to establish current health status and performance indicators&#13;
(ADB will support a final national evaluation survey); (v) a 2.5 year contract for technical&#13;
assistance and operational costs for initial implementation of health centers commissioning (the&#13;
initial recurrent costs and all the costs after the middle of the third year will be the responsibility&#13;
of the Government); and (vi) a provincial Supervision Fund to cover the travel, per diem costs&#13;
and office costs of project supervision within the 10 project provinces.&#13;
3.42  The project will support pilot activities in two areas with cost recovery activities namely:&#13;
the social marketing of bednets and the training and management contract for Phase I health&#13;
centers. During negotiations agreement was reached to implement by January 31, 1997, through&#13;
MOH, a national policy satisfactory to IDA on the collection of service fees in national health&#13;
facilities including the policy on retention of fees, the policy on setting and adjusting the&#13;
schedule offees, and the allowable expenditure offee revenues (para. 7.1 (r)).&#13;
&#13;
&#13;
&amp;#12;&#13;
- 20 -&#13;
4. PROJECT COSTS, FINANCING, PROCUREMENT AND&#13;
DISBURSEMENT&#13;
A. COST ESTIMATES&#13;
4.1     Summary of Project Costs. The total cost of the project is estimated at Cambodian Riel&#13;
87.7 billion, or US$35.6 million equivalent including contingencies. The total costs are&#13;
summarized by project components in Table 4.1, and by expenditure categories in Table 4.2.&#13;
Table 4.1: Summary of Project Cost by Component&#13;
% Total&#13;
(Riel Million)              (US$ Million)        Base&#13;
Local     Foreign     Total    Local  Forelgn  Total   Costs&#13;
A. National Programs&#13;
1. TB Control                       3,151.8    4,151.7    7,303.5     1.3     1.7     3.0       10&#13;
2. Malaria Control                  2,929.7    5,784.4    8,714.1     1.2     2.3     3.5       11&#13;
3. HIV/AIDS Control                 8,208.6    7,731.1   15,939.7     3.3     3.1     6.5       21&#13;
Subtotal National Programs           142T.      17,667     31,957.3     5.8     7.2     1&#13;
B. Health Service Strengthen&#13;
1. Facility Upgrading              17,804.0    7,369.2   25,173.1     7.2     3.0    10.2       33&#13;
2. Equipment &amp; Transportation        569.5    6,478.4    7,048.0      0.2     2.6     2.9        9&#13;
3. Essential Drug Supply             277.2    5,266.8    5,544.0      0.1     2.1     2.3        7&#13;
4. In-service Training               393.8       98.5       492.3     0.2     0.0     0.2        1&#13;
5. MOH Strengthening                2,620.1    3,723.1    6,343.2     1.1     1.5     2.6        8&#13;
Subtotal Health Service Strengthen   21,664.6                                                    3 2,96  44,600.6  -.  9.3    181 5&#13;
Total BASELINE COSTS                 35,954.7   40,603.    76,557---7.9 14.     1      TT 311    T100&#13;
Physical Contingencies              1,622.9    1,944.0    3,567.0     0.7     0.8     1.4        5&#13;
Price Contingencies                 4,868.3    2,671.3    7,539.6     2.0     1.1     3.1       10&#13;
Total PROJECT COSTS                  42,445.    45,218.5   87,64.    17.        18T.    3S6      115&#13;
4.2     Contingency Allowances. Project costs include a contingency allowance for unforeseen&#13;
physical additions at 5 percent of base costs (US$1.4 million equivalent) and for inflation at 10&#13;
percent of base costs (US$3.1 million equivalent) based on the standard Bank-wide guideline (for&#13;
foreign inflation) and regional guideline (for domestic inflation).&#13;
4.3     Taxation. The Government has decided to exempt all the imported goods and consultant&#13;
services purchased under the project from  duties and taxes.  Total project costs for these&#13;
categories are, therefore, calculated net of duties and taxes. During negotiations, confirmation&#13;
was obtainedfor this government exemption (para. 7.2 (a)). Local taxes may be levied to civil&#13;
works at the rates of 3-5 percent. The project cost, therefore, allocates 10 percent of civil works&#13;
cost to the Government contribution to cover any possible local taxes.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 21 -&#13;
Table 4.2: Summary of Project Cost by Category of Expenditure&#13;
% Total&#13;
(Riel Million)               (US$ Million)        Base&#13;
Local     Foreign     Total     Local  Foreign  Total   Costs&#13;
1. Investment Costs&#13;
A. Equipment                    836.2    15,887.3   16,723.5     0.3      6.4     6.8      22&#13;
B. Drug                         285.5    5,424.1     5,709.6     0.1     2.2      2.3       7&#13;
C. Civil Works                17,660.0    7,568.6   25,228.6     7.2     3.1    10.2       33&#13;
D. Local Training              3,690.3     922.6    4,612.8      1.5     0.4      1.9       6&#13;
E. Foreign Training              88.1     1,674.8    1,763.0     0.0     0.7      0.7       2&#13;
F. Local Consultant            1,070.2     267.5     1,337.7     0.4     0.1      0.5       2&#13;
G. Foreign Consultant           245.4    4,661.7    4,907.1      0.1     1.9      2.0       6&#13;
H. Studies                    4,552.4     1,138.1    5,690.5     1.8     0.5      2.3       7&#13;
I. Grant                        862.4      862.4     1,724.8     0.4     0.4      0.7       2&#13;
Total Investment Costs          29,290.4   38,407.2   67,697.5    11.9    15.6    27.5       88&#13;
II. Incremental Recurrent Costs&#13;
A. Operating Cost              3,453.0     863.3    4,316.3      1.4      0.4     1.8       6&#13;
B. Supplies                     243.3      243.3       486.6     0.1     0.1      0.2       1&#13;
C. Prov. Superv. Cost           275.8       68.9       344.7     0.1     0.0      0.1        -&#13;
D. Maintenance for Equipment    587.5      587.5    1,175.1      0.2     0.2      0.5       2&#13;
E. Maintenance for Civil Works  1,267.1    223.6     1,490.7     0.5     0.1      0.6       2&#13;
F. Staff Remuneration           837.6      209.4    1,047.0      0.3     0.1      0.4       1&#13;
Total Incremental Recurrent      6,664.3    2,196.1    8,860.4     2.7      0.9     3.6      12&#13;
Total BASELINE COSTS            35,954.7   40,603.2   76,557.9    14.6    16.5    31.1       100&#13;
Physical Contingencies         1,622.9    1,944.0    3,567.0     0.7     0.8      1.4       5&#13;
Price Contingencies           4,868.3    2,671.3    7,539.6      2.0     1.1      3.1      10&#13;
Total PROJECT COSTS             42,445.9   45,218.5   87,664.4    17.2    18.4    35.6       115&#13;
4.4     Foreign  Exchange  Components.   Direct and  indirect foreign  exchange  costs are&#13;
estimated at about 52 percent of base costs. The foreign exchange components for various&#13;
expenditure categories are as follows: civil works, 30 percent; equipment and vehicles, 95&#13;
percent; drugs, 95 percent; foreign technical assistance, 95 percent; local technical assistance, 20&#13;
percent; overseas training, 95 percent; local training, 20 percent; studies, 20 percent; grant, 50&#13;
percent; operating cost, 20 percent; and supplies, 50 percent.&#13;
4.5    Incremental Recurrent Cost. The investment in civil works and equipment have been&#13;
carefully designed to avoid an unnecessary recurrent cost burden on the government (see&#13;
Chapter 6). Most of the civil works are renovation or upgrading of existing facilities, and most&#13;
equipment provided under the project involve low-cost maintenance. The costs of maintenance&#13;
for civil works (US$0.6 million, or 2 percent of baseline cost) and for equipment (US$0.5&#13;
million, or 2 percent of baseline cost) will be fully  financed  by  the Government.   The&#13;
Government will also provide salaries for disease control staff (US$0.4 million, or 1 percent of&#13;
baseline cost). However, the three communicable disease control programs require substantial&#13;
field work, such as IEC activities, patient follow-up, mosquito net distribution, data collection&#13;
and monitoring; also each of the ten project provinces will conduct field visits down to commune&#13;
and village levels to supervise the project activities. These represent an extra burden of recurrent&#13;
costs during the life of project implementation, which will be financed on a declining basis under&#13;
the categories of operating cost and supplies (US$2.0 million, or 7 percent of baseline cost), and&#13;
the category of provincial supervision costs (US$0.1 million ).&#13;
&#13;
&#13;
&amp;#12;&#13;
- 22 -&#13;
B. FINANCING&#13;
4.6     The estimated total project cost of US$35.6 million equivalent, net of taxes, would be&#13;
financed by:&#13;
(a)     a local counterpart funding of US$5.2 million equivalent, or 14.5 percent of the&#13;
total project cost, from the Government;&#13;
(b)     an ITF credit of US$30.4 million equivalent net of taxes, or 85.5 percent of the&#13;
total project cost, from ITF.&#13;
4.7     The project financing plan by expenditure categories is summarized in Table 4.3, and by&#13;
project components and year in Annex 10. The source of IDA administered funds shown in&#13;
Table 4.3 will be the ITF. The overall program financing plan, including donor contribution, is&#13;
available in the project implementation plan.&#13;
Table 4.3: Financin! Plan&#13;
Intemational&#13;
Government of    Development&#13;
(US$ Million)                            Cambodia         Association         Total&#13;
Amount   %    Amount   %    Amount   %&#13;
I. Investment Costs&#13;
A. Equipment                            0.5     6.2      7.1    93.8       7.5    21.2&#13;
B. Drug                                 0.0       -      2.7   100.0       2.7     7.5&#13;
C. Civil Works                          1.3    11.0    10.8    89.0    12.1    34.1&#13;
D. Local Training                       0.2    10.4      2.0    89.6       2.2     6.1&#13;
E. Foreign Training                     0.0       -      0.8   100.0       0.8     2.3&#13;
F. Local Consultant                     0.0     2.4      0.6    97.6       0.6     1.8&#13;
G. Foreign Consultant                   0.0       -      2.2   100.0       2.2     6.2&#13;
H. Studies                              0.0       -      2.5   100.0       2.5     7.0&#13;
I. Grant                                  -       -      0.7   100.0       0.7     2.0&#13;
Total Investment Costs                    2.0     6.5    29.3    93.5    31.3    88.1&#13;
II. Incremental Recurrent Costs&#13;
A. Operating Cost                       1.3    62.0      0.8    38.0       2.0     5.7&#13;
B. Supplies                             0.0    15.0      0.2    85.0       0.2     0.6&#13;
C. Prov. Superv. Costs                  0.0    15.0      0.1    85.0       0.2     0.5&#13;
D. Maintenance for Equipment            0.6   100.0        -        -      0.6     1.6&#13;
E. Maintenance for Civil Works          0.7   100.0        -        -      0.7     2.1&#13;
F. Staff Remuneration                   0.5   100.0        -        -      0.5     1.4&#13;
Total Incremental Recurrent Costs         3.1    73.8      1.1    26.2       4.2    11.9&#13;
Total Disbursement                        5.2    14.5    30.4    85.5    35.6   100.0&#13;
&#13;
&#13;
&amp;#12;&#13;
- 23 -&#13;
C. PROCUREMENT&#13;
4.8    The procurement arrangements for the project are summarized in Table 4.4 below:&#13;
Table 4.4: Summary of Proposed Procurement Arrangements&#13;
Procurement Methods&#13;
Procurement Elements (US$ million)          ICB     NCB    Other   NBF    TOTAL&#13;
Civil Works                                         7.9      4.1     0.1      12.1&#13;
(7.1)   (3.7)            (10.8)&#13;
Goods&#13;
a. Equipment&amp;Vehicles                       5.3      1.6     0.2     0.5      7.6&#13;
(5.3)   (1.6)   (0.2)             (7.1)&#13;
b. Drugs &amp; Pharmaceuticals                  2.7                               2.7&#13;
(2.7)                            (2.7)&#13;
Training, Technical Assistance &amp; Studies&#13;
a. Training                                                  2.8     0.2      3.0&#13;
(2.7)            (2.7)&#13;
b. Technical Assistance                                      2.8              2.8&#13;
- Policy Support: $0.8 million                            (2.8)             (2.8)&#13;
- Institutional Development: $0.9 million&#13;
- Implementation Support: $1.1 million&#13;
c. Studies                                                   2.5              2.5&#13;
(2.5)            (2.5)&#13;
Grant                                                        0.7              0.7&#13;
(0.7)            (0.7)&#13;
Incremental Operating Cost &amp; Supplies                        1.1     1.1      2.2&#13;
(1.0)            (1.0)&#13;
Provincial Supervision Costs                                 0.2              0.2&#13;
(0.1)            (0.1)&#13;
Maintenance                                                          1.3      1.3&#13;
Staff Remuneration                                                   0.5      0.5&#13;
Total                                       7.9     9.4    14.4    3.8        35.6&#13;
(7.9)   (8.7)   (13.8)           (30.4)&#13;
Figures in parentheses are respective amounts financed by ITF.&#13;
Totals may not add up exactly due to rounding.&#13;
'Other" includes consultancy services and shopping.&#13;
'NBF": Not Bank Financed.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 24 -&#13;
4.9   The procurement arrangements for civil works, goods and services financed by ITF&#13;
would be carried out in accordance with the Bank's Guidelines for Procurement under IBRD&#13;
Loan and IDA Credits, January 19954, and are described as follows:&#13;
(a)   Civil Works.  The civil works (total estimated amount of US$12.1 million&#13;
including contingencies) carried out under the project would be generally small&#13;
and simple, consisting primarily of minor or major renovation of referral hospitals&#13;
and renovations and new construction of health centers, dispersed throughout the&#13;
ten project provinces. The average construction cost for a basic referral hospital&#13;
would be US$259,000 equivalent; for a full referral hospital, it would be&#13;
US$280,000; and for a health center the cost is about US$23,000. Rehabilitation&#13;
cost would be considerably less. Considering the nature and size of the civil&#13;
works under this project, no foreign contractors are likely to be interested in&#13;
bidding for them. Tenders/bids would be invited in accordance with the following&#13;
procedures:&#13;
(i)    National  Competitive  Bidding  for  estimated  contract  values&#13;
&gt; US$100,000.&#13;
(ii)   National Shopping for estimated contract values of US$50,000 - 100,000,&#13;
up to an aggregated amount of no more than US$3.7 million.&#13;
(iii)   Direct Contract for estimated contract values &lt; US$50,000, up to an&#13;
aggregated amount of no more than US$0.3 million.&#13;
The National Competitive Bidding (NCB) procedure, acceptable to the Bank, would be used for&#13;
the majority of the civil works (up to a total amount of US$7.9 million, or 65 percent of total&#13;
civil works cost). The PCU/MOH will carry out appropriate packaging in order to manage the&#13;
NCB efficiently. A portion of civil works (up to a total amount of US$4.1 million, or 33 percent&#13;
of total civil works cost) will be carried out through National Shopping procedure with at least&#13;
three quotations from local contractors. This will apply to those facilities in remote areas where&#13;
packaging for NCB is difficult. For a small number of health centers, for which selecting&#13;
contractors through competition would be extremely difficult, direct contracting procedures,&#13;
acceptable to the Bank, would be used (up to a total amount of US$0.3 million, or about 2&#13;
percent of total civil works cost). The Bank's Standard Bidding Document for Procurement of&#13;
Civil Works (Small Contracts), January 1995 would be used by PCU/MOH in preparing the&#13;
bidding documents for civil works.5&#13;
(b)   Goods (Equipment. Vehicles, and Drugs). The costs of equipment, vehicles and&#13;
materials are estimated to be US$7.6 million, including contingencies. About 70&#13;
4   The proceeds of the ITF Credit may only be withdrawn on account of expenditures for goods and works&#13;
provided by nationals of and products in or supplied from, participating countries. Only consultants from&#13;
participating countries shall be eligible to provide services financed out of the proceeds of the ITF.&#13;
5  Bidding documents will reference the ITF eligibility restrictions.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 25 -&#13;
percent of this amount, amounting to US$5.3 million, will be procured by&#13;
International Competitive Bidding (ICB) procedure.  Under ICB, domestic&#13;
manufacturers would be eligible for a margin of preference in bid evaluations of&#13;
15 percent of the c.i.f. costs of the competing imports or the applicable customs&#13;
duty, whichever is lower. About 21 percent of total equipment cost, up to an&#13;
aggregated amount of US$1.6 million with the estimated cost of US$100,000 or&#13;
less per contract, may be procured by National Competitive Bidding (NCB)&#13;
procedure acceptable to the Bank.  Small items or group of items costing&#13;
US$25,000 or less per contract, up to an aggregate amount of US$0.2 million or 3&#13;
percent of total equipment costs, may be procured by prudent shopping, requiring&#13;
quotations from at least three suppliers. The cost of drugs, estimated at US$2.7&#13;
million including contingencies, would be procured by ICB procedures. The&#13;
PCU/MOH will prepare the bidding documents in accordance with the Bank's&#13;
Standard Bidding document for Procurement of Goods, January 1995, and the&#13;
Standard Bidding Document for Procurement of Pharmaceuticals and Vaccines,&#13;
September 1993 (as amended to reflect the changes as per the Bank's Guidelines,&#13;
January 1995, for procurement of drugs and pharmaceuticals).'&#13;
(c)   Technical Assistance, Training. and Studies. The technical assistance (estimated&#13;
cost of US$2.8 million including contingencies) will be carried out by individual&#13;
consultants or consultant firrns hired by MOH, following the Bank's Guidelines:&#13;
Use of Consultants by World Bank Borrowers and by the World Bank as&#13;
Executing Agency.6 The training (estimated cost of US$3.0 million including&#13;
contingencies) will be carried out by the national and provincial training centers,&#13;
or other contractors. The financial input for studies, (estimated cost of US$2.5&#13;
million including contingencies) would be used to support the special surveys and&#13;
operational research that will be conducted by competent institutions or&#13;
contractors. MOH would arrange these training, survey and study tasks by&#13;
entering into an "agreement" or "contract" with the institution or contractor. Prior&#13;
to negotiations, MOH provided IDA with its standard format for such contracting&#13;
to ensure its compliance with the Bank's Guideline and the Standard Form of&#13;
6&#13;
Contract for Consulting services, June 1995 (para. 7.3)&#13;
(d)   Incremental Operating Cost &amp; Supplies and Provincial Supervision Cost. The&#13;
incremental operating cost and supplies (estimated cost of US$2.2 million&#13;
including contingencies) would be procured through prudent shopping procedure,&#13;
requiring at least three quotations from  local suppliers.  The provincial&#13;
supervision costs (estimated cost of US$0.2 million including contingencies),&#13;
which will support small annual contracts with each provincial project unit to&#13;
cover local supervision costs, and would be procured using direct contracting&#13;
procedures acceptable to IDA.&#13;
6  Procurement of consultants will conform to ITF eligibility restrictions.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 26 -&#13;
4.10 Procurement Prior Review. All civil works contracts with an estimated cost of&#13;
US$200,000 or more, all goods contracts with an estimated cost of US$100,000 or more, and all&#13;
consulting service contracts with an estimated cost of US$100,000 or more for consulting firm&#13;
(US$50,000 for individual) would be subject to prior review by the Bank. With respect to all&#13;
consulting contracts irrespective of their values, prior review by the Bank will be required for:&#13;
(a) terms of reference; (b) single source contract regardless of value; (c) all consultant contracts&#13;
and assignments of a critical nature (because of environment safety or public health&#13;
considerations) regardless of value; (d) contract amendments valued at more than US$100,000&#13;
for firms (US$50,000 for individuals), or those that raise the total contract value to more than.&#13;
US$100,000 for firms (US$50,000 for individuals); and (e) grants more than US$5,000 per grani&#13;
agreement. This will allow prior review for approximately 80 percent of the works and goods&#13;
procured under the project.&#13;
D. DISBURSEMENT&#13;
4.11  The proposed ITF credit of US$30.4 million equivalent would be disbursed over a period&#13;
of five and half years (including a six-month period after the project completion date), by the&#13;
closing date of March 31, 2002. The disbursement percentages for each expenditure category are&#13;
summarized in Table 4.5.  The disbursement schedule and profile are in Annex  10.&#13;
Disbursements would be made against: (a) 90 percent of total expenditure of civil works; (b) 100&#13;
percent of c.i.f. cost of directly imported goods; 100 percent of ex-factory cost for locally&#13;
manufactured goods, and 85 percent of the other off-the-shelf goods procured locally; (c) 100&#13;
percent of total expenditures for training, technical assistance and studies; (d) 100 percent of&#13;
grant made by the National AIDS Office Grant Facility; (e) 85 percent of operating cost and&#13;
supplies; and (f) 85 percent of provincial supervision cost.&#13;
Table 4.5: Disbursement Categories&#13;
ITF Allocation    % of Expenditure to be&#13;
Disbursement Category        (US$ million)     Financed by the Credit&#13;
Civil Works                              10.5    90%&#13;
Goods (including equipment, vehicle,     9.4     100% of foreign expenditure and&#13;
materials and pharmaceuticals)               ex-factory local expenditure;&#13;
85% of expenditure for off-shelf items.&#13;
Training, Technical Assistance and Studies  7.9   100%&#13;
Grants                                   0.7     100%&#13;
Incremental Operating Costs              1.0      85%&#13;
and Supplies&#13;
Provincial Supervision Cost              0.1      85%&#13;
Unallocated                              0.8      NA&#13;
Total                                     30.4&#13;
&#13;
&#13;
&amp;#12;&#13;
- 27 -&#13;
4.12  Disbursements would be made against Statement of Expenditures (SOEs) for civil works&#13;
contracts with a contract value of less than US$200,000 equivalent; for goods contracts with a&#13;
contract value less than US$100,000 equivalent; for consulting services contracts with a contract&#13;
value less than US$100,000 for firms, and less than US$50,000 for individuals; for grants valued&#13;
at less than US$5,000 each; and for all expenditures for operating cost, supplies and provincial&#13;
supervision costs. All documents supporting the SOEs would be retained by PCU/MOH, and&#13;
made available for random sample review by IDA supervision missions.&#13;
4.13  A Special Account with an authorized allocation of US$1.5 million would be established&#13;
in a bank acceptable to the Association. The PCU/MOH would operate the Special Account with&#13;
due procedures for oversight by the Ministry of Economy and Finance. All the documentation&#13;
for the operation of the Special Account would be retained in PCU/MOH, and made available for&#13;
review by IDA.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 28 -&#13;
5. PROJECT MANAGEMENT AND IMPLEMENTATION&#13;
A. ORGANIZATION&#13;
5.1   The implementing agency for the proposed project will be the Ministry of Health.&#13;
Overall direction and guidance for the project will be provided by a high level Steering&#13;
Committee especially created to oversee the implementation of this project. The Steering&#13;
Committee will comprise of representatives from the Ministry of Economy and Finance&#13;
(MOEF), the Ministry of Planning (MOP) and the Cambodia Development Council (CDC), as&#13;
well as senior staff of MOH. A Project Director, nominated by the Ministry of Health, will be a&#13;
member of the Steering Committee, and will have overall responsibility for the implementation&#13;
of the project.&#13;
5.2  In order to facilitate implementation, a Project Coordination Unit (PCU) will be set-up&#13;
within the MOH, with the support of both the World Bank and the ADB. During negotiations,&#13;
assurances were received that the PCU will be headed by a PCU Manager recruited on an&#13;
international basis by the Government and approved by the World Bank and ADB, as a condition&#13;
of effectiveness (para. 7.1 (a)). The Manager will have day-to-day responsibility for ensuring the&#13;
timely and efficient implementation of the ADB and Bank-financed projects, and for building&#13;
capacity within MOH in the areas of project administration, financial management and&#13;
procurement.  The PCU  will have a Finance and Administration Unit responsible for&#13;
procurement, disbursement and accounting for both the World Bank and ADB projects. In&#13;
addition, separate units will be established to oversee implementation of the different projects.&#13;
During negotiations, assurances were also obtained that the Chiefs of the Finance and&#13;
Administration Unit and World Bank Operations Unit and Construction Manager will be&#13;
recruited on an international basis and appointed as a condition of effectiveness (para. 7.1 (a)).&#13;
Certain operational costs of the PCU (PCU Manager, Finance and Administration Unit) will be&#13;
jointly funded by the World Bank and ADB. Details of the organizational structure of the PCU&#13;
and the terms of reference for the Steering Committee and the PCU staff are provided in&#13;
Annex 7.&#13;
5.3   The provincial health authorities will be responsible for the overall management and&#13;
supervision of project activities at the provincial level and will act as the link between the central&#13;
PCU/MOH and the operational district health system. A small Provincial Project Unit (PPU)&#13;
will be set-up within the health directorate, headed by a Provincial Project Director nominated by&#13;
the Provincial Health Director and confirmed by the MOH. During negotiations, agreement was&#13;
reached that appointment of a Provincial Project Director in each of the six Phase Iprovinces is&#13;
a condition of effectiveness and the appointment of a Provincial Project Unit Directors in each&#13;
of the remaining four Phase II project province is due by September 30, 1997 (para. 7.1 (b)).&#13;
The main functions of the PPU include (i) facilitating the timely implementation of the project in&#13;
close coordination with the MOH/PCU; (ii) ensuring the timely flow of funds, particularly travel&#13;
and per diem costs for supervision, paid out of the provincial Supervision Fund; and (iii) day-to-&#13;
day monitoring of the project. During negotiations, agreement was reached that the Provincial&#13;
&#13;
&#13;
&amp;#12;&#13;
- 29 -&#13;
Supervision Fund agreements will be prepared, satisfactory to IDA, by June 30, 1997, and will&#13;
be entered into by September 30, 1997 for the Phase I provinces and by September 30, 1998 for&#13;
the Phase II provinces (para. 7.1 (d)). The detailed arrangements for managing the Provincial&#13;
Supervision Fund are contained in the Project Implementation Plan.&#13;
B. IMPLEMENTATION ARRANGEMENTS&#13;
Health Management Agreements&#13;
5.4  In order to define the expectations and responsibilities of both the MOH and the&#13;
provincial authorities clearly under the Project, Health Management Agreements (HMA) would&#13;
be entered into for each of the ten provinces supported by the Health Strengthening component&#13;
(see Annex 8). The aim of instituting such agreements is to change the nature of the relationship&#13;
between the MOH and the provincial health authorities to one of mutual responsibility and&#13;
accountability, with a single overall purpose of improving performance of public sector health&#13;
services.&#13;
5.5   The HMAs would provide a framework for planning and managing the health programs&#13;
covered by the Project (TB, Malaria, HIV/AIDS, and Health Coverage Plan). They would&#13;
govern the provision of inputs by MOH to the provinces in return for provincial agreement to&#13;
attain annual targets in disease control and other areas. Commitments made by the MOH and the&#13;
Provincial Health Authorities would be clearly specified in terms of annual health objectives,&#13;
inputs, and processes with quantifiable and monitorable targets set. These annual plans would be&#13;
defined and agreed in the context of 5-year goals and outcome/impact indicators. The HMAs&#13;
would have no legal status, rather they would be used as a planning and management tool.&#13;
However, they will be monitored and evaluated and action would be taken in response to&#13;
performance. From the detailed performance indicators contained in the HMAs, a group of more&#13;
broadly indicative measures have been selected as Project Performance Indicators. These are&#13;
presented in Annex 9.&#13;
5.6   The HMAs will be formulated and agreed annually at provincial planning workshops&#13;
with the involvement of representatives from the Provincial Governors' Office, the Provincial&#13;
Health Directorate, MOH (including Ministry level representatives from the three disease control&#13;
programs) and the PCU. The provincial health advisors (PHAs) and donor organizations&#13;
assisting a given province will also be invited to the planning process and negotiations. During&#13;
negotiations, agreement was reached that no expenditures by any province for civil works or&#13;
medical equipment will be made unless the Ministry of Health and the province concerned have&#13;
entered into their respective Health Management Agreement for the first year (para. 7.1 (c)).&#13;
5.7  Ideally this type of agreement would also be made between the provinces and the&#13;
districts, but currently most districts are judged managerially too weak to undertake this type of&#13;
agreement in the early stages of the Project. As district health office capacities improve, they&#13;
could enter into sub-agreements with the provinces.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 30 -&#13;
Implementation of National Disease Control Programs&#13;
Tuberculosis Control Program&#13;
5.8   The overall responsibility for implementation of the TB Control component rests with the&#13;
National Anti-Tuberculosis Center (CENAT). CENAT will be responsible for establishing the&#13;
policies for case management, consolidating annual project plans and budgets, monitoring&#13;
provincial TB control activities, and assisting in the preparation of project reports and&#13;
documentation. CENAT will prepare biannual TB drug forecasts by monitoring drug use and&#13;
stocks and, jointly with CMS, determine drug procurement and provincial allocations. Provincial&#13;
TB Supervisors are responsible for monitoring the distribution of TB drugs and supplies to the&#13;
district health facilities and for the supervision of TB case management. CENAT will conduct&#13;
five training sessions annually in short course chemotherapy, annual training of provincial&#13;
supervisors and arrange international training and fellowships. By the end of 1996, CENAT will&#13;
have trained staff in all facilities eligible to offer hospitalization and short course chemotherapy.&#13;
During negotiations, an understanding was reached that the government, with available donor&#13;
funding, wouldfinance the cost offood supplementation for TB patient hospitalization and, as&#13;
resources permit, for the ambulatory phase of chemotherapy (para. 7.2 (c)).&#13;
Malaria Control Program&#13;
5.9   The responsibility for the Malaria Control Program rests with the National Malaria&#13;
Center (CNM). CNM would have similar responsibilities as CENAT, that is, establishing the&#13;
policies for case management, consolidating annual project plans and budgets, monitoring&#13;
provincial malaria control activities, and assisting in the preparation of project reports and&#13;
documentation. CNM would also prepare biannual malaria drug forecasts by monitoring drug&#13;
use and stocks and, jointly with CMS, determine drug procurement and provincial allocations.&#13;
Provincial Supervisors are responsible for monitoring the malaria control program at the district&#13;
level and organizing training. In addition, over the life of the project, CNM staff will manage&#13;
and conduct studies of vivo and in vitro drug resistance, drug efficacy, malaria prevalence, vector&#13;
control (bednet) effectiveness, bednet social marketing and entomological studies. Research will&#13;
be carried out to test antigen test kits, examination of malaria during pregnancy, and community&#13;
based epidemiologic assessments of bednet effectiveness.&#13;
5.10  The bednet program, including the social marketing pilot activity, would be managed at&#13;
the central level by the CNM under the leadership of a Bednet Program Manager. The Program&#13;
Manager will have overall responsibility for planning and managing CNM support for&#13;
implementation at provincial, district and commune levels, and for program evaluation. A&#13;
National Bednet Steering Committee comprised of CNM, donors and, relevant NGOs, will also&#13;
be established for defining policy, standard setting and identifying resource requirements.&#13;
During negotiations, agreement was reached that government will furnish IDA with a social&#13;
marketing and national bednet distribution and treatment strategy (including a cost recovery&#13;
proposal) by January 31, 1997for IDA review, and thereafter promptly carry out an action plan&#13;
acceptable to IDA (para. 7.1 (o)). Key partners in program implementation are ODA, WHO and&#13;
NGOs already implementing bednet projects in the country.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 31 -&#13;
HIVIAIDS Program&#13;
5.11  Overall responsibility for the management and implementation of the HIV/AIDS&#13;
component will rest with the National AIDS Office located within the Ministry of Health. The&#13;
director of the NAO will be the HIV/AIDS and STD component Project Manager. The status of&#13;
the NAO will be raised to that of a department within MOH and additionally, a finance and an&#13;
administrative officer will be appointed to this department. During negotiations, assurances&#13;
were obtained from government that these two appointments and the elevation of NAO to&#13;
departmental status will take place not later than September 30, 1997 (para. 7.1 (f)). Technical&#13;
assistance will be provided on an intermittent basis to assist with overall project management and&#13;
implementation.&#13;
5.12 The HIV/AIDS Grant Fund will be managed through a Project Grants Committee&#13;
consisting of the director of the NAO (chairperson), a representative of the MOH/PCU and other&#13;
representation to be determined. The Committee will solicit applications to the Fund, review&#13;
these applications and reach decisions about the content of activities to be supported and the&#13;
resources to be allocated. The Committee will also be responsible for reviewing progress and&#13;
evaluating results of activities undertaken through this Fund.  Details of the proposed&#13;
management structure and operational procedures of the Fund are provided in Annex 3.&#13;
5.13  The Project will finance several elements of the blood safety effort under the MOH Blood&#13;
Transfusion Services. Training of counselors to notify HIV positive blood donors will require&#13;
first an agreement on notification and counseling protocols progress on which is well advanced&#13;
between the MOH, the International Commission for the Red Cross and other donors.&#13;
Implementation of Health Service Strengthening&#13;
Civil Works&#13;
5.14  The MOH/PCU will be responsible for initiating, monitoring and ensuring that correct&#13;
implementation procedures are followed during all stages of civil works implementation. During&#13;
negotiations, agreement was reached on the criteria to be usedfor the selection of health centers&#13;
and referral hospitals for upgrading (para. 7.1 (p)). The PCU will contract with qualified&#13;
personnel to prepare technical specifications, supervise construction and disbursements, and be&#13;
responsible for certification of completion. During negotiations, assurances were receivedfrom&#13;
government that final implementation arrangements for contracting and supervision of civil&#13;
works would be established by December 31, 1996 for Phase I provinces and by December 31,&#13;
1997 for Phase II provinces (para. 7.1 (i)).&#13;
5.15  Details of the implementation arrangements are provided in the Project Implementation&#13;
Plan. In summary, the PCU would select consultants, in accordance with Bank guidelines, to&#13;
inspect existing facilities and prepare the final design proposals, based on the PCU models, for&#13;
MOH/PCU approval.  Once approved, the PCU initiates the preparation of the bidding&#13;
documents. Tenders/bids are then invited by the PCU in accordance with agreed procurement&#13;
guidelines. Contract supervision will be carried out by the consultants who will report monthly&#13;
&#13;
&#13;
&amp;#12;&#13;
- 32 -&#13;
to the PCU/Construction Manager. The PPU will also monitor the work on a random basis and&#13;
report to the MOH/PCU.&#13;
5.16  The importance and form of an institutionalized maintenance and repair strategy for civil&#13;
works was agreed with the MOH during preparation. During negotiations, assurances were&#13;
receivedfrom government that a senior technicalfacilities manager will be appointed no later&#13;
than September 30, 1997 in the Phase I provinces and not later than September 30, 1998 in the&#13;
Phase II provinces (para. 7.1 (e)).  The facilities manager will be responsible for the&#13;
management and supervision of regular and preventive maintenance of all health facilities in that&#13;
province. He/she will have a budget specifically for maintenance which will be used to contract&#13;
reliable local contractors to do the work.&#13;
Equipment, Essential Drugs and In-Service Training&#13;
5.17 Both medical equipment and drugs would be procured by the MOH/PCU, in close&#13;
collaboration with the Procurement Unit at the Department of Pharmacy.  Storage and&#13;
distribution would be done through the logistics system of the Central Medical Stores (CMS) of&#13;
the Ministry of Health. This logistics system is considered adequate to meet the needs of the&#13;
project, given the recent expansion in warehouse and trucking capacity under a previous IDA&#13;
project. Basic equipment provided under the project would predominantly be low maintenance.&#13;
Maintenance of more complex equipment, such as X-ray machines, would be written into the&#13;
purchase contract. In addition, training in the routine maintenance of hospital equipment will be&#13;
provided to technicians in the referral hospitals upgraded under the project. Monitoring and&#13;
control of drug and equipment supplies would be done through the existing computerized&#13;
tracking system, so as to avoid irregular supplies. Indicators would be set and their progress&#13;
tracked over time to monitor and improve the planning and timeliness of the procurement and&#13;
distribution of medical supplies, drugs and equipment.&#13;
5.18 During negotiations, assurances were obtained from government that the health centers&#13;
and referral hospitals upgraded under the project be adequately staffed (para. 7.1 (q)). During&#13;
negotiations, assurances were also obtainedfrom Government that a national in-service training&#13;
strategy be implemented by March 31, 1997. Moreover, a time bound plan for the training of&#13;
health staff at the health centers and referral hospitals upgraded under the project will be&#13;
furnished to IDA by March 31, 1997, and promptly thereafter, the government will carry out&#13;
such a plan taking into account IDA's comments (para. 7.1 (n)). Such a plan would include&#13;
disease control training supported by the project. The MOH/PCU will be responsible for&#13;
identifying the medical personnel for the one year training in obstetrics/surgery and&#13;
anesthesiology. The training will take place at national and provincial institutes selected by the&#13;
MOH Committee on surgical training.&#13;
C. ACCOUNTS AND AUDITING&#13;
5.19 The total project account would be managed by the PCU in the MOH, and separate&#13;
accounts for project activities would also be maintained by each province (for the expenses&#13;
eligible for reimbursement under the provincial supervision cost category) and national institutes&#13;
&#13;
&#13;
&amp;#12;&#13;
- 33 -&#13;
in accordance with sound accounting practices. The project accounts would reflect all financial&#13;
transactions during the project implementation period for both the IDA Credit and the&#13;
counterpart funding in two books, one by project components and one by expenditure categories.&#13;
5.20  Project accounts would be audited in accordance with the Guidelines for Financial&#13;
Reporting and Auditing of Projects Financed by the World Bank (1992). During negotiations,&#13;
assurances were obtained that audits of project-related financial records and accounts,&#13;
including the Special Account, will be undertaken in accordance with appropriate accounting&#13;
principles by independent auditors acceptable to IDA.  Audited accounts and financial&#13;
statements, in a format agreed with IDA, and including audited Statement of Expenditures, will&#13;
be sent to IDA within six months after the end of each Government fiscal year (para. 7.1 6)). In&#13;
addition, at negotiations, assurances were obtained that Technical Performance Audits of HMAs&#13;
will be carried out on a random basis beginning in January 1998 (para. 7.1 (h)).&#13;
D. PROJECT MONITORING, EVALUATION AND REPORTING&#13;
5.21  The PCU will be responsible for monitoring project implementation progress and&#13;
performance. A baseline survey would be conducted in the first year of implementation to&#13;
establish project performance indicator measures. The Health Management Agreements would&#13;
set out implementation targets against which project performance will be monitored. During&#13;
negotiations, an understanding was reached that monitoring of these targets would be carried&#13;
out on a semi-annual basis by the PCU, commencing Fiscal Year 1997, which will then report to&#13;
IDA on (i) progress on major activities; and (ii) achievement or production of agreed outputs&#13;
(para. 7.2 (b)). The Project Performance Indicators in Annex 9 provide the framework for the&#13;
semi-annual reports, the format of which should be acceptable to IDA. There will be an annual&#13;
review of HMA performance at the provincial level before planning the following year's&#13;
agreement. During negotiations, assurances were received that an annual project budget will be&#13;
submitted by the PCU to IDA by November 30 of each year in the Project, beginning November&#13;
30, 1996 (para. 7.1 (m)).&#13;
5.22 During negotiations, assurances were received that by March 31, 1999, the MOH will&#13;
submit a comprehensive mid-term review report evaluating project performance based on the&#13;
documented experience of the monitoring, as well as at least one impact study and the technical&#13;
performance audits. Based on this review, discussions will be held with IDA by June 30, 1999,&#13;
as to the need for any changes in project design and the implementation targets (para. 7.1 (k)).&#13;
Also, assurances were obtained from the Government that a final evaluative survey would be&#13;
carried out by June 30, 2001 and the results of this survey would be furnished to IDA for&#13;
comments by March 31, 2002. Within six months of the closing date, the Government will submit&#13;
afinal report to IDA on the project and a plan of such scope and detail, IDA may request for the&#13;
future operation of the completed project (para. 7.1 (1)).&#13;
E. ENVIRONMENTAL ASPECTS&#13;
5.23  The proposed project would have no significant impact on the environment. Protocols&#13;
would be developed for the safe disposal of syringes and medical waste at all health facilities&#13;
&#13;
&#13;
&amp;#12;&#13;
- 34 -&#13;
covered under the Health Strengthening component, and their implementation would be&#13;
monitored during supervision. Permethrin, or another similar insecticide, will be used to&#13;
impregnate bednets distributed under the malaria program. These are non-toxic to mammals and&#13;
are classified as "unlikely to present any health hazard in normal use." They are toxic to aquatic&#13;
fauna, including fish. However, its restricted and supervised use under the bednet program will&#13;
exclude any environmental impact. Project activities will result in no involuntary resettlement or&#13;
displacement.&#13;
F. PARTICIPATION&#13;
5.24  Project preparation was conducted using a participatory approach, and all efforts were&#13;
made to involve various stakeholders in project design and implementation decisions. First,&#13;
extensive discussions were held with MOH staff, provincial and district health authorities and&#13;
donors, including provincial health advisors, to determine the scope and coverage of the project.&#13;
Second, technical working groups drawn from the line departments were convened to consider&#13;
policy and technical issues specific to the project components. Third, a number of seminars were&#13;
held on various topics such as Health Management Agreements, AIDS, and Malaria to invite&#13;
comments and suggestions from a wider audience with representation from NGOs.&#13;
5.25  A PHRD grant has funded key aspects of project preparation, and the execution of the&#13;
grant is split between MOH and the Association. MOH has used these funds to conduct various&#13;
surveys and studies including an infrastructure and equipment survey, a social marketing study, a&#13;
TB patient compliance study and a study of intravenous drug abuse as a potential route of HIV&#13;
transmission (the latter three studies all employed focus group research techniques) to determine&#13;
component inputs based on community needs. A project implementation plan has been prepared&#13;
by MOH and jointly reviewed with the mission on a regular basis. In addition, during the later&#13;
stages of project preparation and implementation, evaluation and assessment activities will be&#13;
carried out to measure potential and actual popular response to service strategies.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 35 -&#13;
6. PROJECT BENEFITS, RISKS AND SUSTAINABILITY&#13;
A. BENEFITS&#13;
6.1   The benefits of the project correspond to measurable indicators of impact on the three&#13;
targeted disease control programs and in the improved access of rural Cambodians to basic health&#13;
services. The performance of the project will be measured in detail in the 10 provinces in which&#13;
the project will combine its health strengthening investments, its managerial improvements, and&#13;
its national disease control activities. In addition, the project will measure results of the three&#13;
disease control programs on a national basis, to evaluate the impact of indivisible national&#13;
program investments. A list of performance indicators by input, output, and impact and by&#13;
project and national program scope is detailed in Annex 9.&#13;
6.2   For TB, the total number of treated cases over the five year period is targeted at 106,000.&#13;
This is based on the need to reach an annual treatment target of 24,000 in the final year of the&#13;
project, at which point the annual prevalent pool of cases should have begun to decrease and the&#13;
incidence of new cases to decline. The project will calculate the annual risk of infection in the&#13;
final year of the project to estimate whether these declines, set to occur over a 5 to 10 year time&#13;
frame, have commenced. Such declines could be delayed by a substantial AIDS-associated rise&#13;
in TB cases. The fatality rate of active, untreated TB cases is not known for Cambodia with&#13;
precision. However, practitioners regard it, with malaria, as one of the leading causes of&#13;
premature fatality among children and especially young adults.&#13;
6.3   For malaria control, the project will intervene to treat the disease through more effective&#13;
case management and to prevent infection through bednet vector control. The incidence of&#13;
malaria in any one area is highly variable from year to year depending on weather, migration and&#13;
work habits, and to the quality of clinics and hospitals which will determine the flow of patients&#13;
with malaria. The malaria program has targeted a 30 percent decline in incidence over three&#13;
years in its first phase provinces for bednet distribution. The overall impact measure will be a&#13;
proxy indicator of the prevalence of malaria at a point in time; this will be determined by means&#13;
of periodic surveys of blood slide positively in the population. The impact on mortality will be&#13;
measured by the hospital case fatality rate, which is targeted to decline to below 2 percent by the&#13;
year 2000.&#13;
6.4   Impact on HIV incidence is difficult to predict due to the early stage of the epidemic, the&#13;
difficulty in predicting its likely trajectory, and the need for more knowledge of the effectiveness&#13;
of the various preventive interventions supported by the project. Further analytical work will be&#13;
conducted under the project to determine the possible path of the epidemic based on recently&#13;
analyzed Thai epidemiologic data. It is certainly probable that at a minimum, the rate of increase&#13;
of sero-positive blood donations will decline from its current doubling every year to far lower&#13;
rates of increase, and that the same will occur in the data on key risk groups (prostitutes and&#13;
soldiers), as has been the case in Thailand. The performance of the HIV component will be&#13;
measured more reliably by input and output indicators in the early stages of the project.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 36 -&#13;
6.5   The beneficiaries of the TB and Malaria Control Programs will tend to be poor, rural&#13;
residents. Children and women will likely share these benefits at least in proportion to their&#13;
shares of population, which in Cambodia are higher than regional averages. The beneficiaries of&#13;
the HIV program will be members of the core risk groups in the near term, as they will receive&#13;
disproportionate levels of interventions through the NGO Small Grants Program, the Outreach&#13;
Program and sentinel surveillance. In addition, rural families in the 10 project provinces will&#13;
benefit from increased access to health centers offering the Government's minimum package of&#13;
services. Upgraded referral hospitals will provide the full range of Health Coverage Plan&#13;
Clinical Services.&#13;
6.6   The Health Strengthening component will improve access and raise utilization of modem&#13;
health services at the health center and hospital level in the 10 project provinces. About 2&#13;
million people will have access to health centers and functioning referral facilities as a result of&#13;
the project.&#13;
B. RISKS&#13;
6.7   There are three main project risks. First, the management capacities of the MOH and its&#13;
provincial counterparts have been overestimated, such that implementation of the provincial Health&#13;
Management Agreements will be slower than planned. Second, there is a possible shortage of&#13;
adequately skilled health personnel to staff and run the upgraded district-level facilities. Third, the&#13;
zone of insecurity (due to the continuing insurgency) may expand rather than contract, causing the&#13;
project to restrict its investments to a smaller scale than envisioned.&#13;
6.8   Care has been taken to minimize these risks during project preparation and appraisal. In&#13;
terms of management capacity, both the scale and phasing of the project have been designed to&#13;
reflect the management and implementation capabilities at the provincial levels. Management&#13;
capacity, measured in part by the presence of a donor-funded health advisor at the provincial&#13;
level, was a key criterion in determining which provinces the project would cover and how to&#13;
phase project inputs. Management training will be provided under a contract for health center&#13;
commissioning and through a parallel WHO-executed project.&#13;
6.9   As for the potential lack of adequately skilled and trained staff, the management and&#13;
skills training needs of the provincial and district health authorities has been assessed and an&#13;
initial estimate made of the resources committed to these programs by other donors. Sufficient&#13;
resources are available to cover most in-service training requirements. The Government has&#13;
agreed to prepare a National In-Service Training Plan to guide the allocation of Government and&#13;
donor resources. The project will provide for training of surgeons and anesthetists placed in full&#13;
referral hospitals. The PCU will coordinate closely with the donors and NGOs involved in&#13;
training, to ensure that the training needs of the IDA-financed provinces will be met.&#13;
6.10  The only risk that cannot be reduced through project preparation efforts is insecurity, a&#13;
factor affecting all development investments in Cambodia. For the past year, the zone of&#13;
insecurity has contracted steadily, an encouraging but not yet definitive development in the&#13;
&#13;
&#13;
&amp;#12;&#13;
- 37 -&#13;
Cambodian context. The project design has taken the current situation into account by reducing&#13;
project activities in provinces where the security situation remains unstable.&#13;
C. SUSTAINABILITY&#13;
Fiscal Impact&#13;
6.11   The annual recurrent cost implications of the project itself are minor. These include&#13;
maintenance and repair costs for facilities, replacement of foreign financed inputs, such as&#13;
medical equipment, bednets and to a much smaller extent drugs, 80 percent of which will be&#13;
financed by the Government budget during the project. Thus, these recurrent costs of US$2.6&#13;
million would consume less than 5.2 percent of the projected health budget in the year 2001.&#13;
Even if the analysis uses total program recurrent costs (instead of the project), the burden is still&#13;
manageable. The annual recurrent cost implications of the program have been estimated to be&#13;
approximately US$12 million a year. These recurrent costs cover the major health programs of&#13;
the MOH and the provincial delivery system. A report on Sustainability Analysis is included in&#13;
the Project Implementation Plan.&#13;
Cost Recovery&#13;
6.12  In several instances, the project has assessed the potential for cost recovery initiatives,&#13;
with positive results. Thus, within the broad public health rationale for public financing, there&#13;
are health services for which there is substantial (if inadequate) willingness to pay, with potential&#13;
benefits to project sustainability and, to a lesser extent, the government's fiscal position.&#13;
6.13  In the case of bednet distribution, a market feasibility study was completed for appraisal,&#13;
indicating that the bednet market in Cambodia was large and well distributed nationally, but that&#13;
prices confined demand to the more well-off households. Using focus group methods, the&#13;
analysis indicated a range of subsidized prices which would be affordable for the populations&#13;
living in endemic areas. These findings will be applied to a social marketing pilot in two&#13;
provinces and to the government's distribution of bednets through health facilities.&#13;
6.14  In the case of new health centers constructed under the project, an analysis of pilot health&#13;
centers and the implementation of a modest out-patient fee schedule revealed promising results&#13;
for the sustainability, utilization, and quality of health center services. Thus, the project will&#13;
finance the introduction of a similar cost recovery mechanism in Phase I provinces.&#13;
6.15   Finally, the study on TB food supplementation (see above) considered lowering the food&#13;
subsidy so as to lower food costs and raise patient contribution to their treatment. Patients&#13;
receive free drugs, hospitalization, and food under current policy, but must pay transport costs,&#13;
and foregone household production. The analysis concluded that the very low income profile of&#13;
TB patients argued for a full food subsidy, as did the evidence of low patient compliance in&#13;
hospitals where food supplementation was interrupted.&#13;
&#13;
&#13;
&amp;#12;&#13;
-38 -&#13;
7. AGREEMENTS REACHED AND RECOMMENDATION&#13;
7.1   During negotiations, the Government provided assurances that:&#13;
(a)   it will establish a Project Coordination Unit, with competent personnel in&#13;
sufficient numbers, and select a PCU Manager, the Chief of the Administration&#13;
and Finance Unit, the Chief of the World Bank Operations Unit and a&#13;
Construction Manager in the World Bank Operations Unit acceptable to IDA, as a&#13;
condition of effectiveness (para. 5.2).&#13;
(b)   a Provincial Project Unit in the Provincial Health Directorate will be established&#13;
and the Provincial Project Director appointed for each of the six Phase I project&#13;
provinces as a condition of effectiveness. The Provincial Project Directors for&#13;
each of the four Phase I1 provinces would be appointed by September 30, 1997&#13;
(para. 5.3).&#13;
(c)   no expenditures by any province for civil works or medical equipment will be&#13;
made unless the Ministry of Health and the province concerned have entered into&#13;
their respective Health Management Agreement for the first year (para. 5.6).&#13;
(d)   it will prepare, satisfactory to IDA, implementation arrangements for the&#13;
provincial supervision costs, including the basic agreement between the MOH and&#13;
the participating Provincial Project Director, by June 30, 1997. It will enter into&#13;
such supervision agreements with Phase I provinces by September 30, 1997 and&#13;
Phase II provinces by September 30, 1998 (para. 5.3).&#13;
(e)   it will appoint senior technical facilities managers responsible for management of&#13;
regular preventive maintenance of upgraded provincial health facilities by&#13;
September 30, 1997 in the six Phase I project provinces, and by September 30,&#13;
1998 in the four Phase II project provinces (para. 5.16).&#13;
(f)   an administrative officer and a financial officer will be appointed to the NAO, and&#13;
the NAO elevated to Department status within the MOH by September 30, 1997&#13;
(para. 5.11).&#13;
(g)   it will prepare a performance evaluation report of the Outreach Program under the&#13;
HIV/AIDS Component covering the first two years of implementation, and submit&#13;
for the approval of IDA, not later than December 31, 1997, the evaluation report&#13;
and recommendations for further financing of the outreach program from the&#13;
unallocated category of the project (para. 3.26).&#13;
(h)   technical performance audits of the implementation of HMAs will be conducted&#13;
on a random basis starting in January, 1998 and the audit reports will be submitted&#13;
to IDA (para 5.20).&#13;
&#13;
&#13;
&amp;#12;&#13;
- 39 -&#13;
(i)   it will enter into a contractual relationship, acceptable to IDA, to prepare the&#13;
technical specifications and bidding documents, to supervise construction and to&#13;
disburse to contractors, for the first phase of construction of facilities by&#13;
December 31, 1996 and for the second phase of construction by December 31,&#13;
1997 (para. 5.14).&#13;
(j)   audits of project-related records and accounts, including the Special Account, will&#13;
be undertaken in accordance with appropriate accounting principles consistently&#13;
applied, by independent auditors acceptable to IDA, and that audited accounts and&#13;
financial statements, in a format agreed with IDA, and including separate audits of&#13;
Statement of Expenditures, will be sent to IDA within six months of the end of&#13;
each Government fiscal year (para. 5.20).&#13;
(k)   it will prepare under terms of reference satisfactory to the Association, and&#13;
furnish to the Association, on or about March 31, 1999, a report integrating the&#13;
results of the monitoring and evaluation activities on the progress achieved in the&#13;
carrying out of the Project during the period preceding the date of the report. This&#13;
report will be reviewed with IDA by June 30, 1999 (para. 5.22).&#13;
(1)   it will conduct a final evaluative survey by June 30, 2001 and submit to IDA, by&#13;
March 31, 2002, the results of this survey. The final evaluation report on the&#13;
project and a plan of such scope and detail as IDA may request for the future&#13;
operation of the completed project will be submitted to IDA within six months of&#13;
the Completion Date of the Project (para. 5.22).&#13;
(m)   it will no later than November 30 in each fiscal year, commencing November 30,&#13;
1996, and until completion of the Project, furnish to the Association the annual&#13;
work program and related budget for all project activities, acceptable to IDA&#13;
(para. 5.21).&#13;
(n)   it will prepare and implement a National In-Service Training Plan and Strategy&#13;
acceptable to IDA by March 31, 1997, including a time bound plan for the&#13;
training of staff at health centers and referral hospitals upgraded under the project,&#13;
and promptly thereafter carry out such plan taking into account IDA's comments&#13;
(para. 5.18).&#13;
(o)   it will submit to IDA for comments and review by January 31, 1997 a social&#13;
marketing strategy for bednet distribution and treatment, including a strategy for&#13;
cost recovery, and based on such discussions prepare a proposed action plan for&#13;
discussion with IDA and promptly carry out said action plan (para. 5.10).&#13;
(p)   it will select health centers and referral hospitals to be upgraded under the project&#13;
in accordance with criteria acceptable to IDA (para. 5.14).&#13;
(q)   it will adequately staff health centers and referral hospitals upgraded under the&#13;
project (para. 5.18).&#13;
&#13;
&#13;
&amp;#12;&#13;
- 40 -&#13;
(r)   it will, not later than January 31, 1997, implement through the MOH a national&#13;
policy satisfactory to IDA on charging and collecting fees from patients for&#13;
services rendered at its national health facilities, including the policy on retention&#13;
of fees, the policy on setting and adjusting the schedule of fees, and the allowable&#13;
expenditure of fee revenues (para. 3.42).&#13;
(s)   it will appoint an HIV/AIDS Project Grant Committee not later than January 31,&#13;
1997, with responsibilities and membership satisfactory to IDA (para. 3.29).&#13;
7.2  In addition to the above agreements, the Government agreed to the following&#13;
understandings:&#13;
(a)   it will exempt the project from customs taxes and duties, or will make available to&#13;
MOH a budget allocation to cover the costs of custom duties and taxes, including&#13;
taxation of consultants (para. 4.3).&#13;
(b)   semi-annual progress reports will be furnished to IDA by June 30 and December&#13;
31 of each year commencing Fiscal Year 1997, in a format acceptable to IDA&#13;
(para. 5.21).&#13;
(c)   the government, with available donor funding, will finance the cost of food&#13;
supplementation for TB patient hospitalization and, as resources permit, for the&#13;
ambulatory phase of chemotherapy (para. 5.8).&#13;
7.3  In addition to the above agreements, prior to negotiations, the MOH provided IDA with&#13;
its standard format for a consultant contract to ensure its compliance with the Bank's guidelines&#13;
and the Standard Form of Contract for Consulting Services, June 1995 (para. 4.9 (c)).&#13;
7.4   Subject to the conditions in paras. 7.1 and 7.2 above, the proposed project would&#13;
constitute a suitable basis for an ITF Credit of SDR 20.6 million (US$30.4 million equivalent) to&#13;
the Kingdom of Cambodia on standard IDA terms with a maturity of 40 years and 10 years&#13;
grace.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 41-                               Annex I&#13;
KINGDOM OF CAMBODIA&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT PROJECT&#13;
Support to National Tuberculosis Program&#13;
The detailed TB component description and budget is found in the project implementation&#13;
plan.&#13;
I. Background&#13;
1.    The National Tuberculosis Program (NTP) was started in 1980 with the establishment&#13;
of a national network of microscopists and treatment centers. The program has been&#13;
reorganized to incorporate short course tuberculosis therapy, long term technical support by&#13;
the World Health Organization (WHO), the production and distribution of a TB program&#13;
manual, a change in clinical and laboratory records in accordance with international&#13;
standards, and a change from suboptimal 12 month anti-TB therapy to a modem short course&#13;
therapy, all starting in 1994.&#13;
2.    The "new" NTP is being implemented by the Centre National Anti Tuberculeux&#13;
(CENAT), one of the seven central institutes in the Ministry of Health. CENAT consists of a&#13;
central office in Phnom Penh with approximately 20 staff and over 115 provincial and&#13;
district hospitals throughout the country. Provincial and district TB control activities are&#13;
conducted in the respective hospitals where TB patients are diagnosed and treated. Some&#13;
provincial supervisors may be members of the provincial hygiene station under the direction&#13;
of the provincial director for public health, others are employees of the provincial hospital&#13;
without direct connections with the hygiene station. Supervision from the provincial level&#13;
down, government programs for patient feeding, and general hospitalization and staffing&#13;
costs are borne by provincial governments. CENAT does not include commune or village&#13;
level facilities.&#13;
3.    Patient Diagnosis and Treatment. Patients suspected of having TB are diagnosed at&#13;
hospitals within the CENAT system. If a patient suspected of having TB is seen outside the&#13;
system, i.e. at a commune clinic, a referral is made to a provincial or district hospital within&#13;
the system. Diagnosis is based upon unconcentrated sputum smears stained for acid-fast&#13;
bacilli (AFB) at each treatment facility. Patients with negative sputum AFB smears undergo&#13;
a series of clinical evaluations over six weeks for the diagnosis of AFB smear negative TB.&#13;
The treatment of TB consists of multiple antibiotics given concurrently for 8 to 12 months.&#13;
Several regimens are used, incorporating all or some of the antibiotics streptomycin,&#13;
pyrazinamide, rifampicin, isoniazid, and ethambutol. Drug requirements are calculated on a&#13;
quarterly basis at all treatment facilities based upon registry tabulations and passed to the&#13;
central office. These requests are then shared with the Central Medical Stores (CMS) in the&#13;
Ministry of Health which in turn is responsible for the acquisition and distribution of drugs&#13;
for the country.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 42 -                              Annex 1&#13;
4.    An intensive phas of treatment, lasting the first two or three months depending on&#13;
the regimen used, is directly observed and is almost always completed on an in-patient basis.&#13;
If ambulatory care is offered during the intensive phase, then the patient must make daily&#13;
visits to the hospital for supervised therapy. The continuation phase of therapy is done on an&#13;
ambulatory basis with the patients given monthly supplies of medications. No formal&#13;
outreach activities are included in the NTP at this time.&#13;
5.    Food supplements in the form of rice, oil, fish and protein biscuits are provided to the&#13;
patients on a daily basis while in the hospital, and on a monthly basis as an out-patient. The&#13;
food program has been credited with enabling the patients to remain in the hospital through&#13;
the intensive phase of therapy and acting as an incentive for completing their therapy as an&#13;
out-patient.&#13;
6.    Training and Supervision. An extensive training program has been established to&#13;
implement the recent changes in the TB control program. In addition, ongoing training for&#13;
microscopists is conducted to maintain competency of AFB smear reading in the field. A&#13;
five day course is required for participants in the new program covering the theoretical&#13;
groundwork for short course chemotherapy, the use of the short course antibiotic regimen,&#13;
the new registries and cohort analysis. The seminar is followed by a field visit by the&#13;
training team to the hospital from which the seminar participants work. In addition, a bi-&#13;
annual meeting of participants is held to present the results of hospital experience and&#13;
program analyses.&#13;
7.    The NTP has had the benefit of a long-term advisor from the WHO for program&#13;
development and implementation. A three tiered supervisory system is established with the&#13;
central office overseeing the provincial offices and the provincial office overseeing the&#13;
district offices. Regular supervisory visits are scheduled at the central and provincial level on&#13;
a monthly basis. Tabulation of TB registry information and cohort analysis is conducted at&#13;
all levels, with the information collected by provincial supervisors and passed on to the&#13;
central office.&#13;
8.    Laboratory Services. In addition to a simple microscopy laboratory at each treatment&#13;
facility, CENAT includes a reference mycobacteriology laboratory. The facility is currently&#13;
being renovated in order to culture for M tuberculosis and to perform identification and&#13;
susceptibility testing. There are two long-term laboratory consultants, one supervisor, and 12&#13;
technicians working at the facility. This team is responsible for the training of all AFB smear&#13;
laboratory technicians, the preparation of AFB staining supplies for the country, the quality&#13;
control of AFB slide staining and interpretation in all of approximately 150 laboratories, and&#13;
the conduct of future M tuberculosis drug-resistance surveys.&#13;
9.    Program Evaluation and Surveys. Quarterly cohort analysis of TB patients is an&#13;
integral part of the program. Indicators included in the analysis include: number of new&#13;
cases and treatment regimens used, number and proportion of patients completing therapy,&#13;
number and proportion of patients confirmed cured by sputum microscopy, number of&#13;
patients who died, number of patients who defaulted from therapy, and the number of&#13;
&#13;
&#13;
&amp;#12;&#13;
I-43-                                Annex 1&#13;
patients who transferred to another treatment facility. These results are compiled and&#13;
computerized at the central office and shared with all supervisors at the bi-annual TB&#13;
supervisors meetings.&#13;
10.   Several surveys are built into the program, including an initial TB prevalence survey,&#13;
tuberculin skin test surveys to be conducted every five years, and M tuberculosis drug-&#13;
resistance and HIV infection prevalence surveys yearly.&#13;
II. Program Function and Implementation&#13;
11.   The NTP is well founded in internationally accepted concepts of TB control in low&#13;
income countries. Given the combination of the extraordinary burden of tuberculosis in the&#13;
population, coupled with the proven efficacy of well implemented TB control, the NTP has&#13;
the potential to greatly impact the future health of Cambodians. CENAT has been able to&#13;
implement the new NTP with an impressive agenda starting in 1994. Implementation&#13;
consists of training and support of hospitals with sufficient staff and facilities to carry out the&#13;
program. Identified staff are trained in Phnom Penh in a five day seminar. After the initial&#13;
training, a team from the CENAT central office visits the facility to help organize pharmacy,&#13;
ward, record, and supervision procedures. For district facilities not yet trained or unable to&#13;
participate in the new program, the old, more simplified program continues. The old&#13;
program does not use the short course antibiotic regimen with its combination drugs and does&#13;
not contain the records necessary for quarterly cohort analysis. Thus, program indicators&#13;
such as the proportion of cases confirmed cured are not known for facilities using the old&#13;
system. But the new program is expanding rapidly and 100% coverage is planned by the end&#13;
of 1996. However, the program is still fragile and its capacity is strained. Human resources&#13;
are short, especially for skilled administrative personnel. None of the staff work full-time&#13;
and absenteeism is a problem. The central office is dependent on 12 key people for its&#13;
function, including direct training and supervision responsibilities. In the provinces and&#13;
districts, staff turnover has been problematic, requiring frequent training of new personnel.&#13;
12.   The program has heavily depended on outside donor support, especially for drugs and&#13;
training and supervision activities, and lack of future support lies in the path of increasing&#13;
program needs. The patient load may increase by 50 percent within the next 5 years,&#13;
requiring an increase in most every capacity and supply during that time. However, with&#13;
comprehensive financing of the components outlined below, along with the support provided&#13;
by the health systems strengthening, CENAT should be able to accommodate the expansion&#13;
of this program projected to the year 2000.&#13;
13.   Under health systems strengthening, facilities will be refurbished, upgraded or built&#13;
anew. These facilities should be incorporated into the new NTP as efficiently as possible.&#13;
Therefore, CENAT staff will be included in the effort to organize and start new facility&#13;
functions. Refurbished buildings and new equipment and supplies will allow district&#13;
facilities which could not support the new NTP in the past to become part of the program&#13;
with the necessary training. Thus, with the upgrade and expansion of old facilities and the&#13;
&#13;
&#13;
&amp;#12;&#13;
-44-                               Annex I&#13;
construction of new facilities, the NTP will be able to expand to meet the goals of the&#13;
program and the needs of the people.&#13;
III. Component Description and Financing Needs&#13;
14.   The financing plan is based upon continuing the current program strategy, including&#13;
feeding and housing of tuberculosis patients in hospitals for the intensive phase of therapy&#13;
(two months) and feeding patients during therapy as an out-patient.&#13;
15.   The number of patients projected for the five year period of the project are based on&#13;
the epidemiologic assumptions previously detailed. The number of cases treated in the years&#13;
1993 to 1995 has increased 13, 000 per year. Projected case numbers for this project are&#13;
based on continuing an 8 to 10 percent increase in the first three years, thereafter leveling off&#13;
at 24,000 cases by the year 2000. Thus, with rounding, the five year projection of case&#13;
numbers would is as follows:&#13;
YEAR         1996        1997        1998         1999        2000&#13;
CASES       18,000      19,500       21,500      23,000      24,000&#13;
16.   Calculations for the proposed financing are based upon these projections. The supply&#13;
of drugs to the TB program is budgeted under essential drugs in the health systems&#13;
strengthening component of the project. Acquisitions will be made through the Central&#13;
Medical Stores (CMS) of the Ministry of Health. Distribution of drugs will proceed&#13;
according to requests processed by CENAT and passed on to CMS.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 45 -                             Annex 2&#13;
KINGDOM OF CAMBODIA&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT PROJECT&#13;
Mosquito Net Distribution and Treatment&#13;
I. National Bednet Program&#13;
A. Objectives&#13;
1.   In support of the overall Malaria Program Goal - to reduce malaria mortality and&#13;
morbidity to the extent that malaria is no longer a major disease problem in Cambodia - the&#13;
national bednet program objectives are:&#13;
(a)   Expansion of and evaluation of insecticide-treated bednets projects, including&#13;
complete coverage of the population at risk in Kg. Cham and Kg. Speu in&#13;
1995-1997, with expansion to 19 other provinces in 1996-2000.&#13;
(b)   Development of social marketing strategies for reaching transient forest&#13;
workers and other population groups in collaboration with NGOs, to begin in&#13;
1995 and increase yearly through 2000.&#13;
B. Structure and Management&#13;
Central Level&#13;
2.    The National Bednet Program is managed at the central level by the National Malaria&#13;
Center (CNM). A Bednet Project Coordinator has been contracted for the duration of the&#13;
project by the Director of CNM, financed by ODA.  The Bednet Coordinator, in&#13;
collaboration with CNM staff and with technical support from a full time WHO&#13;
Malariologist, is responsible for planning, organizing and managing program implementation&#13;
and program evaluation.&#13;
3.    The health education, laboratory, epidemiology, entomology and parasitology units&#13;
within CNM provide technical supervision and support for the implementation of the&#13;
National Bednet Program. The health education unit is currently running health education&#13;
activities in Kg. Chain and Kg. Speu in support of bednet distribution in April 1995. The&#13;
laboratory unit conducts blood surveys as part of program evaluation as well as providing&#13;
technical supervision for routine blood slide surveillance services at provincial and some&#13;
district hospitals. The epidemiology unit provides HIS and census data for planning&#13;
purposes. The entomology and parasitology units are involved in surveillance activities (e.g.&#13;
drug and insecticide sensitivity studies and program evaluation).&#13;
&#13;
&#13;
&amp;#12;&#13;
- 46 -                             Annex 2&#13;
4.   It is proposed that a National Bednet Steering Committee is established with&#13;
representatives from CNM, WHO, donor agencies, NGOs, social marketing and, where&#13;
feasible, provincial malaria supervisors. The committee will be responsible for defining&#13;
policy, for planning, coordinating and standard setting for project implementation, for&#13;
program evaluation and for identifying resource requirements. The committee will be&#13;
established end 1 995/early 1996, meeting on a fairly frequent basis during the early phases of&#13;
program implementation, and biannually thereafter.&#13;
Inputs                  Processes                  Outputs&#13;
Training of CNM staff in   Training, Supervision,    National Bednet Plan of&#13;
bednet technology,         CNM to province.        Action, 1996-2000.&#13;
methodologies and promotion.&#13;
Study tours to other countries  Progress reports, CNM to  Bednet Training Module.&#13;
implementing national bednet  MOH.&#13;
programs.&#13;
Vehicles, supplies and&#13;
equipment.&#13;
Operational budget.&#13;
Provincial Level&#13;
5.    The malaria program is managed in each province by a Provincial Malaria Supervisor&#13;
under the overall responsibility of the provincial health directors, in addition to which there is&#13;
a Malaria Supervisor for all the rubber plantations in the country. The Malaria Supervisors&#13;
are usually attached to the Provincial Hygiene and Epidemiology Station, together with one&#13;
or two microscopists.&#13;
6.    Key duties and functions for the bednet program will be preparation of annual plans&#13;
in consultation with the districts, training and technical support to the districts, storage of&#13;
nets, distribution of nets to the districts, management of the operations budget, preparation of&#13;
progress reports (submitted to CNM) and program evaluation.&#13;
Inputs                  Processes                Outputs&#13;
Training of provincial malaria  Training, technical  Bednet Plan of Action.&#13;
supervisors in net treatment    support and supervision,  Province reports, province to&#13;
technology and             province to district.  CNM.&#13;
methodologies, and&#13;
promotion.&#13;
Supplies and equipment.    Social mobilization.&#13;
Operational budget for     Health education.&#13;
implementation.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 47 -                              Annex 2&#13;
District Leyel&#13;
7.    District malaria supervisors will be responsible for conducting baseline demographic&#13;
surveys, training and supervising commune health staff and villagers in bednet&#13;
methodologies, storage of supplies and equipment, distribution of nets direct to village level,&#13;
treatment and re-treatment of nets, health education and social mobilization. The districts&#13;
will also be expected to follow-up net distribution with household visits to determine&#13;
acceptance and compliance in the target population.&#13;
8.    Funds for implementation of the national Bednet Program will be provided by the&#13;
Provincial Health Team on a periodic basis, according to planned activities as reflected in the&#13;
district annual plans. The districts will provide quarterly progress reports to the Provincial&#13;
Health Teams with the focus on operational issues, particularly constraints, and will&#13;
participate in annual review meetings at the province.&#13;
Inputs                    Processes                  Outputs&#13;
Training in insecticide-treated  Monitoring. Technical  Plan of Action. Monitoring&#13;
bednet technology,          support and supervision,    reports, district to province.&#13;
methodologies and promotion.  district to commune.&#13;
Supplies and equipment.&#13;
Operational budget for      Social mobilization. Health&#13;
implementation.             education.&#13;
Commune Level&#13;
9.    Staffing capacity at this level is severely limited. Hence staff at this level will only be&#13;
expected to support the district in an organizational capacity, e.g. for baseline demographic&#13;
and socio-economic baseline surveys and for treatment and re-treatment exercises.&#13;
Inputs                     Processes                  Outputs&#13;
Training in insecticide-treated  Social mobilization and health  Monitoring reports.&#13;
bednet technology,          education reports (promotion).&#13;
methodologies and promotion. Follow up at household level.&#13;
II. Program Strategies &amp; Options for Cost Recovery&#13;
10.   The national bednet program will adopt two approaches for the distribution and&#13;
treatment of nets - a public sector health service strategy and a private sector social marketing&#13;
strategy - each of which offers a set of advantages over the other. The public sector approach&#13;
will: (a) ensure equity and access by the majority of the poor rural population; and&#13;
(b) achieve high coverage thereby reducing malaria transmission. The social marketing&#13;
approach has the advantages of: (a) creating high levels of demand, regardless of disposable&#13;
&#13;
&#13;
&amp;#12;&#13;
- 48 -                              Annex 2&#13;
income levels, through mass media campaigns; (b) catering for specific sub-groups of the&#13;
population which are less accessible e.g. forest workers; and (c) providing better options for&#13;
cost recovery.&#13;
11.   Both sectors will be represented in a national Bednet Steering Committee, which will&#13;
serve a number of purposes including: (a) to define and agree on policy; (b) to ensure&#13;
standardization and quality control of bednet services, particularly in the private sector; and&#13;
(c) to provide guidance on program evaluation.&#13;
A. Cost Recovery - Public Sector&#13;
12.   As an intervention in support of public good, bednet use has a strong rationale for&#13;
public subsidy. The objective of cost recovery here will be an attempt to promote better&#13;
utilization of nets at household level based on the logic described earlier - that nets with a&#13;
cost attached to them will be better 'valued' by the buyer, and consequently used and cared&#13;
for correctly.&#13;
13.   There are several options for the flow of funds generated from net fees through the&#13;
public sector distribution program. Revenue from the sale of nets can (a) be used to&#13;
strengthen health services at the commune level, e.g. for renovations, supplementary drugs&#13;
and/or services; (b) be retained in the community to support community-managed health&#13;
and/or development projects; (c) used to strengthen district health services, e.g. provision of&#13;
mobile outreach services.&#13;
14.   The choice of one of these options will very much depend on capacity for financial&#13;
management (structures or intermediaries) at the village level, which will undoubtedly vary&#13;
from place to place, and it may be worthwhile to pilot cost recovery schemes in communities&#13;
with well-established infrastructure. Health staff should begin a dialogue with community&#13;
committees and associations in target communes well before distribution takes place, so that&#13;
commune leaders, committee members and other community leaders can meet to decide on&#13;
how to spend revenue generated from net sales in their commune/village. The bednet&#13;
committees and community leaders should be given the responsibility for organizing public&#13;
forums to create awareness about the distribution program, the 'net fund', and proposed uses&#13;
of the fund.&#13;
B. Cost Recovery - Social Marketing&#13;
15.   The private sector/social marketing approach provides several options for cost&#13;
recovery, two of which are considered here - distribution through private retailers and&#13;
distribution through organizations such as NGOs, rubber plantation companies and the&#13;
military service.&#13;
16.   Nets and insecticide will be provided through the Ministry of Health's national&#13;
program and sold at or below cost to private retail outlets and distributors, NGOs and other&#13;
large institutions and/or companies. Nets will be sold through these outlets at a mark-up&#13;
price in order to cover overheads and provide a profit margin. The outlets then buy more nets&#13;
&#13;
&#13;
&amp;#12;&#13;
-49-                                 Anex 2&#13;
from the social marketing agency once their stocks are depleted. In principle this approach&#13;
should provide a high level of cost recovery, depending on the willingness to pay of target&#13;
populations. However, complete cost recovery is impossible due to costs incurred by the&#13;
agency, including: (a) cost of the initial 'seed' supply of nets; (b) cost of the social marketing&#13;
campaign; (c) running costs; and (d) lower than market prices to assure high retail sales to&#13;
target groups. The social marketing program will therefore require significant donor subsidy.&#13;
C. Rubber Plantations and the Military Service&#13;
17.   Workers on the rubber plantations and the army are particularly at risk from malaria.&#13;
Estimates of bed occupancy rates by soldiers in hospitals around the country exceed 50&#13;
percent in general wards.  Rubber plantation managers report they have to provide&#13;
supplementary curative services (in the form of mobile clinics) for their workers and their&#13;
families during periods of heavy malaria transmission.&#13;
18.   The full impact of malaria on the rubber plantation companies in economic terms has&#13;
yet to be determined but is likely to be considerable due to both loss of productivity and the&#13;
cost of providing extensive curative services for workers and their families. Nevertheless the&#13;
biggest burden of malaria is at the household level, where family income is almost entirely&#13;
generated from work in the plantations. Loss of earnings by workers through illness is&#13;
exacerbated by significant, often crippling, expenditure on curative care both for themselves&#13;
as well as their families. Death is also not uncommon.&#13;
19.   There is need for dialogue between CNM/Ministry of Health, the military service and&#13;
the rubber plantation companies to develop a mutually agreeable strategy for bednet&#13;
distribution and treatment services for soldiers and workers (and their families) respectively.&#13;
The strategy should provide for a cost recovery component, preferably with a high degree of&#13;
subsidy by the employer. This strategy has the added advantage that employers can use a&#13;
'direct debit' approach for recovering net fees by deducting fees from salaries, with the option&#13;
of payment in installments.&#13;
III. Project Support to the National Bednet Program&#13;
A. Social Marketing&#13;
20.   An international non-profit organization will be contracted to develop a social&#13;
marketing strategy suitable to the Cambodian situation. The first requirement is a detailed&#13;
market survey, the findings of which will determine the feasibility and level of support&#13;
required to implement a social marketing bednet distribution and retreatment program in&#13;
Cambodia. This study was completed in April 1996 and its findings incorporated into the&#13;
appraisal of the project. Feasibility was judged to be high. The TOR for a two year first&#13;
phase implementation were prepared and agreed.&#13;
21.   The social marketing component will utilize existing private sector resources, such as&#13;
distributors, retailers and advertising agencies, to sell a branded insecticide-treated bednet&#13;
product. Nets provided through the program (in the first four years; perhaps thereafter from&#13;
&#13;
&#13;
&amp;#12;&#13;
- 50 -                               Annex 2&#13;
wholesalers) will be repacked with an appealing package and image, and sold to retailers and&#13;
distributors at a subsidized price. The retailers and distributors will in turn sell the brand-&#13;
name bednets at a mark-up price to cover overheads. If sales are successful, the retailer buys&#13;
more nets from the project and the cycle continues. Implicit in the project is the need to&#13;
control the mark-up price, the modalities of which must be determined prior to project&#13;
implementation.&#13;
22.   Demand creation activities for nets and retreatment will be implemented alongside&#13;
sale and distribution. Information on affordability, access and KAP from the market survey&#13;
will be used to formulate appropriate information, education and communication (IEC)&#13;
strategies and for specific target groups. In addition to creating demand for brand-name nets,&#13;
it is anticipated that the IEC strategy developed by the social marketing project will also&#13;
increase demand for insecticide-treated bednets provided through the public sector program.&#13;
B. Health Education and Social Mobilization&#13;
23.   The health education unit at CNM has already developed a number of IEC materials&#13;
which include insecticide-treated bednets as a component of malaria control strategies&#13;
suitable for community participation. Support will be provided for printing and reproduction&#13;
of existing materials, as well as a limited operational budget for implementation. In addition&#13;
to education of the general population, traditional healers, health activists and TBAs will be&#13;
targeted through local workshops run by district and commune health staff. Community&#13;
mobilization for bednet distribution and retreatment will be the responsibility of provincial&#13;
governors, community leaders, health workers at provincial, district and commune levels,&#13;
NGO personnel and employers. Mobilization campaigns should be conducted prior to net&#13;
distribution and every six months thereafter, prior to retreatment exercises.&#13;
C. Training&#13;
24.   CNM will be responsible for training all personnel involved in bednet distribution and&#13;
treatment - health staff, NGO employees, managers of the social marketing project, managers&#13;
of the rubber plantations, villagers etc. This is critical to ensuring standardization and quality&#13;
control of bednet services. WHO has provided TA for a period of four months for training of&#13;
CNM staff in insecticide-treated bednet technology and associated methodologies (e.g.&#13;
method for collective dipping, bioassays, insecticide sensitivity assays).&#13;
25.   In-service training will be required at all levels of the health service - at national,&#13;
provincial, district and commune levels - to ensure the delivery of quality services. A pre-&#13;
requisite to training will involve an assessment of the training needs at each level, preferably&#13;
during the planning session with provincial health management teams.&#13;
&#13;
&#13;
&amp;#12;&#13;
-51 -                               Annex 2&#13;
D. Logistics&#13;
Procurement and Distribution&#13;
26.   Nets and insecticide will be procured by CNM using MOH procurement services and&#13;
delivered to the Central Medical Store of the MOH for storage and subsequent distribution to&#13;
the provinces. Procurement will take place on an annual basis in the second quarter [to allow&#13;
six months lead time], based on planning estimates. A request can be made to the supplier&#13;
for delivery in two or more installments, to reduce the amount of storage required at CMS.&#13;
After the first year, annual requirements can be revised according to the pace of&#13;
implementation in the previous year.&#13;
27.   Distribution to the provinces will follow the implementation schedule outlined in the&#13;
Project Implementation Plan and a limited number of provinces, grouped into five 'regions'&#13;
(Northwest, Central, Southwest, Southeast and Northeast), will implement the program each&#13;
year. This is expected to simplify logistics and facilitate the distribution process. CMS will&#13;
use the same distribution channels as currently used for drugs, immunization supplies and&#13;
equipment.&#13;
28.   The provinces will provide temporary storage for nets and deliver them to the districts&#13;
as scheduled in the provincial plan of action. Districts will then be required to store nets and&#13;
insecticide for a brief period, until they are delivered to the community level. Health centers&#13;
are not expected to handle supplies.&#13;
Transport&#13;
29.   The Central Medical Store of the MOH will have five trucks suitable for the&#13;
distribution of bednets and insecticide from Phnom Penh to the provinces. Additional&#13;
transport can be sought from private companies at reasonable rates. For purposes of&#13;
transportation from provincial headquarters to the districts, malaria supervisors will rely on&#13;
common-use MOH transport and NGOs.&#13;
Supplies and Equipment&#13;
30.   Supplies and equipment required for the bednet program include nets, insecticide,&#13;
plastic buckets, gloves, measuring cylinders, bioassay kits, insecticide sensitivity kits,&#13;
equipment for blood surveys and vehicles.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 52 -                              Annex 3&#13;
KINGDOM OF CAMBODIA&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT PROJECT&#13;
HIV/AIDS COMPONENT: MANAGEMENT AND IMPLEMENTATION&#13;
1.    The detailed project description and budget is found in the Project Implementation Plan&#13;
(PIP). The following items reflect subjects of particular interest in relation to the management&#13;
and implementation of the HIV/AIDS component.&#13;
Organization and Management of the Government's response to the Epidemic&#13;
2.    The Government's response to the epidemic is anchored in the National AIDS Office&#13;
(NAO) which was established in 1993. The position of this office within the MOH has not been&#13;
clear, but to rectify this situation, a condition of the credit will be to upgrade the office to the&#13;
level of department through appointing an administrator and financial officer. The relationship&#13;
between the NAO and the Institute of Dermatology and Venereology has also required&#13;
clarification, but a decision has been reached that the Institute will fall under the NAO as its&#13;
primary function relates to the STD program.&#13;
3.    Policy guidance and interministerial coordination is conducted through the National&#13;
Committee on HIV/AIDS/STD which is chaired by the Minister of Health. The First Prime&#13;
Minister is the honorary chairman of this committee which meets irregularly and infrequently.&#13;
There is no representation of the NGO community on the committee which, otherwise, broadly&#13;
reflects those ministries with an interest in the epidemic. The national committee acts as a forum&#13;
for discussion but it makes no decisions about resources and how those should be expended&#13;
across ministries. The National AIDS Office at the MOH acts as the -secretariat for the national&#13;
committee.&#13;
4.    Earlier, there was an intent to establish a secretariat and a technical committee to assist&#13;
advising the national program. In reality, the so called secretariat was another committee but&#13;
comprised of lower level staff from across the concerned ministries. The technical committee&#13;
meets infrequently.&#13;
5.    The issues related to the Government's organization of its response were discussed at a&#13;
World Bank/UNDP/WHO sponsored workshop conducted on August 17, 1995. While there was&#13;
no immediate outcome, what has emerged is that the National AIDS Office in will become&#13;
known as the National HIV/AIDS/STD Secretariat obviating the proposed "secretariat&#13;
committee". The technical committee will serve the HIV/AIDS/STD Secretariat.&#13;
6.    Currently, the whole Government's response to the epidemic is conducted through and by&#13;
the Ministry of Health. Therefore, the Project will make available its resources through the&#13;
MOH and the HIV/AIDS/STD Secretariat.&#13;
&#13;
&#13;
&amp;#12;&#13;
-53 -                                     Annex 3&#13;
7.     The following organogram sets out the relations of the key actors in the Government's&#13;
response and the organizational structure within MOH.&#13;
Figure 3.1&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT PROJECT&#13;
HIVIAIDSISTD COMPONENT ORGANOGRAM&#13;
Ministryr of H"tth &#13;
National Commitee ror&#13;
'HlVAIDS1STD PreventIon &amp;L ---  Olreror General&#13;
ConImI (NSAC)          of Heal&#13;
- - - - - - - - - - -&#13;
p           HIVIAIDSISTD&#13;
Tadenical                                     Natonal Blood&#13;
Sub-Commttee                      - - - - - -  - -  Trnsusion Center&#13;
I~~~~~"  I I                       &#13;
Natcnal MioSsTD   so tMa nagement IEC Unwl GreFund Unit Admnlarit&amp;    Toing Unit Eres atuoniabeor  | Pero gprcami&#13;
Cenasa teSDcntradfrterinroucionancte Uniticapoaht tedagoi&#13;
and management of STDs in the helth care delivery system. AdminiReseari Ungt  Unt S&#13;
a II&#13;
| fIVrIoSfSTD N&#13;
I Proslndal   l&#13;
l Programs  F&#13;
8.      Within the National AIDS office, units have been established to be responsible for&#13;
specific functions of the NAO. The STD management unit will be responsible for the specialized&#13;
programs at the STD center and for the introduction of the syndromic approach to the diagnosis&#13;
and management of STDs in the health care delivery system. Administering the  Small Grants&#13;
Fund  for NGO  activities and responsibility for the National Committee for HIV/AIDS/STD&#13;
Prevention and Control will rest with the Grants Fund Unit. An IEC unit, managed by a media&#13;
director to be specifically recruited for this purpose, will orchestrate the public information&#13;
campaigns to be developed and launched through the project. The Outreach Program will&#13;
continue to receive direction and support from the unit already established for this purpose. All&#13;
surveillance and evaluation activities will be managed by a specific unit for this purpose. Human&#13;
resource development will be the responsibility of the training unit which will need to coordinate&#13;
closely with more specialized units which have specialized staff development responsibilities.&#13;
Finally, the administration and finance unit will provide the services necessary to ensure the&#13;
smooth functioning of the NAO.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 54 -                             Annex 3&#13;
9.    The majority of the Provincial AIDS Offices (PAO) have a complement of five staff&#13;
although a few smaller provinces only have three. The PAOs are technically under the direction&#13;
of the NAO. The outreach and STD programs in each province are under the direction of&#13;
assigned staff at the provincial office with the responsibility for fostering and managing the&#13;
outreach program, currently mainly aimed at prostitutes, and managing the introduction of the&#13;
syndromic approach to the diagnosis and treatment of STDs. Involvement in the epidemiological&#13;
and other survey activities will form part of PAO work programs as well as organizing training&#13;
activities at provincial level on a variety of themes including counseling.&#13;
10.   The National Blood Transfusion Center (NBTC) is responsible for organizing and&#13;
directing the country's blood transfusion services. The Director of the NBTC reports to the&#13;
MOH.&#13;
Small Grants Fund for NGOs&#13;
11.   The significance of the role of the NGO sector in the response within the country so far&#13;
cannot be over estimated, from the successful social marketing of condoms to preparing&#13;
informational materials to working directly with high risk groups. The Government recognizes&#13;
that synergy between the government and non-government sector is important for the country's&#13;
effort to contain the epidemic.&#13;
12.  In recognition of the continued importance of NGO efforts, under this project, a fund will&#13;
be established to provide small grants for the NGO sector. The fund will work in two ways,&#13;
responding to proposals submitted by NGOs and proposing activities to the NGO sector which&#13;
they are best able to conduct. The fund is expected to contribute to attainment of government&#13;
policy and priorities in relation to the epidemic. The following lays out the mechanism by which&#13;
the fund will operate.&#13;
NATIONAL AIDS OFFICE - NGO SMALL GRANTS PROGRAM&#13;
National AIDS Program&#13;
13.   The National AIDS Program is a coordinated effort by the Royal Government of&#13;
Cambodia to address the increasing presence of HIV within the country. The program will&#13;
receive assistance from the World Bank through the Disease Control and Health Development&#13;
Project and through other multilateral and bilateral support.&#13;
14.   The role of the NGO community in dealing with the prevention of the further spread of&#13;
HIV in Cambodia is well known and documented. The synergy between the Government's&#13;
program and those of the NGO community needs to be enhanced, each recognizing the relative&#13;
strengths and merits of their activities.&#13;
&#13;
&#13;
&amp;#12;&#13;
55-                               Annex 3&#13;
Small Grants Program&#13;
15.   The Small Grants program, set up under this project, will award grants to NGOs and&#13;
other community groups for small-scale projects and activities that address HIV/AIDS issues.&#13;
The principal objective of the programn is to facilitate and carry out innovative activities to further&#13;
limit the spread of the HIV virus. Such activities may be proposed by the NGO conmmunity or&#13;
proposed to them by the National AIDS Program.&#13;
16.   Under this program, grants will be provided directly to NGOs and community groups to&#13;
carry out specific projects and activities which fall within the overall strategy of containing the&#13;
HIV epidemic. Grants will be made after evaluating proposals received from NGOs and&#13;
community groups by the Project Grant Committee on an open and competitive basis. Grants&#13;
will only be made to organizations and not to individuals. Such organizations must be&#13;
organically and functionally outside the formal Government structure. The foregoing committee&#13;
will administer the program.&#13;
Project Grant Committee&#13;
17.   The committee will consist of  the Director of the National AIDS Program, a&#13;
representative of UNAIDS Theme Group, a representative of the World Bank's Project&#13;
Operation Unit, a representative of a Khmer NGO and a representative of an International NGO.&#13;
In the latter two cases, the organizations represented will be those substantially dedicated to&#13;
addressing the HIV/AIDS issue in Cambodia. The responsibility for selection of representatives&#13;
from the Khmer and International NGO community will rest with the NGO HIV/AIDS&#13;
Coordinating Committee.&#13;
18.   The chairperson of the committee will be the Director of the National AIDS Program or&#13;
his/her designee.  The chairperson will organize the committee in consultation with the&#13;
concerned parties and will be responsible for all committee meetings whose frequency will be at&#13;
his/her discretion. The presence of three members will represent a quorum.&#13;
19.   Responsibility for administering the approved projects, including disbursements, and for&#13;
the preparation and submission of reports will rest with the staff of the National AIDS&#13;
Secretariat.&#13;
The terms of reference for the committee will be to:&#13;
(i)  Promote the NGO Grant program;&#13;
(ii) Select and approve project proposals submitted to the committee;&#13;
(iii) Review progress reports of projects; and&#13;
(iv) Review and approve project completion reports for submission to the World Bank's&#13;
PCU and other concerned entities.&#13;
Application Eligibility&#13;
20.   Whatever the type of organization, certain basic requirements need to be fulfilled as part&#13;
of the selection criteria and include the following:&#13;
&#13;
&#13;
&amp;#12;&#13;
- 56 -                              Annex 3&#13;
(i)  A basic organizational structure or constitution;&#13;
(ii)  At least two years experience in relevant fields of activity;&#13;
(iii) Some demonstrated capacity in project management, reporting and accounting;&#13;
(iv) Adequate coverage in clientele and geographic terms;&#13;
(v)  Some form of registration either with a Government institution or an NGO network, to&#13;
establish both authenticity and accountability; and&#13;
(vi) A statement of financial accounts for the previous year, to indicate the ability to manage&#13;
project money.&#13;
21.   Information on the above and other aspects of organizational history and strength will be&#13;
asked for in the standard project proposal format which must be filled in by all parties applying&#13;
for grants. If there is uncertainty whether an organization is eligible to apply for a grant,&#13;
clarification may be sought from the Project Grant Committee.&#13;
Type of Project Activities to be Supported&#13;
22.   Grants will be awarded to innovative preventive activities, with a focus on populations&#13;
particularly vulnerable to the impact of sexually transmitted diseases and HIV. For the target&#13;
populations, areas of interest include, but are not limited to:&#13;
(i)  Peer education programs for target populations;&#13;
(ii)  Participatory and innovative workshops;&#13;
(iii) Information, Communication and Education;&#13;
(iv) Advocacy; and&#13;
(v)  Specialized studies and research framed in a social and gender context.&#13;
Duration of Grants&#13;
23.   Grants will initially be made to support project activities with a 12 month or less time&#13;
frame. However, prospective applicants are encouraged to submit project plans covering a 2-3&#13;
year period. It is possible that follow-up grants may be made based on performance, at a later&#13;
stage.&#13;
Nature of Grants&#13;
24.   Initially, the range for an individual grant will be up to US$25,000 equivalent. However,&#13;
the actual size of grant will be determined depending on specific project requirements and the&#13;
absorption capacity of the group concerned. The grants will be made in US$ riel equivalents&#13;
based on budget estimates submitted with project proposals.&#13;
25.   It is expected that the grants will be made in installments. The final installment will be&#13;
made on satisfactory completion of the activity and the receipt of a final report. Funding can be&#13;
provided for both new programs and for continuing existing activities. Co-funding of activities&#13;
may be considered when appropriate.&#13;
&#13;
&#13;
&amp;#12;&#13;
-57 -                              Annex 3&#13;
26.   Funding will not be available for construction and other infrastructure development&#13;
activities nor for the purchase of vehicles. The cost of project related transport may be included&#13;
in the budget estimate submitted with the project proposal. Limited budget support can be&#13;
provided, if critical need is established, for the acquisition of items of office equipment if the cost&#13;
does not exceed 30 percent of the total budget estimate for the project. Staff salaries may also be&#13;
supported either on a partial or full basis for the duration of the project, but such support should&#13;
be clearly indicated in the proposal submission.&#13;
27.   Money allocated for the activities described in the project proposal cannot be assigned by&#13;
the grantee for other purposes if it is greater than five percent of the total budget without prior&#13;
approval from the Small Grants Program Approval Committee.&#13;
28.   The grantee organization may propose to charge, in the budget estimate, an amount not to&#13;
exceed 15 percent of total project budget for administrative overheads and such other expenses.&#13;
29.   Each organization is expected to indicate what counterpart contributions it can make to&#13;
projects over and above the grant from the program. This might include voluntary services and&#13;
time on part of members of the organization, use of premises and equipment, mobilization of&#13;
voluntary technical advice from competent sources and co-financing from the organization's&#13;
other funds. The amount of counterpart funds, which should represent a minimum of five&#13;
precent of the total project budget, will be reviewed during project assessment, although the&#13;
magnitude of those contributions will not, in itself, be a key determinant.&#13;
Submission of Proposals&#13;
30.   All project proposals should be developed according to the prescribed project format&#13;
copies of which are freely available at the National AIDS Office and the Project Coordination&#13;
Unit. The proposals may be submitted in Khmer with an English translation or in English. They&#13;
should be submitted to the Director of the National AIDS Office at the Ministry of Health for the&#13;
attention of the Project Grant Committee. Submissions will be accepted twice yearly.&#13;
31.   Applicants whose proposals are selected for funding will be asked to enter into a&#13;
"Memorandum of Agreement" which will outline the nature of the project, duration, amount&#13;
granted and other arrangements such as for reporting.&#13;
Proposal Format&#13;
32.   Each submission is expected to adopt the following format and to be no longer than three&#13;
pages:&#13;
(i)  Name of Organization, list of principal officers and contact information;&#13;
(ii) Brief background about the organization including background and experience of key&#13;
people;&#13;
(iii) Proposal indicating rationale, objectives and implementation schedule; and&#13;
(iv) Budget - costs of personnel, project (travel, activities, communication), materials and&#13;
overhead.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 58 -                              Annex 4&#13;
KINGDOM OF CAMBODIA&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT PROJECT&#13;
Health Services Strengthening - Provincial Selection and Phasing&#13;
National Health Coverage Support under the Project&#13;
1.   In order to achieve a rational allocation and utilization of resources at the operational&#13;
district level, the Government has developed a National Health Coverage Plan. Based on&#13;
discussions with the government, and in keeping with government policy, the project will&#13;
support the health coverage plan at the operational district level as a means to better deliver&#13;
primary health care and disease control programs at the community level. The plan attempts&#13;
to rationalize the provision of health facilities by changing the focus of the referral-peripheral&#13;
unit from being linked to an administrative unit of a district, to being linked to the population&#13;
size served (operational district). It aims at developing the physical infrastructure and human&#13;
resources in the health system based on a geographical and population basis. It defines the&#13;
catchment areas for each level of treatment and specifies the location of health facilities.&#13;
Workshops were held with representation from provincial and district health authorities,&#13;
NGOs and provincial health advisors. The decisions emerging from these workshops have&#13;
been used as the basis for defining the needs of operational districts in terms of facilities,&#13;
equipment and drugs.&#13;
Determination of Province Selection and Phasing&#13;
2.    The project will support the Government's National Health Coverage Plan by&#13;
providing basic health services strengthening at the health center and referral hospital level.&#13;
All provinces in the country have conducted a mapping exercise to determine the location of&#13;
the health facilities under the coverage plan. Government also held a series -of provincial&#13;
workshops in which provincial and district authorities reconciled the population-based&#13;
numbers of health centers and referral hospitals to reflect the mapping exercise and needs of&#13;
the operational district. The health facilities that would be upgraded/newly constructed and&#13;
equipped under the project was determined using the provincial numbers of health centers&#13;
and referral hospitals that emerged from the discussions as the basis.&#13;
3.   In order to determine the provinces that would be included during the time frame of&#13;
the project, the following criteria were used:&#13;
(a)   Exclusion of ADB assisted provinces - K.Cham, K. Chhnang, Takeo, Svey&#13;
Reng and Prey Veng)&#13;
(b)   Prevalence of disease - TB, and malaria (high is positive, low is negative; 2 =&#13;
tuberculosis and 2 = tuberculosis + malaria))&#13;
&#13;
&#13;
&amp;#12;&#13;
-59-                                      Annex 4&#13;
(c)    Management capacity - presence of provincial health advisor (H.A.) is&#13;
positive, absence of H.A. is negative.&#13;
(d)    Access (good is positive, poor is negative)&#13;
(e)    Population size (large is positive, small is negative)&#13;
Table 1&#13;
Scoring System Used for Provincial Selection&#13;
No. Name of          Criteria -     Criteria -&#13;
Province       Positive        Negative&#13;
1  B. Meanchey    1,2,5            3,4&#13;
3   K. Cham                        I&#13;
(ADB)&#13;
4   K. Chhnang&#13;
(ADB)&#13;
1111-114.   I   0-4;11-   ...........&#13;
18E S|iauokill   1, 2,              3, 5    &#13;
9   Koh Kong       1,2,            3,4,5&#13;
I I  Mondulkiri     1, 2,           3, 4, 5&#13;
1 2   P. Vihear     1, 2, 5         3, 4&#13;
14  Prey VengI&#13;
(ADB)&#13;
18   Sihanuoukville I, 2, 4         3, 5&#13;
19  Stung Treng     1, 2, 4         3, 5&#13;
20   Svay Rieng                     I&#13;
(ADB)_&#13;
21   Takeo (ADB) &#13;
*2 =high prevalence of tuberculosis and 2 = high prevalence of tuberculosis + malaria&#13;
**The provinces that scored positive in four or all of the five criteria were included under the&#13;
project.&#13;
4.     Phasing of provinces is planned in 2 phases - phase I activities would begin during the&#13;
1 st year of the project and phase II activities would commence a year later. Phase I provinces&#13;
are: Battambang, Kampot/Kep, Kampong Speu, Kandal, Phnom Penh and Siem Reap.&#13;
Phase II provinces are: Kampong Thom, Kratie, Pursat and Rattanakiri.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 60 -                                     Annex 4&#13;
Table 2&#13;
HEALTH CENTER PHASING&#13;
No.       Name of      Total HCs   Yr. 0                   Yr.  Yr.  Y., r.. Yr.  Yr.  Yr.&#13;
Province     targeted/   Govt.   1    2 ....        - :   5    6    7&#13;
achieved   other   X&#13;
donors                   ....&#13;
I   *  Battambang      30/30      0                  ..  .. .   0    0   0&#13;
2   K. Speu            50/31      8               . 6  . .      8    3    0&#13;
3   K. Thom            50/26      4            0 . X            10   10    0&#13;
4   Kampot/Kep         50/23      6               - 5    6    7    8    8    5&#13;
5   Kandal             88/43      7    .10   10 1               15   15  8&#13;
6   Kratie             22/10      1                      X 3    -    4    5    6    0&#13;
7    *  Phnom          20/20      0          .  7        .   - 0    0    0&#13;
Penh~~~~~~~~~~~~~~~~~~~ .. ... ....   .   ..   ....  . &#13;
Penh        _____&#13;
8   Pursat             30/12      6      Q      .   4    .    4    4    4&#13;
9   Rattanakiri         10/7      0               ; 3 .   2    3            0&#13;
10    *  Siem Reap      28/28      0          &amp; .         6    0    0    0&#13;
Total  Total             378/230    32   .: S    64  6..    53   46   17&#13;
* shaded portion represents project period.&#13;
v  The numbersfor health centers that emergedfor 3 provincesfrom the health coverage plan workshops were&#13;
modifiedfor targeting under the project:&#13;
(a)    Battambang:  Given access considerations, though a total of 59 are to be&#13;
provided under the health coverage plan, 30 were targeted as realistic for the&#13;
project period.&#13;
(b)    Phnom  Penh:  Given the urban location of Phnom  Penh, and the greater&#13;
availability of both public and private health facilities, though the health&#13;
coverage plan estimates 39 health centers, the project would target 20 health&#13;
centers.&#13;
(c)    Siem  Reap: Given  access considerations, though a total of 57 are to be&#13;
provided under the health coverage plan, 28 were targeted as realistic for the&#13;
project period.&#13;
5.     The selection of health centers and referral hospitals for upgrading within each&#13;
province was based on the health coverage plan needs (determined by the provincial&#13;
workshops and mapping exercise described above) as well as phasing considerations taking&#13;
capacity (both staffing and managerial) into account.&#13;
6.     The project would therefore support upgrading and equipping of 230 Health Centers,&#13;
of which 173 would be new construction and 57 would be renovations (26 of the renovated&#13;
health centers would also have TB ward facilities). Existing district hospitals which are to be&#13;
converted into functioning health centers would be given priority for renovation purposes.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 61 -                                      Anne 4&#13;
Table 3&#13;
REFERRAL HOSPITAL PHASING&#13;
No.  Name of          Total RHs   Yr. 0                                           Yr. 5&#13;
Province        targeted!    Govt.!     .............&#13;
achieved    other      .&#13;
donors&#13;
1    Battambang           3/3                                           . .....&#13;
2    K. Speu              3/3                     .   . .&#13;
3    K. Thom              3/3               ...&#13;
4    Kampot/Kep           5/4         1                                       X .&#13;
5    Kandal               5/5                 .+lbr                           ... .&#13;
6    Kratie               2/2               X..&#13;
7        Phnom            5/0                          ...... ... . ..&#13;
Penh_____             _&#13;
8    Pursat               2/2                             1 &#13;
9    Rattanakiri    X                                         . .-  .&#13;
10   Siem Reap           4/3          1         1&#13;
Total            228      X 2                                       6       0&#13;
* shaded portion represents project period.&#13;
**br = basic referral hospital.&#13;
*  Given its urban location and the 7 national hospitals in Phnom Penh, no referral hospital in Phnom Penh&#13;
will be upgraded under the project.&#13;
7.     The project would support upgrading and equipping of 26 referral hospitals, of which&#13;
8 would be basic referral hospitals and 18 would be full referral hospitals. Of the 18 full&#13;
referral hospitals selected under the project, 3 would be major renovations and 15 would be&#13;
minor renovations. Of the eight basic referral hospitals, two would be major renovations and&#13;
six would be minor renovations.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 62 -                                        Annex 5&#13;
KINGDOM OF CAMBODIA&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT PROJECT&#13;
LIST OF MEDICAL EQUIPMENT FOR HEALTH CENTERS&#13;
CONSULTATION&#13;
1 Otoscope set basic for clinic&#13;
2 Scale Adult&#13;
3 Sphygmomanometer Aneroid 300Mm&#13;
4 Stethoscope&#13;
5 Tongue Depressor 165Mm Metal&#13;
6 Thermometer Clinic Rectal&#13;
MINOR SURGERY&#13;
I Basin Kidney 475MI Ss&#13;
2 Bottle Wash Lab Use 250MI Polyethylene&#13;
3 Box For 4 Syringes Unmarked Aluminium&#13;
4 Brush Hand Surgeon White Nylon Bristles&#13;
5 Drum, Sterilizing Cylindrical 290 Mm Dia&#13;
6 Forceps Dressing Spring Type 155Mm Ss&#13;
7 Forceps Hemostat Straight Rochester Pean 160Mm&#13;
8 Holder Needle Straight Narrow-Jaw Mayo Hegar 160Mm&#13;
9 Knife Blade Surgical For Major Surgery # 22Pkt 5&#13;
10 Knife Handle Surgical For Major # 4&#13;
11 Metal Case 170X9OX40 Mm&#13;
12 Probe Round Point &amp; Tongue-Tie 145Mm&#13;
13 Scissors Dissect Curved Mayo 145 Mmb/B SS&#13;
14 Scissors Surgical Straight 145 Mmb/B SS&#13;
15 Sterilizer Dressing Press Ckr 300X300 Mm 24L Fuel&#13;
16 Stove Kerosene Single Burner 2 Litres&#13;
17 Tray Instrument Covered 225X125X50Mm SS&#13;
18 Tray Instrument Shallow 343X247X16Mm SS&#13;
MA TERNAL AND CHILD HEALTH&#13;
1 Basin Kidney 475 Ml Ss&#13;
2 Bed Labour And Delivery W/Two Piece Mattress&#13;
3 Forceps Sponge Holding Straight 280Mm&#13;
4 Holder Needle Straight Narrow Jaw Mayo Hegar 160Mm&#13;
5 Scale Infant Clinic Metric 15,5Kg 5G&#13;
6 Scale With Trousers Infant Spring Type Hanging&#13;
7 Scissors Episiotomy Angular Braun 145Mm SS&#13;
8 Speculum Vaginal Bi Valve Grave Large SS&#13;
9 Speculum Vaginal Bi Valve Grave Medium SS&#13;
10 Speculum Vaginal Bi Valve Grave Small SS&#13;
11 Sphygmomanometr Aneroid 300Mm&#13;
12 Stethoscope Adult&#13;
13 Stethoscope Foetal Pinard Monaural&#13;
14 Tape Umbilical Non-Sterile 3Mm WidexlOOM Spool&#13;
15 Tape-Measure 1.5/60" Vinyl-Coated Fibreglass&#13;
16 Weight For Height Chart&#13;
&#13;
&#13;
&amp;#12;&#13;
- 63 -                                         Annex 5&#13;
VACCINATION SET&#13;
1 Ice Pack For Vaccine Carrier&#13;
2 Sterilizer Pressure Double Rack 84 Syringes Fuel&#13;
3 Vaccine Carrier 17-Litres Net Capacity&#13;
EMERGENCY SET&#13;
Stretcher folding type                                          I&#13;
|Tourniquet|&#13;
FURNITUREIOFFICE EQUIPMENT&#13;
Bed&#13;
Bench&#13;
Cabinet&#13;
Calculator&#13;
Chair&#13;
Clipboard&#13;
Desk&#13;
Diaper pail&#13;
Partition screen&#13;
Plastic utility basin&#13;
Shelvings&#13;
Table&#13;
Water filter&#13;
Water jar&#13;
White board&#13;
IN ADDITION REFRIGERATORS WILL BE PROVIDED FOR&#13;
25 HEALTH CENTERS IN REMOTE AREAS&#13;
&#13;
&#13;
&amp;#12;&#13;
- 64-                                         Annex 5&#13;
MEDICAL EQUIPMENT LIST: REFERRAL HOSPITAL&#13;
Pediatrics                                          Medicine&#13;
1 Aspirator, portable, foot operated               1 Basin kidney&#13;
2 Autoclave vertical                               2 Bottle, oxygen&#13;
3 Basin kidney                                     3 Box for 4 syringes aluminum&#13;
4 Box for 4 syringes AL                            4 Cart dressing I dispensing&#13;
5 Drum sterilizing cylindrical small               5 Drum sterilizing cylindrical small&#13;
6 Forceps dressing spring type 155mm ss            6 E chart&#13;
7 Forceps intubation Magill infant                 7 Forceps dressing spring type 155mmss&#13;
8 Forceps sponge holding straight                  8 Forceps sponge holding straight 200mmss&#13;
9 Height measurement unit, infant                  9 Needle, lumbar puncture&#13;
10 Laryngoscope                                    10 Needle, pleural puncture&#13;
11 Needle for lumbar puncture                      11 Occluder with pinhole&#13;
12 Needle for pleural puncture                     12 Ophthalmoscope-Direct&#13;
13 Otoscope                                        13 Otoscope&#13;
14 Resuscitator infant                             14 Reading test type&#13;
15 Scale infant                                    15 Scale adult&#13;
16 Scissors bandage                                16 Scissors bandage&#13;
17 Sphygmomanometer aneroid infant                 17 Sphygmomanometer aneroid&#13;
18 Stethoscope                                     18 Stethoscope&#13;
19 Stove kerosene                                  19 Stretcher army type folding&#13;
20 Tank oxygen + manometer                         20 Table examination&#13;
21 Thermometer oral/rectal                         21 Thermometer oral/rectal&#13;
22 Tongue depressor metal 165mm                    22 Tongue depressor165 mm metal&#13;
23 Tray instrument cover. 225x 125x50 mm ss        23 Torch with batteries&#13;
24 Tray instrument shallow 342x 243x16mm ss        24 Tray instrument shallow343x247x16 mm ss&#13;
25 Trocar for puncture ascites&#13;
26 Urinal female 900ml Polypropylene&#13;
27 Urnal male 1,5 i Polypropylene sterilizable&#13;
Surgery&#13;
i Autoclave vertical                                              Consultation&#13;
2 Basin kidney 475ml ss&#13;
3 Bottle wash for lab use 250ml polyethylene       1 Basin kidney 475 ml ss&#13;
4 Bowl, sponge 600ml ss                            2 Drum sterilizing cylindrical small&#13;
5 Brush,surgeon ,with nylon bristles               3 Hammer reflex testing Taylor solid rubber head&#13;
6 Cart dressing/dispensing                         4 Otoscope&#13;
7 Case, minor surgery                              5 Scale adult&#13;
8 Dressing set                                     6 Speculum nasal child 140mm ss&#13;
9 Drum sterilizing cylindrical small               7 Sphygmomanometer aneroid&#13;
10 Generator                                        8 Stethoscope&#13;
11 Leg splint                                       9 Thermometer oral /rectal&#13;
12 Oxygen bottle+regulator                         10 Tongue depressor 165mm metal&#13;
13 Plaster shears Stille AESCULAP 36cm             11 Tray instrument shallow 342x247 xl 6mm ss&#13;
14 Retractor plaster HENNIG 27cm&#13;
15 Scissors plaster&#13;
16 Sphygmomanometer aneroid&#13;
17 Splint -board aluminum&#13;
18 Stethoscope&#13;
19 Stove kerosene single bumer pressure type&#13;
20 Stretcher army type folding&#13;
21 Tray, instrument covered 225x125x50mm ss&#13;
22 Tray, instrument shallow 343x247x16mm ss&#13;
&#13;
&#13;
&amp;#12;&#13;
- 65 -                                      Annex 5&#13;
Obstetrics/Gynecology                                            TB&#13;
I Adult resuscitator                               I Adult scale&#13;
2 Aspirator, portable,foot operated                2 Basin Kidney&#13;
3 Basin wash shallow 4 liters ss                   3 Bottle, oxygen&#13;
4 Bed labor and delivery w/ two piece mattress     4 Box for 4 syringes AL&#13;
5 Box for 4 syringes AL                            5 Drum sterilizing cylindrical small&#13;
6 Clamp umbilical ss                               6 Forceps dressing spring -type 155mm ss&#13;
7 Dilatation -curettage kit                        7 Forceps sponge -holding straight&#13;
8 Drum sterilizing cylindrical small               8 Scissors bandage angular Lister 180mm ss&#13;
9 Forceps obstetrical - TARNIER                    9 Sphygmomanometer aneroid&#13;
10 Irrigator 1.51tr ss                             10 Stethoscope&#13;
11 Kidney basin 475 ml ss                          11 Thermometer oral/rectal&#13;
12 Light examining table articulated hosp. 110/220v  12 Urinal female 900 ml polypropylene&#13;
13 Oxygen bottle and regulator                     13 Urinal male 1.5 liters polypropylene&#13;
14 Pelvimeter Collyer external grad cms/ inches&#13;
15 Pump breast hand rubber bulb glass/ plastic                       Pharmacy&#13;
16 Scale Adult&#13;
1 7 Scale infant clinic metric 15.5kg x 5g          1 lce box&#13;
18 Scissors episiotomy Braun -Stadler 14 cm 1/2     2IRefrigerator&#13;
19 Scissors umbilical SCHUMACHER&#13;
20 Set dressing                                                     Laboratory&#13;
21 Sphygmomanometer aneroid&#13;
22 Stethoscope adult                                1 Alcohol lamp (with match)&#13;
23 Stethoscope foetal Pinard monaural               2 Analytical balance&#13;
24 Stove kerosene single bumer pressure type        3 Beaker 250ml&#13;
25 Syringe ear &amp; ulcer rubber tip 90ml              4 Blade holder I&#13;
26 Syringe rectal infant rubber bulb hard tip 30ml  5 Blade holder 11&#13;
27 Tape- measure 1 .5m/60"viny / coated fiberglass  6 Brush for hemolysis tubes&#13;
28 Thermometer oral/rectal                          7 Brush for test tube (set of 4)&#13;
29 Tray instrument covered 225x125x50mm ss          8 Desktop mechanical timer&#13;
30 Tray instrument shallow343x247xl6mm ss           9 Dish staining glass&#13;
31 Urinal female 900ml Polypropylene               10 Droplet- counter flask&#13;
32 Vacuum -extractor MALMSTROM                     11 Flat bottom tank 500ml&#13;
33 Vertical autoclave                              12 Furnel&#13;
13 Graduated flask 100 ml&#13;
14 Graduated flask 500mi&#13;
15 Graduated pipette 1ml, 2ml, 5mi, 1OmI&#13;
16 Hematocrit reading rule&#13;
17 Hemolysis tube&#13;
18 Kidney basin&#13;
19 Laboratory wood holder&#13;
20 Mechanical desktop counter&#13;
21 Microscope Olympus&#13;
22 Mortar and pestle&#13;
23 Neubauer counting chamber&#13;
24 Pasteur pipette (1000 units)&#13;
25 Pasteur pipette bulb&#13;
26 Pen for writing on glass&#13;
27 Potain dilution pipette&#13;
28 Reagent storage flask&#13;
29 Rubber tube + plastic tip&#13;
30 Sahli hemoglobinometer&#13;
31 Sahli pipette&#13;
32 Sampling plate&#13;
33 Slide container with 100 slides&#13;
&#13;
&#13;
&amp;#12;&#13;
66-                                            Annex 5&#13;
Other Items - General                                         Laboratory (contd.)&#13;
1 Bedpan                                            34 Table- top centrifuge&#13;
2 Cabinets for drugs/instruments                    35 Test tube holder&#13;
3 Cart dressing/dispensing                          36 Test tubes&#13;
4 Chairs/Stools                                     37 Thomas dilution pipette&#13;
5 Examination Table                                 38 Three-way suction bulb&#13;
6 Hospital bed                                      39 Wash boKtle 125ml&#13;
7 Stand irrigator double hook type                  40 Water filter&#13;
8 Tables                                            41 Weighing spatula&#13;
42 Westergren holder&#13;
43 Westergren pipette (5 units)&#13;
44 Wicks for lamp&#13;
v                                                            __          _   _ _ _ _ _   _ _ _     _ _&#13;
The lists for full referral hospitals (which offer surgical facilities) differs from&#13;
the above list only in the obstetrics/gynecology, surgical and radiological&#13;
categories. The additional items for full referral hospitals for these three&#13;
categories are listed below.&#13;
Obstetrics/Gynecology                                          Surgery&#13;
1 Caeserotomy and Hysterectomy set (20 items)        1 Amputation set&#13;
2 Forceps biopsy Faure 24cm                          2 Anaesthesia Apparatus&#13;
3 Forceps bone BOER 29cm                             3 Laparotomy set&#13;
4 Forceps placenta and ovum                          4 Plaster shears Stille AESCULAP 36cm&#13;
5 Forceps placenta and ovum AESCULAP&#13;
6 Forceps ruptured IOWA 26cm                                      Operating Room&#13;
7 Forceps scalp flap WilleKt 18 cm 1/2&#13;
1 Airconditioner&#13;
2 Apparatus anesthesia + accessories&#13;
3 Aspirator electric 220V&#13;
4 Aspirator, portable, foot operated + 2 bottles&#13;
Radiology                                          5 Autoclave universal capacity (CSSD)&#13;
6 Basin wash shallow 6 litres&#13;
1 Alphabet lead(lset)                                7 Cart dressing/dispensing&#13;
2 Cassette with intensifying18x24                    8 Cart for oxygen tank&#13;
3 Cassefte with intensifying screen 35x43            9 Drum sterilizing large size&#13;
4 Cassette with intensifying screen30x40            10 Electrosurgical unit 220V&#13;
5 Developing hanger 18x 24                          11 Forceps intubation MAGILL adult&#13;
6 Developing hanger 30x40                           12 Forceps intubation MAGILL infant&#13;
7 Developing hanger 35x43                           13 Laryngoscope set of 3 slides&#13;
8 Eye glasses, protection                           14 Light operating ceiling&#13;
9 Gloves lead rubber protection x                   15 Negatoscope&#13;
10 Lead apron                                        16 Stand double-bowl type without bowl&#13;
11 Negatoscope                                       17 Stand single-bowl type without bowl&#13;
12 Pump aspirating electric 220v+ 2 bottles          18 Stretcher, combination wheel and knockdown&#13;
13 Tank developing film                              19 Table anesthesia on casters without tray&#13;
14 Test pen                                          20 Table instrument MAYO with tray&#13;
15 X-Ray Machine                                     21 Table operating&#13;
22 Ultraviolet lamp&#13;
&#13;
&#13;
&amp;#12;&#13;
- 67 -                                        Annex 6&#13;
KINGDOM OF CAMBODIA&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT PROJECT&#13;
LIST OF PRIORITY DRUGS SUPPORTED&#13;
UNDER THE NATIONAL DRUG SUPPLY SYSTEM&#13;
No.             DESCRIPTION             No.              DESCRIPTION&#13;
MED. ORAL                38 PPHEN METH PENICILLIN&#13;
1 ACETYL SALICYLIC ACID               39 PHENOBARBITAL&#13;
2 ALUMINUM HYDROXIDE                   40 PRAZIQUANTEL&#13;
3 AMINOPHYLLINE                       41 PREDNISOLONE&#13;
4 AMOXYCILLIN                          42 PROMETHAZINE&#13;
5 CEFTRIAXONE                         43 PROPRANOLOL&#13;
6 CHLORAMPHENICOL                      44 PYRAZINAMIDE&#13;
7 CHLORPROMAZINE                       45 RIFAMPICINIISONIAZID&#13;
8 CHLOROQUINE (BASE)                  46 SALBUTAMOL&#13;
9 CIMETIDINE                           47 SPECTINOMYCIN&#13;
10 CIPROFLOXACIN                       48 SULFADOXINE/PYRIMETH&#13;
11 CLOXACILLIN                         49 TETRACYCLINE&#13;
12 COTRIMOXAZOLE (pediatric)            50 THIABENDAZOLE&#13;
13 COTRIMOXAZOLE (adult)               51 QUININE&#13;
14 DIAZEPAM                            52 VITAMIN B1&#13;
15 IDIGOXIN                       I|.    MED. INJEC7IONS&#13;
16 DOXYCLINE                           53 AMINOPHYLLINE&#13;
17 ERYTHROMYCIN                        54 AMPICILLIN&#13;
18 ETHAMBUTOL                          55 ATROPINE SULPHATE&#13;
19 ETHAMBUTOL/ISONIAZID                56 BUTYLSCOPOLAMINE&#13;
20 FERROSULFATE+FOLIC ACID             57 BUPIVACAINE 0,5%&#13;
21 |FOLIC ACID                         58 CALCIUM GLUCONATE 10%&#13;
22 |FUROSEMIDE                          59 CHLORAMPHENICOL&#13;
23 HYDRALAZINE                          60 CHLORPROMAZINE&#13;
24 HYDROCHLOROTHIAZIDE                 61 CLOXACILLINE&#13;
25 INDOMETHACIN                         62 DEXAMETHASONE&#13;
26 ISONIAZID                           63 DEXTROSE 50%&#13;
27 LUGOL Goutte                        64 DIAZEPAM&#13;
28 MEBANDAZOLE                          65 DIGOXIN&#13;
29 MEFLOQUINE                          66 DOPAMINE&#13;
30 METHYLDOPA                          67 WATER FOR INJECTION&#13;
31 METRONIDAZOLE                       68 EPHEDRINE (FOR DILUTION) 1ml&#13;
32 MICONAZOLE                          69 EPINEPHRINE/ADRENALINE&#13;
33 MULTIVITAMINS                        70 ERGOMETRINE METHYL&#13;
34 NICLOSAMIDE                          71 FENTANYL 2ml&#13;
35 NYSTATINE Pessary                   72 FUROSEMIDE&#13;
36 ORS                                  73 GENTAMYCIN&#13;
37 PARACETAMOL                          74 HYDRALAZINE&#13;
&#13;
&#13;
&amp;#12;&#13;
Annex 6&#13;
-   68  -_ _ _ _ _&#13;
No.             DESCRIPTION           No.    DESCRIPTION&#13;
f  MED. INJECTIONS (contd.)         109 TETRACYLINE 1%&#13;
75 HYDROCORTISONE                      110 ZINC SULFATE COLL.&#13;
76 KETAMINE                           VII.  MATERIALS&#13;
77 LIDOCAINE 1 %                       112 ADHESIVE TAPE ZINC OXIDE ROLL&#13;
78 LIDOCAINE 2%/ADRE 0.01 %            113 BAGS, BLOOD (CPDI + TAKING SET&#13;
79 METOCLOPRAMIDE                      114 BAGS, URINE COLL. WITH TAP&#13;
80 METRONIDAZOLE                       115 BANDAGE, CREPE&#13;
81 OXYTOCIN                            116 BANDAGE GAUZE NON-STERILE&#13;
82 PENICILLIN BENZATHINE               117 BLADES FOR SURGICAL KNIFE&#13;
83 PENICILLIN-G, IM/IV                 118 BLOOD TRANSF. SET W/ NEEDLE&#13;
84 PENIPROCAINE+PENI-G                 119 CATHETER, FOLEY&#13;
85 STREPTOMYCIN                        120 CATHETERS, IV (VENFLONI&#13;
86 VITAMIN Bl (THIAMINE)               121 CONDOMS&#13;
87 VITAMIN K                           122 COTTON WOOL&#13;
88 VECURONIUM                          123 DRAINAGE STRIP IDELBET)&#13;
/i1.  PERFUSIONS                         124 GAUZE COMP. PARAFFIN IMPR.&#13;
89 DEXTROSE 10%(+SET)                  125 GAUZE ROLLS&#13;
90 DEXTROSE 5% (+SETI                  126 GLOVE EXAM NON-STERILE LATEX&#13;
91 DEXTRAN 70(+SET)                    127 GLOVE SURGICAL STERILE/REUS.&#13;
92 NSS 0.9%(+SETI                      128 NEEDLE SUTURE CUTTING&#13;
93 RINGERS LACTI+ SET)                 129 NEEDLE SUTURE ROUND&#13;
IV.  EXTERNAL USE                        130 NEEDLES, LUER, REUSABLE&#13;
94 BENZ. ACID 6%+AC SALIC.             131 NEEDLES, SPINAL DISPOSABLE&#13;
95 BENZOATE BENZYL 25%                 132 NEEDLES, DENTAL REUSABLE&#13;
96 CHLOREX 1.5%+CETRIM.15%             133 PLASTER OF PARIS ROLLS&#13;
97 GENTIAN VIOLET                      134 SCALP VEIN&#13;
98 ZINC OXIDE 10%                      135 SHARPENING STONE&#13;
99 PODOPHYLLINE pommade                136 STERILE EYE PADS&#13;
100 POVIDONE IODINE 10%                 137 SUT/ CATGUT PLAIN TRN 1/2 35mm&#13;
101 CALAMINE LOTION                     138 SUTI NYLON TRN 3/8 30mm&#13;
102 VASELINE                            139 SUT/ NYLON TRN&#13;
V.  OPHTHALMIC USE                       140 SUT/METALLIC wire for tendon-30cm&#13;
103 ATROPINE SULPHATE 1 % COLL          141 SUT/SILK 6mm needle&#13;
104 FLUORESCEIN EYE STRIPS              142 SUT/ VICRYL RB 1/2 16mm&#13;
105 GENTAMYCIN 1 % COLL                 143 SUT/ VICRYL RB 3/8 30mm&#13;
106 PILOCARPINE 2% COLL                 144 SYRINGES, GLASS&#13;
107 PREDNISOLONE ACET. 1 % COLL         145 SYRINGES, PLASTIC&#13;
108 TETRACAINE 0.5% COLL.               146 TALC&#13;
&#13;
&#13;
&amp;#12;&#13;
-69 -                                         Annex 6&#13;
No.             DESCRIPTION             No.               DESCRIPTION&#13;
VIl.  MATERIALS (contd.J                VI.  MATERIALS /contd.)&#13;
147 TAPE UMBILICAL NON-STERILE3mm       158 X-RAY FILM&#13;
148 TAPE TEST FOR AUTOCLAVE             159 FIXER&#13;
149 TAPE/STRIPS, TEST FOR POUPINEL      160 DEVELOPER&#13;
150 THERMOMETER ORAL                    161 PLASTIC BAGS FOR TABS&#13;
151 THORAX DRAIN +TROCAR                162 PLASTIC BAGS&#13;
152 TUBES CONN. DRAIN "REDON            163 ZINC OXIDE / EUGENOL&#13;
153 TUBES DRAIN "REDON"                 164 GLASS IONOMER&#13;
154 TUBES LIAISON FOR "REDON"           165 PLASTIC MATRIX&#13;
155 TUBES SUCTION DISPOSABLE            166 AMALGAM&#13;
156 TUBES, NASOGASTRIC                  167 METAL MATRIX&#13;
157 VALVE - ANTI RETOUR                 168 LUBRICANT&#13;
&#13;
&#13;
&amp;#12;&#13;
- 70 -                            Annex 7&#13;
KINGDOM OF CAMBODIA&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT PROJECT&#13;
Project Management Arrangements&#13;
I.    The Ministry of Health (MOH) will be the implementing agency for both the CDCP&#13;
and the ADB-assisted Basic Health Services Project (BHSP). A Steering Committee&#13;
consisting of representatives from the Ministry of Economy and Finance (MOEF), Ministry&#13;
of Planning (MOP), Cambodia Development Council (CDC) as well as senior MOH staff&#13;
will provide overall technical and managerial direction during project implementation.&#13;
2.    The central Project Coordination Unit (PCU) will manage the timely and efficient&#13;
implementation of the CDCP and BHSP, and activities common to both projects will be&#13;
financed jointly by the two projects (Finance and Administration Unit). In addition, activities&#13;
specific to each project will be managed by the respective sub-unit within the PCU. The PCU&#13;
will rely on the line departments in MOH (Planning and Statistics, Budgeting, Financial&#13;
Department, Director General of Health, etc.) and the national institutes (CENAT, CNM,&#13;
NAO) to provide technical guidance and supervision to the local implementation units in the&#13;
project provinces. Also, appropriate technical resources will be identified to form an&#13;
advisory group, for providing specialized inputs into the implementation process.&#13;
3.    The provincial health authorities will be responsible for the overall management and&#13;
supervision of project activities at the provincial level and will act as the link between the&#13;
central PCU/MOH and the operational district health system. A Provincial Project Unit&#13;
(PPU), headed by a Provincial Project Director, will be established in the ten provinces&#13;
receiving provincial inputs and will be responsible for project implementation at the&#13;
peripheral level.&#13;
Figure 7.1&#13;
Organization Structure&#13;
|Minister|&#13;
Steering Committee&#13;
Chairman: Minister of Health&#13;
Members: Financing, Planning, National Bank, Customs, Auditor..&#13;
Secretary General: Project Director&#13;
Project Director&#13;
Project Deputy Director&#13;
Project Coordination Unit, MO"&#13;
Project Manager&#13;
Provincial Project Unit&#13;
Project Provincial Health Director&#13;
&#13;
&#13;
&amp;#12;&#13;
- 71-                             Annex 7&#13;
The detailed structure of the Project Coordination Unit is described below:&#13;
Figure 7.2&#13;
PCU&#13;
Manager&#13;
Chief, Finance and       Chief, World Bank        Chief, ADB&#13;
Administration Unit    Project Operation Unit  Project Operation Unit&#13;
- Disburs/Accounting     - Planning/Budgeting&#13;
-Assistant to Chief      -Monitor/Supervision&#13;
Procurement/logistics   -Technical Liaison&#13;
Assistant for Procurement            Malaria&#13;
Secretary                            TB&#13;
-  Driver                               HIV/AIDS&#13;
Health Service Strengthening&#13;
Construction Manager&#13;
&#13;
&#13;
&amp;#12;&#13;
- 72 -                            Annex 7&#13;
Staffing&#13;
4.    Members of the Steering Committee will be assigned by the agency which they would&#13;
be representing on the Committee. The Steering Committee will meet every six months and&#13;
all secretarial and logistical support for these meetings will be provided by the PCU.&#13;
5.    The Project Director and Deputy Director will be high level MOH officials and will&#13;
perform their duties as Project Director and Deputy Director in addition to their normal&#13;
duties.&#13;
6.    The PCU will have three kinds of personnel: international contractual staff, local staff&#13;
and   government  staff-on-leave.   The  following   positions  are  identified:&#13;
* PCU Manager, will be in charge of the overall management of the PCU. He/she will be&#13;
appointed by the MOH and approved by the Steering Committee and the World Bank and&#13;
ADB. The Manager will be recruited on an international basis and serve for a minimum&#13;
period of two and one half years, during which time training of a local replacement would&#13;
be achieved.&#13;
*  Chief, World Bank Project Unit, will be selected by the Manager of the PCU and&#13;
appointed by the MOH, and subject to approval by the World Bank. Three contractual&#13;
staff will assist him/her in project planning/monitoring and technical liaison.&#13;
*  Chief, Finance and Administration Unit, will be selected by the Manager of PCU and&#13;
appointed by the Minister of Health and subject to approval by the World Bank and&#13;
ADB. Three contractual staff, namely the Chief Procurement Officer, Chief Accountant&#13;
and Administrative Secretary, will assist the Finance and Administrative Chief in his/her&#13;
duties. In addition, three support staff may also be hired as necessary.&#13;
Functions&#13;
Steering Committee:&#13;
*  Approve the Annual Action Plan and Budget for the CDCP.&#13;
*  Review any proposals for amendment to the Credit Agreement before sending to&#13;
the Government and the World Bank.&#13;
*  Review and approve the appointment of the Manager and Unit Chiefs of the&#13;
Project Coordination Unit.&#13;
*  Review the progress reports and supervision reports, and make relevant policy&#13;
decisions.&#13;
*  Mobilize resources from the member ministries/agencies to support the CDCP's&#13;
implementation.&#13;
&#13;
&#13;
&amp;#12;&#13;
-73-                             Annex 7&#13;
Project Director and Deputy Director:&#13;
*  Liaise with the Steering Committee on project implementation issues&#13;
*  Review the Annual Action Plan and Budget and submit to the Steering Committee for&#13;
approval.&#13;
*  Review the appointment of the Manager and Unit Chiefs of PCU, and submit to the&#13;
Steering Committee for approval after consulting with the World Bank and Asian&#13;
Development Bank;&#13;
*  Consult with the World Bank and Asian Development Bank on policy decisions before&#13;
submitting to the Steering Committee;&#13;
*  Lead the supervision team, which involves key staff from MOH, the national institutes&#13;
and the provincial health directorates, to inspect the facility construction quality,&#13;
equipment distribution/utilization, and local health workers' performance, and to assure&#13;
the activities under CDCP and BHSP are carried out as planned.&#13;
* Review the Bidding Document and Bids Evaluation Report for International Competitive&#13;
Bidding before submitting to the government and the World Bank through the Project&#13;
Director.&#13;
* Review expenditures and replenishment applications for the World Bank special account.&#13;
Project Coordination Unit:&#13;
3  Prepare the draft Annual Action Plan and Budget.&#13;
3  Execute and follow-up on the decisions made by the Steering Committee and the Project&#13;
Directors.&#13;
3  Coordinate closely with the line departments in MOH, the National Institutes, and the&#13;
project provinces, and ensure that all the activities are carried out in conformity with the&#13;
approved Annual Action Plan in terms of budget and schedule.&#13;
3  Liaise with the member ministries/agencies of the Steering Committee on policy support&#13;
for the implementation of CDCP and BHSP.&#13;
*  Liaise with the World Bank, Asian Development Bank and other foreign financiers, and&#13;
respond promptly to their requirements concerning the implementation of CDCP and&#13;
BHSP.&#13;
*  Organize training courses or study tours for PCU staff and provincial project officers, in&#13;
order to strengthen the skills needed for project monitoring, procurement, disbursement&#13;
and accounting.&#13;
*  Develop administrative procedures and file/record keeping system for CDCP and BHSP,&#13;
maintain all documentation related to the Project (including government decree, minutes&#13;
of Steering Committee and Coordination Committee meetings, routine progress reports&#13;
and field supervision reports, correspondence with the World Bank or Asian&#13;
Development Bank, etc.), and provide secretarial services to the Steering Committee and&#13;
Coordination Committee.&#13;
*  Organize field supervision teams, monitor implementation progress, and consolidate all&#13;
information related to the CDCP Project into the periodic Progress Report for review by&#13;
the Steering Committee, Coordination Committee and the World Bank.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 74 -                           Annex 7&#13;
* Carry out procurement of goods and civil works in conformity with the government&#13;
regulation and the World Bank Procurement Guidelines, including preparing detailed&#13;
technical specifications and bidding documents, opening and evaluating the bids,&#13;
awarding and signing the contacts, receiving and inspecting the goods (works), arranging&#13;
distribution and installation of goods, and collecting information and keeping records for&#13;
all kinds of procurement under CDCP and BHSP.&#13;
*  Select and hire foreign and local consultants in conformity with the government&#13;
regulation and the World Bank Guidelines for Consultant Services, including drafting&#13;
Terms of Reference and Letter of Invitation for Proposal, assessing the proposals and&#13;
signing the contracts.&#13;
*  Operate the Special Account established exclusively for CDCP and BHSP, withdraw&#13;
funds from the Special Account for eligible project expenditures, apply for replenishment&#13;
or Direct Payment from the World Bank, and keep all transaction records, monthly&#13;
statements and annual reports for review by the authorized auditor and the World&#13;
Bank/ADB.&#13;
*  Operate a Counterpart Funds Account established separately from the normal budgetary&#13;
account of MOH, release the funds to the implementation units, and keep transaction&#13;
records, monthly statements and annual report for review by the authorized auditor and&#13;
the World Bank/ADB.&#13;
*  Provide logistical services for the visiting missions from the World Bank and Asian&#13;
Development Bank.&#13;
7.   In order to obtain specific technical support, the following specialists will be&#13;
identified and hired as local consultants as necessary:&#13;
* One pharmacist for drug specification and quality control.&#13;
* One engineer for medical equipment specification and evaluation.&#13;
One construction manager to oversee the contracting, bidding and construction of&#13;
facilities.&#13;
8.    The PCU will manage both the proposed World Bank -assisted CDCP as well as the&#13;
ADB-assisted BHSP. However, the detail staffing of the ADB operation unit will be&#13;
finalized by ADB and MOH.&#13;
Budget&#13;
9.    The Government will provide office space for the PCU. The World Bank project and&#13;
ADB project will share equally the following PCU expenditures:&#13;
* the PCU manager&#13;
* the staff costs, operating cost, supplies and equipment for the Finance and&#13;
Administration Unit.&#13;
10.   The assignment of specific costs to the two projects will be decided by the&#13;
Administration and Finance Chief The World Bank Project will cover the costs of the&#13;
World Bank Operation Unit.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 75 -                            Annex 7&#13;
Terms of Reference for Key Staff of PCU/MOH&#13;
PCU Manager&#13;
11.   This is a full-time, senior official position appointed by the Minister of Health and&#13;
reporting to the Project Director. He/she would be the project manager of CDCP and BHSP,&#13;
and will have overall responsibility for project implementation and the running of the PCU.&#13;
He/she will also act as the secretary-general of both the Steering Committee and the&#13;
Coordination Committee for CDCP. He/she will sign all written reports or correspondence&#13;
sent by PCU to the World Bank or other government agencies. He/she is the authorized&#13;
person to access the Special Account and sign the Withdrawal Application. He/she makes&#13;
decision on hiring of staff and consultants.&#13;
Qualifications:&#13;
8 years experience working in MOH, 3 years at a senior position;&#13;
strong coordination ability with planning, financing or managerial&#13;
background;&#13;
fluency in English.&#13;
Chief, World Bank Operation Unit&#13;
12.   This is a full-time, senior official position appointed by the Minister of Health. He/she&#13;
will be responsible for drafting the Annual Plan and Budget, organizing supervision&#13;
activities, liaison with implementation units, collecting data and drafting progress reports.&#13;
Qualifications:&#13;
6 years working experience, and 2 years at a senior position;&#13;
strong planning and budgeting ability with monitoring/evaluation background;&#13;
fluency in English and good computer skills.&#13;
Chief of Finance/Administration Unit&#13;
13.   This is a full-time, senior official position appointed by the Minister of Health.&#13;
He/she will be responsible for supervising the staff maintaining the: (a) filing system for&#13;
PCU, (b) providing administrative and logistical services for PCU, (c) procuring goods and&#13;
works according to the Annual Action Plan, (d) operating the bank accounts and (e) keeping&#13;
the accounting books. He/she will be the alternative person authorized to access the Special&#13;
Account while the Manager is absent.&#13;
Qualifications:&#13;
6 years working experiences, and 2 years at a senior position;&#13;
strong administrative background with some procurement experiences;&#13;
fluency in English.&#13;
14.   The World Bank Project Operation Unit will employ a full-time internationally&#13;
recruited construction advisor for two years. After two years, a local consultant will fill the&#13;
position for an additional three years.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 76-                            Anex7&#13;
Chief Accountant of PCU&#13;
15.   He/she is responsible for: (a) disbursement of eligible expenditures, (b) preparing&#13;
withdrawal applications to the World Bank, (c) keeping the complete accounting books of&#13;
CDCP and BHSP, and (d) preparing annual accounting report for auditing. He/she will&#13;
supervise the cashiers' work.&#13;
Qualifications:&#13;
hold an accounting certificate from an accredited financial/accounting&#13;
institute;&#13;
5 years relevant work experience;&#13;
fluency in English and good computer skills.&#13;
Chief Procurement Officer of PCU&#13;
16.   He/she is responsible for: (a) phasing and packaging of procurement, (b) organizing&#13;
the technical advisory groups to prepare specifications for equipment, drugs and civil works,&#13;
and (c) organizing bidding or shopping, evaluating the bids and making recommendation for&#13;
awarding contract. He/she will supervise the assistant procurement officer and provide&#13;
guidance on provincial procurement activities.&#13;
Qualifications:&#13;
5 years experience with large quantity of procurement financed by public&#13;
funds or international agencies;&#13;
familiarity with government regulations on contracting, taxation, customs,&#13;
inspection;&#13;
fluency in English.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 77- A-nnx&#13;
KINGDOM OF CAMBODIA&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT PROJECT&#13;
Health Management Agreements (HMA)&#13;
1.    These are intended to be a jointly agreed and committed plan among the Ministry&#13;
of Health (MOH), provincial health management, and provincial civil administration (the&#13;
provincial governor's offices). They will agree to the substance of health inputs,&#13;
processes/ activities, and outputs as well as the processes of planning, organizing, and&#13;
managing health services, including how these Agreements themselves will function.&#13;
They will be planned in the context of 5-year goals and expected outcomes and long term&#13;
impacts.&#13;
2.    These Health Management Agreements (HMA) should become the basis for how&#13;
health is planned and managed. They should change the nature of the relationship&#13;
between the MOH and the Provinces. However, they are proposed, not for the sake of&#13;
change, but with a single overall purpose of improving performance of public sector&#13;
health services.&#13;
3.    The Agreements have the following characteristics. They will:&#13;
(a)   be formulated and agreed annually, but will have no legal status as such;&#13;
(b)   involve the following groups in the process' who will each sign the&#13;
agreement:&#13;
(i)   Provincial Governors' Office representatives;&#13;
(ii)   Provincial Health Directorate representatives;&#13;
(iii)  Ministry of Health [MOH] representatives; and&#13;
(iv)  the Project Coordination Unit [PCU].&#13;
(c)   usually be prepared in the Provinces during planning workshops;&#13;
(d)   define a planning, operating and monitoring/evaluation framework. This&#13;
may be done in project management software.  This will provide&#13;
consistency of various health functions [e.g. case management], and will&#13;
allow comparisons:&#13;
See draft example HMA format in the Project Implementation Plan for a more&#13;
detailed listing of all proposed organizational units who are likely to participate in the&#13;
process.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 78 -                          Annex 8&#13;
(i)   across programs; and&#13;
(ii)  across provinces;&#13;
(e)   specify responsibilities according to the major stages in operations -&#13;
inputs, activities, and process outputs;&#13;
(f)   have process outputs as the primary focus, which is a change from past&#13;
management focus which tends to focus on inputs and activities;&#13;
(g)   make a clearer division of labor and responsibilities so there is little doubt&#13;
who does what, not only between the Provinces and the MOH generally,&#13;
but among the organizational units within the MOH and Provinces which&#13;
may be expressed in sub-agreements annexed to the main Agreement;&#13;
(h)   have clear indicators of performance so that they are measurable and&#13;
objectively monitorable;&#13;
(i)   have clear performance consequences that are known to all parties in&#13;
advance that are clearly defined and categorized; and&#13;
(j)   remain flexible in their design and use - both the Agreement's content and&#13;
in the manner in which they are planned, implemented, and monitored.&#13;
4.    The content of these Agreements and the manner in which they will be&#13;
implemented was reviewed by a cross section of managers from all signatory parties.&#13;
This review culminated in a one-day Workshop during the pre-appraisal mission during&#13;
which all parties concluded that the Agreements were both desirable and feasible. They&#13;
should be tried during the first year of the Project with the Phase I provinces. This should&#13;
be considered a trial year. Full implementation will be only at the beginning of the&#13;
second project year. Therefore, there is some time to prepare the exact nature of the&#13;
Agreements and further orient managers to their use. Using these Agreements as the&#13;
"centerpiece" of managerial relationships requires:&#13;
(a)   majority of managers and staff contributing or expressing their views on&#13;
the changes;&#13;
(b)   improving overall performance of the MOH at any level, and improving&#13;
motivation and morale;&#13;
(c)   improving relationships with related public sector managers: e.g.&#13;
Governors, other Ministers, etc.&#13;
5.   In order for these Agreements to have a meaningful impact on public sector&#13;
performance, concurrent improvements in the following are also needed:&#13;
(a)   improving managers' knowledge and skills;&#13;
&#13;
&#13;
&amp;#12;&#13;
- 79 -                                Annex 8&#13;
(b)    changing  MOH   organization  structures  and  management  systems&#13;
including:&#13;
(i)    national MOH structure;&#13;
(ii)    provincial health  structures including  relationships with  the&#13;
governors' office;&#13;
(iii)   district health structures;&#13;
(iv)   related changes in responsibilities, authorities, and accountabilities;&#13;
(v)    a health information system  [HIS] to support actual decision&#13;
making&#13;
(vi)   resource  procurement and  distribution  including: drugs  and&#13;
supplies, equipment, transport, and facilities; and&#13;
(c)    improving staff technical knowledge and skills in order to be able to&#13;
deliver on the Agreements' commitments at reasonable quality levels.&#13;
Figure 8.1&#13;
6.     Figure        8.1&#13;
outlines    the    basic&#13;
outlines    the    basicHealth Management Agireements&#13;
structure    of      this                           MOH - Provincial Relationships&#13;
agreement between the&#13;
central MOH  and  the             p-nvieinputon.&#13;
provinces.   Figure  8.2         ....&#13;
below outlines the types            Impute                    Prvin  to&#13;
of inputs  and  actions                                       e"Itmof A a&#13;
each of the three parties        Poli m. &#13;
would agree to. Ideally           Ipedt M-nitoring&#13;
this type of Agreement           Cenprl inkild Service s                       Oul&#13;
would  also  be  made             Ashl        Senrice Actvites              Immunized Chilmn&#13;
between  the  provinces                        Pubgc Heath                   PevnlodCurd&#13;
and  the  districts, but                       Health Eduation              TB &amp; Maluri&#13;
currently  most districts                     Supervlsior                    Haly Mothers &amp;&#13;
are judged managerially                       InformIt n&#13;
too weak to undertake&#13;
this type of agreement in&#13;
the early stages of the Project. As district's become developed through the Accelerated&#13;
District Development (ADD) program, they could enter into sub-agreements with the&#13;
provinces.&#13;
&#13;
&#13;
&amp;#12;&#13;
-80 -                            Annex 8&#13;
Figure 8.2&#13;
Health lM,a riaavemenrt Aa reeme rntm&#13;
MOCH - =Irovincial FleIlationships&#13;
n | isintry of I-ealth &#13;
Policy Frame&#13;
Impact Monltoring&#13;
Central Services&#13;
Inputs - In kind 8 cash&#13;
Provinciel  H_aith                                    ncial&#13;
EMDr_ctorat_t                                _   ornor'. O)fQfict &#13;
Service Activitas                               Land&#13;
Public Hmalth                                   FadIc&#13;
Helaith Eiducatlon                              Community Involvement&#13;
Sup_rvii-onlTraining                           COth_r ministry coordinatlon&#13;
Informatlon                                     Admin oupport&#13;
7.    The HMA format will be a selection of indicators by input, by output, and&#13;
outcome; all of which will be attainable on an annual basis. The format must be&#13;
consistent across provinces. Part of the Agreement should also define the specific steps&#13;
in the process by which Agreements are planned, implemented, monitored, and evaluated&#13;
along with the consequences for good and poor performance [see Sections IV and V of&#13;
the HMA example in the Project Implementation Plan (PIP) for details of what is&#13;
currently proposed]. These steps may be agreed only once at the beginning of the project&#13;
or they may be "re-agreed" each year. However this is done, the development and use of&#13;
these Agreements must relate to the total Government/MOH planning, implementing, and&#13;
monitoring/evaluation cycle.&#13;
8.    A format for district level planning is being developed by the MOH. This same&#13;
structure can and should be used at the provincial level so that district plans can be&#13;
aggregated into provincial plans. In order to ease the planning of repetitive tasks and&#13;
operations management/monitoring, it is suggested that all this information be entered in&#13;
project management software. The draft district planning format information can all be&#13;
accommodated in common project management software. This computer supported&#13;
planning and management can be done only at the provincial and national level (PCU)&#13;
until computers are provided to districts. This application can be one of the uses of the&#13;
computers the Project is providing to the provinces. The workplans generated by the&#13;
software can also be a formal part of the HMA process. They can be aggregated to form&#13;
the basis for the overall annual Project plan. The HMA system will be monitored from&#13;
the central MOH by the Provincial Project Unit, as well as the PCU, and should be&#13;
&#13;
&#13;
&amp;#12;&#13;
- 81 -                          Annex 8&#13;
implemented in a phasing which is linked to the overall Disease Control and Health&#13;
Development project implementation and supervision.&#13;
9.    The completed provincial HMA can then be disaggregated into program/project&#13;
components and the parts given to the respective program managers. These would, at a&#13;
minimum, cover the health strengthening investments and the three disease control&#13;
programs, TB, malaria, and HIV/AIDS in a component-specific workplan. Those&#13;
workplans could be centrally aggregated by each program at the Ministry level to produce&#13;
a master workplan.&#13;
10.   While these are not contracts, in order to verify participation and agreement, the&#13;
HMAs should be signed by the major concerned parties - the provincial Governor or&#13;
his/her representative, MOH representative, the provincial health director, and the Project&#13;
Coordination Unit. The provincial health advisors (HAs) and donor organizations&#13;
assisting a given province should be included in the preparation of the annual plan and&#13;
subsequent HMA negotiations with the MOH. Other donors' specific inputs, activities,&#13;
and outputs may also eventually be included in the HMA later.&#13;
11.   The Agreement commits three parties - the MOH, the Provincial Governors&#13;
Office, and the Provincial Health Directorate - to a variety of actions and results. The&#13;
process of Agreement planning, implementation, monitoring and evaluation will be given&#13;
primary support and supervision by the MOH's Provincial Coordination Section (PCS)&#13;
and secondary supervision by top management of the MOH, the Royal Government's&#13;
central agencies, and the donors, in particular the World Bank. [see Figure 8.3] This&#13;
indirect supervision will usually be carried out during missions coming at six monthly&#13;
intervals. The joint World Bank/ADB Project Coordination Unit (PCU) will assist PCS&#13;
in Agreement implementation, reporting progress, and problem identification/analyses for&#13;
these missions.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 82 -                             Annex 8&#13;
Figure 8.3&#13;
Health Management Agreements&#13;
First and Second Level Management &amp; Supervisory Relationships&#13;
iRoyal Govemment 1i&#13;
prrn.stssnwProv ac                      and mana      t an g&#13;
the statusofambodisHealth d    s       i       Governor's t&#13;
/          ~~~~Directorate                     Office   :\&#13;
Donors/ iMO                                                                       L&#13;
The World t                                                                Tophe&#13;
Bank  f                                                               Managementds&#13;
12.   If any party to this Agreement fails to satisfy their commitments, the parties will&#13;
meet to discuss the relevant issues and agree to steps to remove such constraints on&#13;
performance. As this is a new approach to program planning and management, and given&#13;
the status of Caembodias health delivery system, it is expected that there will be&#13;
adjustments in the HMA processes in the first one tNwo  years of implementation. In the&#13;
case  of severe  breach   of perfoatance  targets, and  the  inability  of 'second&#13;
level'management to resolve the issue, the issue may be taken  up to first level&#13;
management for decision.&#13;
13.   All parties have the right and obligation to assess whether they themselves and all&#13;
others are in or out of compliance with the Agreement. A case may be made at any time&#13;
if the situation seems especially serious, but generally these assessments will be made&#13;
during joint program/project supervision missions. No party will be expected to perforTn&#13;
at 100 percent for 100 percent of all the elements in their set of respective commitments.&#13;
However, generally the "80/80" rule should be the performance guideline. The "80/80"&#13;
rule implies good and acceptable performance is: 80 percent on-time/on-quantity/on-&#13;
quality performance for 80 percent of the elements within the HMA.&#13;
&#13;
&#13;
&amp;#12;&#13;
-83 -                           Annex 8&#13;
14.   Nevertheless, judgments on compliance/out-of-compliance will need to take into&#13;
account unexpected factors for the first one to three years. Objective assessment of&#13;
performance would have to be based on objective information. The development of&#13;
monitoring and research systems with their requisite information systems, while generally&#13;
good in MOH, may not be operating at levels to produce valid and reliable information&#13;
before that time. Until that time, out-of-compliance will jointly be judged on the basis of&#13;
intent to perform according to the Agreement. That is, can a case be made that the&#13;
concerned party was genuinely trying to perform.&#13;
15.   If there is a dispute over performance and the indicators of the intent to perform,&#13;
the MOH PCS [with the support of the Project's PCU] will be the initial arbitrator of the&#13;
performance assessment. If the dispute can not be resolved at this level, then the matter&#13;
will be forwarded to the next formal Project supervision mission. The Bank and top&#13;
management of the MOH, [if necessary with the assistance of the Royal Government's&#13;
central agencies] will resolve the matter.&#13;
16.   Just as a judicial system  has various consequences for various acts; the&#13;
consequences of out-of compliance performance should follow a spectrum according to&#13;
the seriousness. Conversely performance above levels of commitment can result in&#13;
increased rewards and resources.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 84 -                                 Aex 9&#13;
KINGDOM OF CAMBODIA&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT PROJECT&#13;
Project Performance Indicators&#13;
1.    The monitoring indicators for the Disease Control and Health Development Project&#13;
(CDCP) intend to capture the progress and impact of two different but related aspects of:&#13;
(a) IDA financing of specific inputs and activities as part of an integral project and (b) when&#13;
possible, the relationship- of IDA-financed inputs to the processes, outcome and impact&#13;
performance of the three national health programs being supported by the project.&#13;
2.    The indicators will be defined, measured and reported as part of a process that is linked&#13;
with the day-to-day details of Government's management and execution of the project and the&#13;
overall programs. The key indicators would provide signals of underlying processes and&#13;
determinants of project performance which are feasible to monitor during project&#13;
implementation. In addition to the overall project indicators, specific performance goals and&#13;
objectives will be negotiated and agreed to annually between the Ministry of Health and each of&#13;
the ten provinces supported by the project. The performance indicators will be included as part&#13;
of the Health Management Agreements. (see Annex 8, Health Management Agreements).&#13;
3.    The definition of indicators selected to monitor and evaluate overall project&#13;
implementation progress and results are described in Part A below. Part B provides the detailed,&#13;
specific list of input, outcome and impact indicators against which each of the project&#13;
components will be assessed.&#13;
A. Indicator Definition&#13;
4.    Loan Disbursement Rate (semi-annual; ITF-financing specific), defined as the cumulative&#13;
amount of project expenditures incurred by the Government and withdrawn from Loan proceeds&#13;
as a percentage of the total Loan amount. Actual disbursements would be measured against the&#13;
projected disbursement schedule (Annex 12)&#13;
5.    Project Milestones (annual; project-wide scope). Actual accomplishment of project&#13;
milestones would be measured against the agreed upon project implementation schedule.&#13;
Milestones would include the negotiating, signing, monitoring of the Health Management&#13;
Agreements with the 10 provinces, employment of consultants, delivery of key outputs,&#13;
completing planned training and IEC, establishment of the HIV grant program and others as&#13;
defined in the project implementation schedule (See Annex 13).&#13;
&#13;
&#13;
&amp;#12;&#13;
- 85 -                                  Annex 9&#13;
Project Inputs:&#13;
6.    The project can be considered a set of inputs (civil works, equipment, transportation,&#13;
drugs and supplies, training, technical assistance) designed to allow the desired program&#13;
activities (service delivery, institutional strengthening, research) to be undertaken in order to&#13;
achieve desired outcomes and impact. The performance indicators for input will determine if&#13;
they are adequate in quantity and timely in procurement.&#13;
7.    Input Accomplishment Rates (semi-annual; project-wide scope), defined as the&#13;
cumulative quantity of physical accomplishments attained by the project expressed as a&#13;
percentage of total physical targets. This would include facilities constructed or rehabilitated,&#13;
and equipment installed for the 10 targeted provinces. For drugs, the project will monitor&#13;
procurement and delivery according to the national drug procurement plan.   Actual&#13;
accomplishments would be measured against total project objectives for each of the 10 targeted&#13;
provinces and upon physical implementation schedules negotiated annually in the Health&#13;
Management Agreements.&#13;
Program and Project Outputs&#13;
8.    Program Delivery Accomplishment Rates (first, third and fifth year, program-wide) for&#13;
all three disease control programs, the project will monitor qualitative improvements in the case&#13;
management of the diseases by assessing provider performance against predefined clinical&#13;
standards. For TB, the project will monitor the total number of cases treated and cured. For&#13;
malaria, in addition to case management, the project will monitor program performance in the&#13;
distribution, household coverage and sale of bed nets to high risk populations and to the targeted&#13;
communes. The number of staff trained specifically in disease control protocols and procedures&#13;
will be monitored. For HIV/AIDS, the project will monitor the number and the value of NGO&#13;
grants, the number of TV and radio programs produced and other indicators as outlined below.&#13;
9.    Service Availability Indicators (first, third and fifth years of project; project-wide scope),&#13;
defined as the proportion of total public health facilities capable of delivering the minimum&#13;
package of services as defined in the Government's Health Coverage Plan (health centers and&#13;
referral hospitals). Capable of delivery is defined as having available in a referral hospital and&#13;
health center the physical facility, equipment, trained staff and supplies necessary to deliver the&#13;
minimum package of services defined in the Health Coverage Plan. It should be noted that the&#13;
range of services available in the coverage plan include but are not limited to the specific&#13;
services supported by the project, i.e. tuberculosis, malaria and HIV/STDs. Service availability&#13;
would be expressed in terms of the ratio of actual to expected new or rehabilitated facilities that&#13;
are capable of service delivery in each of the 10 provinces. A complete health facility and&#13;
equipment baseline survey is being conducted in the 10 project provinces and will be completed&#13;
by project appraisal.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 86 -                                  Annex 9&#13;
Outcome/Impact&#13;
10.   Access to and Utilization of facility Indicators (first, third and fifth years of project;&#13;
project-wide scope), defined as the proportion of the population residing within a set distance in&#13;
terms of normal travel time of health centers and referral hospitals capable of delivering health&#13;
services (as defined in para. 9 above). Service access would be expressed as a proportion of the&#13;
population with access to service, and would be compared to a baseline determined at the start of&#13;
the project. Facility utilization would be monitored using two indices: (a) the number of clinic&#13;
or outpatient visits by facility; the first post rehabilitation year utilization figure will be&#13;
considered the baseline (b) trends in percent of hospital bed occupancy will be monitored .&#13;
11.   Risk Reduction Indicators (first, third and fifth years of project; program-wide scope).&#13;
The project objective is to assist the Government reduce the risk to the Cambodian population of&#13;
three priority health problems including: malaria, tuberculosis and HIV/STDs. The project will&#13;
seek to monitor how project inputs assist the national programs for Malaria, Tuberculosis and&#13;
HIV/STDs, achieve improvements in the national program outputs and impact through the&#13;
reduction in risk. The project will monitor case fatality and death rates, prevalence, and cure&#13;
rates for TB and Malaria.&#13;
12.   Malaria. Two sets of key indicators would be used to monitor the national program&#13;
progress in reducing the risk of malaria. First, the project will seek to assess reduction in case&#13;
fatality rates (case management) and second, assess the actual reduction in the incidence of&#13;
malaria among high risk individuals and populations (vector control and prevention).&#13;
13.   Monitoring improvements in case management, the project will, in addition to monitoring&#13;
the continuous supply of service inputs necessary for malaria case management (see para. 7.&#13;
above), conduct two assessments of health provider skills and performance in the diagnosis and&#13;
treatment of malaria cases. Actual provider performance will be assessed against the predefined&#13;
case management standards and protocols for the various drug-resistant forms of malaria.&#13;
Malaria outcome and impact will be monitored by observing trends in case fatality and death&#13;
rates, incidence, prevalence and the distribution of household bednet coverage in highly endemic&#13;
areas.&#13;
14.   The major program strategy to reduce malaria transmission (prevention) is to expand the&#13;
use of impregnated mosquito bednets. The project will monitor the coverage and use of bednets&#13;
by two different target populations. The objective is to achieve 80 percent impregnated bednet&#13;
use by the population in the 347 highly endemic communes identified for bednet targeting and&#13;
distribution. A second objective is to reach as many as possible of the migrant population at risk&#13;
through the social marketing of bednets. The project will monitor the program performance in&#13;
raising sales of marketed bednets to targeted high risk groups and areas of the country, based on&#13;
surveys conducted in the first and final years of the project.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 87 -                                 Annex 9&#13;
15. Tuberculosia. The two key tuberculosis program impact indicators are the_Annual_Risk&#13;
of Infection (ARI) and TB prevalence. The risk of infection is an index of the magnitude of the&#13;
tuberculosis problem in a society. The risk of infection at any point in time indicates the current&#13;
magnitude of the rate of recent infections and can be used to estimate the prevalence of infectious&#13;
cases in the population. In addition, it gives an indication of the tuberculosis problem in the&#13;
future. A decline in the ARI is an early indicator of a reduction in the transmission of&#13;
tuberculosis. Conversely, an increase could signal new risk factors, such as HIV infection or the&#13;
breakdown in the national control program. Exact measures of prevalence by survey is a more&#13;
costly but more accurate measure than estimates derived from ARI. A baseline national TB&#13;
prevalence survey will be conducted in the first year of the project. These figures will be used as&#13;
initial targets to monitor overall progress of TB case management by the national program. The&#13;
total number of cases treated and cured will be monitored. as will trends in case fatality and TB&#13;
death rates.&#13;
16.   HIV/AIDS/STD. The outcome/impact indicator for this component is behavior change&#13;
leading to a reduction in HIV and STD incidence. Given the difficulty in measuring incidence,&#13;
the practice is to measure prevalence through surveys of high risk populations. For HIV, this&#13;
will be undertaken annually and for STDs it will be undertaken every two years. To monitor&#13;
changes in behavior, surveys will be undertaken to determine changes in behavior related to risk&#13;
reduction during sexual encounters. Supplementing understanding of the course of the HIV&#13;
epidemic, information about the prevalence of HIV among blood donors will be gathered on a&#13;
continuous basis. It has to be recognized that the latter measure is not a reliable measure of&#13;
incidence of HIV in the population, as changes in policy about the acceptability of donors may&#13;
significantly alter apparent levels of HIV in the population.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 88 -                                         Annex 9&#13;
B. Detailed Indicators by Project Component&#13;
Component              Indicator&#13;
HEALTH&#13;
STRENGTHENING&#13;
Input                   Total number of facilities rehabilitated and equipped; by province:&#13;
InPut                     - basic referral hospitals (without major surgical facilities)&#13;
- full referral (with major surgical facilities)&#13;
- health centers&#13;
- health centers with TB beds&#13;
Number of facilities constructed and equipped:&#13;
- basic referral hospitals&#13;
- full referral&#13;
- health centers&#13;
Quantities of essential drugs, reagents, laboratory equipment and materials provided&#13;
Output                   % of 8 total basic referral hospitals rehabilitated and equipped&#13;
% of 18 total full referral hospitals rehabilitated and equipped&#13;
% of 57 health centers rehabilitated and equipped&#13;
% of 173 new health centers completed and equipped&#13;
% of facilities fully staffed and offering a full minimum package of services&#13;
% of facilities out of stock for essential, TB, malaria and STD drugs&#13;
Outcome/Impact           % at or above access norm&#13;
Increasing annual utilization rates for facilities&#13;
MALARIA&#13;
Input                  Number of bednets procured&#13;
Laboratory and other equipment procured and installed&#13;
Renovation of CNM office&#13;
Number of training courses provided&#13;
Output                 % of health providers judged skilled and knowledgeable in the case management of&#13;
malaria&#13;
% of hospital cases managed appropriately according to protocols for each type of drug&#13;
resistance&#13;
% of authorized facilities with fully trained staff&#13;
(% of highly endemic communes achieving 80% population coverage of bednets)&#13;
Outcome/Impact         Case Fatality Rate&#13;
Malaria Death Rate&#13;
Malaria Incidence&#13;
Annual number of bednet sales; by high risk groups and in target areas&#13;
Reduction in the incidence in the highly endemic communes&#13;
&#13;
&#13;
&amp;#12;&#13;
- 89 -                                         Annex 9&#13;
TUBERCULOSIS&#13;
Input                 Staff training courses provided&#13;
Renovation of Central HQ facility&#13;
Central lab equipment provided and installed&#13;
TB microscopes procured and distributed&#13;
Output                Total number of staff trained&#13;
Renovations complete and equipment installed&#13;
% of patients receiving food supplementation&#13;
Number of short course therapy cases completed annually&#13;
Outcome/Impact        TB prevalence&#13;
% TB cases cured&#13;
Case Fatality Rate&#13;
Annual Risk of Infection (ARI)&#13;
HIV/STDs&#13;
Input                 Additional blood transfusion centers established&#13;
Workshops for outreach program&#13;
Condoms purchased&#13;
Workshops for STD case management training&#13;
Survey of STDs&#13;
HIV surveillance surveys&#13;
Behavioral surveys&#13;
Output                Number of TV and radio programs produced&#13;
Number of peer educators trained&#13;
% of STDs managed correctly&#13;
Number of NGO grants awarded&#13;
Outcome/Impact        Blood tested for HIV&#13;
Decline in STDs&#13;
Decline in HIV incidence&#13;
Decline in the incidence of STDs&#13;
&#13;
&#13;
&amp;#12;&#13;
-90-                                       Annex 10&#13;
KINGDOM OF CAMBODIA&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT PROJECT&#13;
Project Costs&#13;
Table 10-1: Project Component by Year - Total Including Contingencies&#13;
(US$ Million)                                       Totals Including Contingencies&#13;
1996    1997    1995    1999    2000    Total&#13;
A. National Programs&#13;
1. TB Control                             1.1      0.5      0.5      0.5      0.7      3.3&#13;
2. Malaria Control                         1.0     0.8      0.7      0.7      0.7      4.0&#13;
3. HIV/AIDS Control                        1.6     1.6      1.4      1.3      1.4      7.2&#13;
Subtotal National Programs                   3.      Z.       2.       Z.       Z.      145&#13;
B. Health Service Strengthen&#13;
1. Facility Upgrading                       -      2.5      3.5      3.5      2.7    12.2&#13;
2. Equipnient &amp; Transportation              -      1.5      1.3      0.4      0.1      3.2&#13;
3. Essential Drug Supply                    -        -      0.8      0.9      0.9      2.6&#13;
4. In-service Training                     0.1     0.0      0.1      0.1        -      0.2&#13;
5. MOH Strengthening                      1.2      0.6      0.4      0.3      0.3      2.9&#13;
Subtotal Health Service Strengthen           1.      4.       61.&#13;
Total PROJECT COSTS                          4.       7.       8.      77       6.      3&#13;
Table 10-2: Expenditure Accounts by Year - Total Including Contingencies&#13;
(US$ Million)                                     Totals Including Contingencies&#13;
1995    11995        99I    1999    2000    Total&#13;
I. Investment Costs&#13;
A. Equipment                             1.7     2.2      1.9      0.9      0.8      7.5&#13;
B. Drug                                 0.1        -      0.8      0.9      0.9     2.7&#13;
C. Civil Works                          0.4      2.5      3.4      3.3      2.5    12.1&#13;
D. Local Training                       0.5      0.4      0.4      0.5      0.4      2.2&#13;
E. Foreign Training                     0.1      0.2      0.2      0.2      0.2      0.8&#13;
F. Local Consultant                     0.1      0.1      0.1      0.1      0.1      0.6&#13;
G. Foreign Consultant                   0.6      0.7      0.3      0.3      0.3      2.2&#13;
H. Studies                              0.7      0.5      0.4      0.4      0.4      2.5&#13;
I. Grant                                0.1      0.2      0.2      0.2      0.2     0.7&#13;
Total Investmnent Costs                   4.       6.       7.       6.       57      3&#13;
II. Recurrent Costs&#13;
A. Operating Cost                       0.4      0.4      0.4      0.4      0.4      2.0&#13;
B. Supplies                             0.0      0.0      0.0      0.0      0.0     0.2&#13;
C. Prov. Superv. Cost                   0.0      0.0      0.0      0.0      0.0      0.2&#13;
D. Maintenance for Equipment            0.1      0.1      0.1      0.1      0.1     0.6&#13;
E. Maintenance for Civil Works          0.0      0.1      0.1      0.2      0.3     0.7&#13;
F. Staff Remuneration                   0.1      0.1      0.1      0.1      0.1      0.5&#13;
Total Recurrent Costs                     07                0.       1.      1.        4.&#13;
Total PROJECT COSTS                        4        7.       8.      77       6.      35.&#13;
&#13;
&#13;
&amp;#12;&#13;
Table 10-3: Expenditure Accounts by Component - Total Including Contingencies&#13;
Health Service Strengthen&#13;
National Programs                                  Essential&#13;
(US$ Million)                           TB    Malana  HIV/AIDS   Facility    Equipment &amp;       Drug    In-service       MOH&#13;
Control Control  Control  Upgrading  Transportation    Supply    Training   Strengthening   Total&#13;
I. Investment Costs&#13;
A. Equipmnent                           1.1      2.0       1.1          -             3.0          -           -            0.4      7.5&#13;
B. Drug                                   -      0.1         -          -               -        2.6           -              -      2.7&#13;
C.CivilWorks                            0.2      0.1       0.2       11.6               -          -           -            0.0    12.1&#13;
D0 Local Training                       0.7      0.3       0.8          -             0.0          -         0.2            0.2      2.2&#13;
E. Foreign Training                     0.3      0.1       0.3          -               -          -           -            0.0      0.8&#13;
F. Local Consultant                       -        -       0.2          -               -          -           -            0.4      0.6&#13;
G. Foreign Consultant                   0.1      0.2       0.9          -               -          -           -            1.0      2.2&#13;
H. Studies                              0.3      0.3       1.5          -               -          -                        0.4      2.5&#13;
I. Grant                                  -        -       0.7          -                    -           -                    -      0.7&#13;
Total Investment Costs                    2.7      3         5.        1                3.         2.          0.2            2.5    31.                     'D&#13;
11. Recurrent Costs&#13;
A. Operating Cost                       0.2      0.6       1.1          -               -          -           -            0.1      2.0&#13;
B. Supplies                             0.1        -       0.1          -               -          -           -              -      0.2&#13;
C. Prov. Superv. Cost                     -        -         -          -               -          -           -            0.2      0.2&#13;
D. Maintenance for Equipment            0.0      0.1       0.1          -             0.2          -           -            0.1      0.6&#13;
E. Maintenance for Civil Works          0.1        -       0.0        0.6               -          -           -            0.0      0.7&#13;
F. Staff Remuneration                   0.2      0.2       0.1          -               -          -           -              -      0.5&#13;
Total Recurrent Costs                     u6        .        106                        0.2          -           -            0.4    74.&#13;
Total PROJECT COSTS                                                                      3 32 7.  122  3.  2.   0              2. &#13;
&#13;
&#13;
&amp;#12;&#13;
Table 10-4: Expenditure Accounts by Component - Base Cost&#13;
Health Service Strengthen&#13;
National Programs                                Essential                                        Physical&#13;
(US$ Million)                 TB    Malarna  HIVIAIDS   Facility    Equipment &amp;    Drug    In-service      MOH                  Contingencies&#13;
Control Control  Control  Upgrading  Transportation   Supply    Training   Strengthening   Total     %    Amounr&#13;
1. Investnent Costs&#13;
A. Equipment                  1.0     1.8       1.0         -             2.7          -          -            0.3      6.8     5.0      0.3&#13;
B. Drug                        -      0.1         -         -               -        2.3          -              -      2.3     5.0      0.1&#13;
C. CivilWorks                 0.2     0.1       0.2       9.7               -          -          -            0.0    10.2      5.0      0.5&#13;
D. Local Training             0.6     0.2       0.7         -             0.0          -        0.2            0.2      1.9     4.9      0.1&#13;
E. Foreign Training           0.3     0.1       0.3         -               -          -          -            0.0      0.7     5.0      0.0&#13;
F. Local Consultant            -        -       0.2         -               -          -          -            0.3      0.5     4.6      0.0&#13;
G. Foreign Consultant         0.1     0.2       0.8         -               -          -          -            0.9      2.0     4.8      0.1&#13;
H. Studies                    0.3     0.3       1.3         -               -          -          -            0.4      2.3     2.6      0.1&#13;
I.Grant                        -        -       0.7         -               -          -          -              -      0.7       -        -&#13;
Total Investnent Costs          f.       7        5.     T .                2.7     2.            0.3    Z7.                      46&#13;
I. Recurrent Costs&#13;
A. Operating Cost             0.2     0.5       0.9         -               -          -          -            0.1      1.8     4.7      0.1&#13;
B. Supplies                  0.1        -       0.1         -               -          -          -              -      0.2     5.0      0.0&#13;
C. Prov. Superv. Cost          -        -         -         -               -          -          -            0.1      0.1     5.0      0.0&#13;
D. Maintenance for Equiprment  0.0    0.1       0.1         -             0.2          -          -            0.1      0.5     5.0      0.0&#13;
E. Maintenancefor Cil Work    0.1       -       0.0       0.5               -          -          -            0.0      0.6     5.0      0.0&#13;
F. Staff Remuneration         0.2     0.2       0.1         -               -          -          -              -      0.4     5.0      0.0&#13;
Total Recurrent Costs            5      03                  0.              0.2          -          -            0.3      3.6     4.       0&#13;
Total BASELINE COSTS            3        3.       65        1                2.9       Z.          0.             2.6    3.        47       1.&#13;
Physical Contingencies        0.1     0.2       0.3       0.5             0.1        0.1        0.0            0.1      1.4       -        -&#13;
Price Contingencies           0.2     0.3       0.5       1.5             0.2        0.2        0.0            0.2      3.1     4.8      0.1&#13;
Total PROJECT COSTS             3        4        7.        l Z.             3.2                                              -- -TZ  Z  3  5  1.&#13;
C)&#13;
&#13;
&#13;
&amp;#12;&#13;
-93 -                            Annex 10&#13;
Table 10-5: Projet Component by Financer&#13;
Intenatonal&#13;
Government of    Delopment&#13;
(US$ Milion)                              Cambodia        Asoclsaton          Total&#13;
Amoount   To   AMOUnt    T    Amount    %&#13;
A. Natonal Progrms&#13;
1. TB Control                           0.4    11.7      2.9    88.3      3.3      9.4&#13;
2. Malaria Control                       1.3    32.2      2.7    67.8      4.0    11.2&#13;
3. HIV/AIDS Control                      1.1    15.4      6.1    84.6     7.2    20.3&#13;
Subtotal Natonal Programs                  2.8    19.1 ----        8         4.     4.&#13;
B. Helth Service S btngthen&#13;
1. FacilIy Upgrading                     1.8    14.5    10.4    85.5    12.2    34.2&#13;
2. Equipment &amp; TransportlSon             0.2     6.7      3.0    93.3      3.2     9.0&#13;
3. Essontial Drug Supply                 0.0       -      2.6   100.0      2.6     7.3&#13;
4. In-seice Traning                      0.0       -      0.2   100.0      0.2     0.6&#13;
5. MOH Strengteing                       0.4    14.4      2.4    85.6      2.9     8.0&#13;
Subtotal Health Service Stre en            Z.4T- T       1X7    88.T   21.1 5T79.2&#13;
Total Disbursemnt                                                85.        35.    iW.o&#13;
&#13;
&#13;
&amp;#12;&#13;
- 94 -                                      Annex 11&#13;
KINGDOM OF CAMBODIA&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT PROJECT&#13;
Procurement and Disbursement Matrix&#13;
Contracts           Amount         Procurement Method     Approval        Disbursement&#13;
(US$)                                               Documentation&#13;
Civil Works              &lt; 50,000        Direct Contracting    Ex-post Review      SOE&#13;
&lt; 100,000       National Shopping    Ex-post Review       SOE&#13;
&gt; 100,000      National Competitive   Ex-post Review      SOE&#13;
Bidding&#13;
&gt; 200,000      National Competitive    Prior Review    Full Documentation&#13;
=__ __ __ ___ __ __  ___  Bidding  _&#13;
Goods &amp; Equipment        &lt; 25,000        National Shopping    Ex-post Review       SOE&#13;
&lt; 100,000      National Competitive   Ex-post Review      SOE&#13;
Bidding&#13;
&gt; 100,000          International     Prior Review    Full Documentation&#13;
________________ |Competitive Bidding&#13;
All Drugs               &lt; 100,000           International    Ex-post Review        SOE&#13;
Competitive Bidding&#13;
&gt; 100,000          International     Prior Review    Full Documentation&#13;
Competitive Bidding&#13;
Technical Assistance  Firms &lt; 100,000   Consultant Guidelines  Ex-post Review      SOE&#13;
Firms &gt; 100,000    Consultant Guidelines   Prior Review    Full Documentation&#13;
Individuals &lt; 50,000  Consultant Guidelines  Ex-post Review   SOE&#13;
Individuals &gt; 50,000  Consultant Guidelines   Prior Review    Full Documentation&#13;
Operating Expenses                       National Shopping    Ex-post Review       SOE&#13;
Provincial&#13;
Supervision                               Direct Contracts    Ex-post Review       SOE&#13;
E xpenses__            _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _  __ _ _ _ _ _ _ _ _&#13;
Grants              &lt;5,000                                   Ex-post Review        SOE&#13;
Grants              &gt;5,000                                    Prior Review  I Full Documentation&#13;
&#13;
&#13;
&amp;#12;&#13;
- 95 -                                  Annex 12&#13;
KINGDOM OF CAMBODIA&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT PROJECT&#13;
Disbursement Schedule and Profile&#13;
Fiscal   Calendar  EAP Reoion   Project&#13;
Semester   Year        Year       Average   Estimation&#13;
1st                 19w          U'O         U'/O&#13;
2nd      FY97                    3%          0%&#13;
1st                 1997         6%          7%&#13;
2nd      FY98                    14%         14%&#13;
1St                 1998        22%         26%&#13;
2nd      FY99                    30%/o       37%&#13;
1st                 1999        42%         49%&#13;
2nd      FY00                    50%         61%&#13;
1st                 2000        62%         72%&#13;
2nd      FY01                    74%         82%&#13;
1st                 2001        86%         91%&#13;
2nd      FY02                    94%        100%&#13;
1St                 2002        100%&#13;
Dibursment Profile&#13;
100%&#13;
90%  i&#13;
80%.&#13;
70% _x&#13;
*60%&#13;
E  40%                                                          -O-Esm   j&#13;
20%&#13;
10% &#13;
Calendar Year&#13;
&#13;
&#13;
&amp;#12;&#13;
-96-                                 Annex1&#13;
KINGDOM OF CAMBODIA&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT PROJECT&#13;
Pre   mpm            Schedule&#13;
1.    The project is complex with a number of organizations involved and&#13;
organizational units within the MOH. All the implementation managers will have to&#13;
manage many of their respective responsibilities cooperatively as there are many&#13;
interdependent tasks.&#13;
2.    The Project Implementation Plan, Volume 1, contains a Summary Project&#13;
Workplan. This contains only the major tasks which must be performed during the first&#13;
year of this Project. Note that for all 11 sub-components, the tasks total to 1086 separate&#13;
steps, an indication of the importance of project management software to assist in project&#13;
management. The Project Coordination Unit will update the summary workplan based on&#13;
inputs from the component managers in the MOH and provincial Health Directorates.&#13;
3.    The major headings of the workplan in the Project Implementation Plan are&#13;
"Summary" tasks. In fact most all entries in this presentation are a summary of more&#13;
detailed tasks, and these can be found also in the Project Implementation Plan, Volume 1,&#13;
as part of each component's chapter. These were prepared by the Ministry of Health with&#13;
training from the World Bank task team. The World Bank will refer to the baseline&#13;
workplans for the purposes of project supervision.&#13;
4. ,  The workplans prepared for the PIP is part of a process designed to be part of the&#13;
Health Management Agreement annual formulation (see Annex 8), and the tasks agreed&#13;
and negotiated will fit into revised workplans by component.&#13;
&#13;
&#13;
&amp;#12;&#13;
- 97 -                           Annex 14&#13;
KINGDOM OF CAMBODIA&#13;
DISEASE CONTROL AND HEALTH DEVELOPMENT PROJECT&#13;
IDA SUPERVISION PLAN&#13;
1.   IDA Supervision lrpul. The staff input indicated in the table below is in addition to&#13;
regular supervision needs for the review of progress reports, procurement actions, supervision&#13;
report preparation and correspondence (estimated for this project to require six staff weeks&#13;
per year throughout implementation).&#13;
2.    Borrower's Contribution to Supervision&#13;
(a)   Annual work plans and budgets for the project, including the Health&#13;
Management Agreements, would be prepared by each central MOH&#13;
department and institute responsible for implementing specific project&#13;
activities, and each participating province. The plans and budgets of the&#13;
central departments/institutes would be reviewed by the appropriate technical&#13;
and financial staff of the MOH and the Project Coordination Unit (PCU). The&#13;
supervision plans of the provinces would be reviewed by the Project Director&#13;
and PCU, and would be agreed upon between the PCU and the provinces. The&#13;
MOH, PCU and the participating provinces would also be responsible for&#13;
negotiating the Health Management Agreements.&#13;
(b)   Semi-annual reports would be prepared by the PCU in a format to be agreed&#13;
upon with IDA during the project launch mission. The reports would:&#13;
(i) include a concise, narrative section describing major project achievements&#13;
and problems encountered; and (ii) utilize a simple, tabular account to show&#13;
details of actual accomplishments compared to agreed upon plans. The initial&#13;
progress report would be due on June 30, 1997, with successive reports due on&#13;
December 31 and June 30 of each year until project completion. The reports&#13;
would constitute the basis for the semi-annual project performance reviews to&#13;
be conducted by the Government and IDA.&#13;
(c)   Monitoring and reporting of implementation progress in accordance with the&#13;
annual plans would be the responsibility of the PC, with inputs from the&#13;
relevant MOH departments/institutes and the provincial project units. The&#13;
PCU would also be responsible for organizing annual workshops to review&#13;
implementation progress with provinces, which would be timed to support the&#13;
annual updating of the Health Management Agreements.&#13;
(d)   The PCU would be responsible for coordinating arrangements for supervision&#13;
missions, and for providing information required by missions. Mission&#13;
briefings upon arrival and wrap-up meetings would be presided over by the&#13;
Project Director or a designated representative.&#13;
&#13;
&#13;
&amp;#12;&#13;
-98-                                e14&#13;
(e)   The PCU would prepare and submit to IDA within six months of the Closing&#13;
Date, a final evaluation report on the project and a plan for the future&#13;
operation of the completed project.&#13;
3.    Field Supervision Plan&#13;
Approximate Dates                  Activity                    Staff Inputs&#13;
(staff-weeks)&#13;
07/96       Project launch/initial supervision mission       6&#13;
12/97       Semi-annual review mission                       6&#13;
06/97       Semi-annual review mission                       4&#13;
12/97       Semi-annual review mission                       6&#13;
06/98       Semi-annual review mission                       4&#13;
12/98       Semi-annual review mission                       6&#13;
06/99       Mid-term review mission                          8&#13;
12/99       Semi-annual review mission                       4&#13;
06/00       Semi-annual review mission                       6&#13;
12/00       Semi-annual review mission                       4&#13;
06/01.      Semi-annual review mission                       6&#13;
12/01       Semi-annual review mission                       6&#13;
06/02       Final supervision/ICR mission                    8&#13;
Note: ICR = Implementation Completion Report&#13;
(a)   Semi-annual reviews of project performance would be normally held in June&#13;
and December of each year to assess progress in project implementation.&#13;
(b)-   A comprehensive mid-term review would be completed on June 30, 1999 to&#13;
determine any need for modification to the design and implementation targets&#13;
of all project components.&#13;
(c)   Each IDA supervision mission would: (i) require at least two weeks in the&#13;
field; (ii) the services of specialists in public health including disease control,&#13;
civil works, and project management/implementation on a regular basis; and&#13;
(iii) review progress of procurement, financial statements and disbursements,&#13;
Credit covenants and the implementation of technical assistance and training&#13;
activities. Specialized skill requirements would be added to the missions&#13;
according to needs identified by previous supervision missions and would&#13;
include, among others, the following: malaria, TB and HIV/AIDS control&#13;
programs, health financing, grant administration, outreach program&#13;
strengthening, health center commissioning and sample survey methodologies.&#13;
&#13;
&#13;
&amp;#12;&#13;
-99-                           Annex 15&#13;
Selected Documents Available in the Project File&#13;
1.    Ministry of Health. National Health Development Plan 1994-1996. Prepared by&#13;
Planning Unit, Ministry of Health in June 1994.&#13;
2.    Ministry of Health. Guide for the Strengthening of the District Health System in&#13;
Cambodia. Prepared by the Planning Unit, MOH in May 1995.&#13;
3.    Ministry of Health.  National Tuberculosis Programme Plan 1993-1997.&#13;
November 1993.&#13;
4.    Ministry of Health. National Malaria Control Programme: Summarv of Activities&#13;
1996-2000. Prepared by National Malaria Center and WHO, Phnom Penh in 1995.&#13;
5.    Ministry of Health. Comprehensive National Plan for AIDS Prevention and&#13;
Control in Cambodia 1993-1998. Prepared by the National AIDS Committee in 1993.&#13;
6.    Ministry of Health. Essential Drugs Progress Report: January - June 1995.&#13;
Prepared by the Pharmaceutical Department in July 1995.&#13;
7.   Institute of Khmer Habitat. Disease Control and Health Development Project:&#13;
Design Model for Health Center and Referral Hospital. March 1996.&#13;
8.    Bowman, C. Disease Control and Health Development Project: Civil Works Sub-&#13;
component. March 1996.&#13;
9.    Braden, C.  Disease Control and Health Development Project: Cambodia&#13;
Tuberculosis Control Study. March 1995&#13;
10.   Champeaux, A. Disease Control and Health Development Project: Tuberculosis&#13;
Patients Food Supplementation: Evaluation of Utility. April 1996.&#13;
11.   Hill, J. Disease Control and Health Development Project: Implementation Plan&#13;
for Mosquito Net Distribution and Treatment. December 1995.&#13;
12.   Population Services International. Disease Control and Health Development&#13;
Project: Feasibility Study for the Distribution and Marketing of Impregnated Mosquito&#13;
Nets (IMNs) and Retreatment Services for Malaria Prevention in Cambodia. April 1996.&#13;
13.   Colin, A and Adam, G. Disease Control and Health Development Project:&#13;
HIV/AIDS in Cambodia: An Outline Strategy for IEC. Prepared by Health Unlimited in&#13;
March 1996.&#13;
14.   Herm, J. Disease Control and Health Development Project: Organization and&#13;
Management Component Report. August 1995.&#13;
&#13;
&#13;
&amp;#12;&#13;
-100 -                          Annex 15&#13;
15.   Oppenheimer, E.  A Rapid Assessment of Drug Abuse in Cambodia and&#13;
Concomitant HIV Risk Behaviors. November 1995.&#13;
16.   Dunn, J. Demographic Working Practices and AIDS Awareness of Commercial&#13;
Sex Workers in Tuol Kork Dike Area, Phnom Penh. Cambodia. April 1995.&#13;
17.   Asian Development Bank. Basic Health Services Project. Prepared by Technical&#13;
Assistance team in September 1995.&#13;
18.   Put, W. Emptv Hospitals. Thriving Business: Utilization of Health Services and&#13;
Health Seeking Behavior in Two Cambodian Districts. April 1992.&#13;
&#13;
&#13;
&amp;#12;&#13;
IBRD 27986&#13;
THAILAND             ,,)                                            'LAO  PEOPLE'S DEM. REP.          'CAMBODIA&#13;
&lt;   f   ;   ~~~~~~~~~  _tX                 rS ~~~~~~~~PROJECT&#13;
7 tS                                             k                     ARC                        X                      !0Chet=_,~~~~IEMEA-ODARVIEA&#13;
T. 8_9                                                       Ph-| Thr 9                                I                                     AD A,&lt;- PRVN-E UNE T HEN &#13;
't              MEA_CHEY                                                                                                  BASIC/ HEAVLVIETNM  'aS P.DOR.CT&#13;
W \-- gf v WA D ) \ 2~~&#13;
J ~     ~ MEN7E      *                                                                                                         SELECTEAK      2-t .      :BDI C&#13;
SioonouwilleC  &lt;  )_  L  &gt;&gt; - --- ) EjPhA _~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~PRVICECAITL&#13;
I~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~TN                               TRN                                                 AIOA CAI _&amp; -,._TA'Lo,&#13;
0~~~~~~- S2 T50 Mie              0                                                                                                       hRUINS&#13;
&#13;
&#13;
&amp;#12;&#13;
&#13;
&#13;
&amp;#12;&#13;
&#13;
&#13;
&amp;#12;&#13;
IMAGING&#13;
Report No:       15596 KH&#13;
Type: SAR&#13;
&#13;
&#13;
&amp;#12;&#13;
</ml:original-txt><ml:search-metadata><doc id="696128">
        <url>
            http://documents.worldbank.org/curated/en/1996/11/696128/cambodia-disease-control-health-development-project
        </url>
        <availablein>English</availablein>
        <url_friendly_title>http://documents.worldbank.org/curated/en/1996/11/696128/cambodia-disease-control-health-development-project</url_friendly_title>
        <new_url>1996/11/696128/cambodia-disease-control-health-development-project</new_url>
        <disclosure_date>2010-07-01T00:00:00Z</disclosure_date>
        <disclosure_type>NA</disclosure_type>
        <ext_pub_date>2010-07-01T00:00:00Z</ext_pub_date>
        <disclstat>Disclosed</disclstat>
        <txturl>http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/1996/11/15/000009265_3970311113909/Rendered/INDEX/multi0page.txt</txturl>
        <pdfurl>http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/1996/11/15/000009265_3970311113909/Rendered/PDF/multi0page.pdf</pdfurl>
        <credit_no>P997;N005</credit_no>
        <datestored>2001-04-21T00:00:00Z</datestored>
        <docdt>1996-11-15T00:00:00Z</docdt>
        <totvolnb>1</totvolnb>
        <versiontyp>Final</versiontyp>
        <versiontyp_key>1309935</versiontyp_key>
        <volnb>1</volnb>
        <repnme>
            Cambodia - Disease Control and Health
            Development Project
        </repnme>
        <abstracts>
            The Disease Control and Health
            Development Project will support the Government of Cambodia
            in pursuing two of its principal health sector objectives:
            a) reduce death and sickness from preventable disease; and
            b) rehabilitate the health system infrastructure. To achieve
            these objectives, the project will have two components.
            National Program Support for the malaria, tuberculosis and
            HIV/AIDS control programs including provision of: a) drugs
            and laboratory supplies; b) impregnated bednets; c)
            training; d) logistical support; and e) technical
            assistance. Basic health strengthening including investments
            in: a) reconstruction and rehabilitation of first and
            referral level facilities; b) medical equipment and
            furniture; c) essential drugs; d) in-service training; and
            e) Ministry of Health (MOH) strengthening.
        </abstracts>
        <docna>
            Cambodia - Disease Control and Health
            Development Project
        </docna>
        <display_title>Cambodia - Disease Control and
            Health Development Project</display_title>
        <listing_relative_url>/projects/documents/1996/11/696128/cambodia-disease-control-health-development-project</listing_relative_url>
        <projn>KH-Disease Control And Health Development
            Project -- P004034</projn>
        <docty>Staff Appraisal Report</docty>
        <subtopic>Health Monitoring &amp; Evaluation,Agricultural Knowledge and Information Systems,Housing &amp; Human Habitats,Health Systems Development &amp; Reform,Adolescent Health</subtopic>
        <teratopic>Health, Nutrition and Population</teratopic>
        <count>Cambodia</count>
        <geo_region_mdks>
            <geo_region_mdk>World!$!80475</geo_region_mdk>
            <geo_region_mdk>Asia!$!80451</geo_region_mdk>
            <geo_region_mdk>Southeast Asia!$!80471</geo_region_mdk>
        </geo_region_mdks>
        <entityids>
            <entityid>000009265_3970311113909</entityid>
        </entityids>
        <subsc>Health,Central government administration</subsc>
        <admreg>East Asia and Pacific,East Asia and Pacific</admreg>
        <colti>World Development Sources, WDS 1996</colti>
        <lang>English</lang>
        <historic_topic>Health, Nutrition and Population</historic_topic>
        <sectr>(Historic)Health, Nutrition &amp; Population</sectr>
        <majdocty>Project Documents</majdocty>
        <keywd>
            Acquired Immune Deficiency Syndrome; Disease
            control; Furniture; Health; Health care facilities;
            Laboratories; Malaria; Medical equipment; Medical supplies;
            Nongovernmental organizations; Pharmaceuticals; Training; Tuberculosis
            accurate diagnosis,acute respiratory
            infections,AIDS Control,Basic Health
            Services,beds,births,blood donors,burden of disease,care
            providers,chemotherapy,child health,clinical
            services,clinics,communicable
            diseases,communities,condoms,cost effectiveness,curative
            health care,deaths,Disease Control,district
            hospital,districts,doctors,drug sellers,DRUG SUPPLY,drug
            trafficking,drug treatment,drug use,epidemiological
            data,epidemiology,essential drugs,expenditures,family
            planning,HEALTH CENTERS,Health conditions,health
            education,health facilities,health institutions,health
            needs,Health Policy,health programs,health sector,HEALTH
            SERVICES,health system,health workers,heart disease,HIV
            infection,hospital
            services,hospitalization,HOSPITALS,households,human
            immunodeficiency virus,Immunization,immunodeficiency,infant
            mortality,infant mortality
            rate,infants,injuries,integration,intervention,isolation,laboratories,laboratory
            equipment,laboratory services,low income,Malaria,malaria
            treatment,Maternal health,maternal mortality,medical
            care,MEDICAL EQUIPMENT,medical personnel,MEDICAL
            SUPPLIES,medical
            technologies,medicines,morbidity,mortality,National
            Health,NGOs,nutrition,outpatient clinic,patient care,patient
            compliance,patients,pharmacies,population
            distribution,pregnant women,preventive health,preventive
            health services,Primary care,primary health care,primary
            health care services,private sector,prostitutes,Public
            Health,public hospitals,quality of health
            care,radiology,rehabilitation,risk behaviors,risk
            groups,Risk of Infection,rural areas,rural
            communities,safety,sexually transmitted diseases,social
            marketing,STDs,Treatment of malaria,victims,workers,young
            adults,young men
        </keywd>
        <owner>Human Development Sector Dept (EASHD)</owner>
        <geo_regions>
            <geo_region>World</geo_region>
            <geo_region>Asia</geo_region>
            <geo_region>Southeast Asia</geo_region>
        </geo_regions>
        <trustfund>TF026599-JSDF-CAMBODIA: ENHANCING NGO
            PARTICIPATION IN HIV/AIDS PREVENTION AND C,TF039609-CAMBODIA:  DISEASE CONTROL
            &amp; HEALTH DEVELOPMENT PROJECT,TF036935-CAMBODIA - DISEASE CONTROL AND
            HEALTH DEV.,TF036602-LAO PDR - THE NAM THEUN SOCIAL
            AND ENVIRONMENTAL PROJECT,TF036085-CAMBODIA - DISEASE CONTROL AND
            HEALTH DEVELOPMENT PROJECT,TF034298-CAMBODIA - DISEASE CONTROL PROJECT,TF029261-PHRD-DISEASE CONTROL &amp;
            HEALTH DEVELOPMENT PROJECT --,TF029390-PHRD-DISEASE CONTROL &amp;
            HEALTH DEVELOPMENT PROJECT --</trustfund>
        <repnb>15596</repnb>
    </doc></ml:search-metadata><ml:annotations><ml:concepts><ml:concept>Finance and Development</ml:concept><ml:concept>Finance and Financial Sector Development</ml:concept><ml:concept>Teaching and Learning</ml:concept><ml:concept>Environment</ml:concept><ml:concept>General Public Administration Sector</ml:concept><ml:concept>Governance and Public Sector Management</ml:concept><ml:concept>Government</ml:concept><ml:concept>Institutions</ml:concept><ml:concept>Public Administration</ml:concept><ml:concept>Public Sector Development</ml:concept><ml:concept>Public Sector Management and Reform</ml:concept><ml:concept>Public Sector and Governance</ml:concept><ml:concept>Social Protections and Labor</ml:concept><ml:concept>Financial Sector Development</ml:concept><ml:concept>Private Sector Development</ml:concept><ml:concept>Education</ml:concept><ml:concept>Environment and Natural Resources</ml:concept><ml:concept>Health, Nutrition and Population</ml:concept><ml:concept>Public Sector Management</ml:concept><ml:concept>Social Protection and Labor</ml:concept><ml:concept>Health Monitoring and Evaluation</ml:concept><ml:concept>Human Resource Management Capacities</ml:concept><ml:concept>Human Resource Management Systems</ml:concept><ml:concept>Staffing Needs Assessments</ml:concept><ml:concept>Delivery of Health Care</ml:concept><ml:concept>Health Care Delivery</ml:concept><ml:concept>Health Service Management and Delivery</ml:concept><ml:concept>Health Systems</ml:concept><ml:concept>Medical Supplies, Drugs</ml:concept><ml:concept>Pharmaceutical Industry</ml:concept><ml:concept>Medical Devices</ml:concept><ml:concept>Communicable Diseases</ml:concept><ml:concept>AIDS HIV</ml:concept><ml:concept>HIV AIDS</ml:concept><ml:concept>HIV/AIDS</ml:concept><ml:concept>Nutritional supplements</ml:concept><ml:concept>Vitamins</ml:concept><ml:concept>Vaccines</ml:concept><ml:concept>Behavior Change Communication</ml:concept><ml:concept>HRH</ml:concept><ml:concept>Health Labor</ml:concept><ml:concept>Health Workers</ml:concept><ml:concept>Demographics</ml:concept><ml:concept>Management of Public Finance</ml:concept><ml:concept>Public Finance Management</ml:concept><ml:concept>Public Finances</ml:concept><ml:concept>Public Sector Economics</ml:concept><ml:concept>Public Sector Economics &amp; Finance</ml:concept><ml:concept>Analysis &amp; Monitoring</ml:concept><ml:concept>Delivery Units</ml:concept><ml:concept>Grievance Redress</ml:concept><ml:concept>Indicators</ml:concept><ml:concept>M&amp;E</ml:concept><ml:concept>Performance Measurement</ml:concept><ml:concept>Performance Reviews</ml:concept><ml:concept>Rapid Results Approaches</ml:concept><ml:concept>Health Monitoring &amp; Evaluation</ml:concept><ml:concept>Banking</ml:concept><ml:concept>Human Resources</ml:concept><ml:concept>Health Services Delivery</ml:concept><ml:concept>Pharmaceuticals</ml:concept><ml:concept>Medical Equipment</ml:concept><ml:concept>Diseases</ml:concept><ml:concept>Communicable Disease</ml:concept><ml:concept>HIV and AIDS</ml:concept><ml:concept>Tuberculosis</ml:concept><ml:concept>Malaria</ml:concept><ml:concept>Supplements</ml:concept><ml:concept>Immunizations</ml:concept><ml:concept>Health Education</ml:concept><ml:concept>Forests</ml:concept><ml:concept>Prevention</ml:concept><ml:concept>Infrastructure</ml:concept><ml:concept>Human Resources for Health</ml:concept><ml:concept>Public Health</ml:concept><ml:concept>Population</ml:concept><ml:concept>Public Finance</ml:concept><ml:concept>Monitoring and Evaluation</ml:concept><ml:concept>Negotiation</ml:concept></ml:concepts><ml:geo-regions><ml:geo-region>Asia</ml:geo-region><ml:geo-region>Cambodia</ml:geo-region><ml:geo-region>Eastern Asia</ml:geo-region></ml:geo-regions></ml:annotations></ml:doc-envelope>